{"parse":{"title":"Epoxyeicosatrienoic acid","pageid":4367754,"revid":845144300,"text":{"*":"<div class=\"mw-parser-output\"><div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:352px;\"><a href=\"/wiki/File:Epoxyeicosatrienoic_acid.png\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/ce/Epoxyeicosatrienoic_acid.png/350px-Epoxyeicosatrienoic_acid.png\" width=\"350\" height=\"39\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/ce/Epoxyeicosatrienoic_acid.png/525px-Epoxyeicosatrienoic_acid.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/ce/Epoxyeicosatrienoic_acid.png/700px-Epoxyeicosatrienoic_acid.png 2x\" data-file-width=\"3369\" data-file-height=\"378\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Epoxyeicosatrienoic_acid.png\" class=\"internal\" title=\"Enlarge\"></a></div>Chemical structure of 14,15-epoxyeicosatrienoic acid.</div></div></div>\n<p>The <b>epoxyeicosatrienoic acids</b> or <b>EETs</b> are signaling molecules formed within various types of cells by the metabolism of <a href=\"/wiki/Arachidonic_acid\" title=\"Arachidonic acid\">arachidonic acid</a> by a specific subset of <a href=\"/wiki/Cytochrome_P450\" title=\"Cytochrome P450\">Cytochrome P450</a> enzymes termed cytochrome P450 <a href=\"/wiki/Epoxygenase\" title=\"Epoxygenase\">epoxygenases</a>.<sup id=\"cite_ref-boron108_1-0\" class=\"reference\"><a href=\"#cite_note-boron108-1\">&#91;1&#93;</a></sup>  These <a href=\"/wiki/Nonclassic_eicosanoid\" title=\"Nonclassic eicosanoid\">nonclassic eicosanoids</a> are generally short-lived, being rapidly converted from epoxides to less active or inactive dihydroxy-eicosatrienoic acids (diHETrEs) by a widely distributed cellular enzyme, <a href=\"/wiki/Soluble_epoxide_hydrolase\" class=\"mw-redirect\" title=\"Soluble epoxide hydrolase\">Soluble epoxide hydrolase</a> (sEH), also termed Epoxide hydrolase 2.  The EETs consequently function as transiently acting, short-range <a href=\"/wiki/Hormone\" title=\"Hormone\">hormones</a>; that is, they work locally to regulate the function of the cells that produce them (i.e. they are <a href=\"/wiki/Autocrine_signalling\" title=\"Autocrine signalling\">autocrine</a> agents) or of nearby cells (i.e. they are <a href=\"/wiki/Paracrine_signalling\" title=\"Paracrine signalling\">paracrine</a> agents). The EETs have been most studied in animal models where they show the ability to lower blood pressure possibly by <b>a)</b> stimulating arterial <a href=\"/wiki/Vasodilator\" class=\"mw-redirect\" title=\"Vasodilator\">vasorelaxation</a> and <b>b)</b> inhibiting the kidney's retention of salts and water to decrease intravascular blood volume.  In these models, EETs prevent arterial occlusive diseases such as <a href=\"/wiki/Heart_attack\" class=\"mw-redirect\" title=\"Heart attack\">heart attacks</a> and <a href=\"/wiki/Brain_stroke\" class=\"mw-redirect\" title=\"Brain stroke\">brain strokes</a> not only by their anti-hypertension action but possibly also by their <a href=\"/wiki/Anti-inflammatory\" title=\"Anti-inflammatory\">anti-inflammatory</a> effects on blood vessels, their inhibition of platelet activation and thereby blood clotting, and/or their promotion of <a href=\"/wiki/Fibrinolysis\" title=\"Fibrinolysis\">pro-fibrinolytic</a> removal of blood clots.<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup> With respect to their effects on the heart, the EETs are often termed cardio-protective. Beyond these cardiovascular actions that may prevent various <a href=\"/wiki/Cardiovascular_diseases\" class=\"mw-redirect\" title=\"Cardiovascular diseases\">cardiovascular diseases</a>, studies have implicated the EETs in the pathological growth of certain types of cancer and in the physiological and possibly pathological perception of <a href=\"/wiki/Neuropathic_pain\" title=\"Neuropathic pain\">neuropathic pain</a>.  While studies to date imply that the EETs, EET-forming epoxygenases, and EET-inactivating sEH can be manipulated to control a wide range of human diseases, clinical studies have yet to prove this.  Determination of the role of the EETS in human diseases is made particularly difficult because of the large number of EET-forming epoxygenases, large number of epoxygenase substrates other than arachidonic acid, and the large number of activities, some of which may be pathological or injurious, that the EETs possess.<sup id=\"cite_ref-Front_Pharmacol_2014_3-0\" class=\"reference\"><a href=\"#cite_note-Front_Pharmacol_2014-3\">&#91;3&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Structure\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Structure</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Production\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Production</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Metabolism_of_EETs\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Metabolism of EETs</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Biological_effects\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Biological effects</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Clinical_significance\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Clinical significance</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-6\"><a href=\"#Regulation_of_blood_pressure\"><span class=\"tocnumber\">5.1</span> <span class=\"toctext\">Regulation of blood pressure</span></a></li>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#Heart_disease\"><span class=\"tocnumber\">5.2</span> <span class=\"toctext\">Heart disease</span></a></li>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Strokes_and_seizures\"><span class=\"tocnumber\">5.3</span> <span class=\"toctext\">Strokes and seizures</span></a></li>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#Portal_hypertension\"><span class=\"tocnumber\">5.4</span> <span class=\"toctext\">Portal hypertension</span></a></li>\n<li class=\"toclevel-2 tocsection-10\"><a href=\"#Cancer\"><span class=\"tocnumber\">5.5</span> <span class=\"toctext\">Cancer</span></a></li>\n<li class=\"toclevel-2 tocsection-11\"><a href=\"#Inflammation\"><span class=\"tocnumber\">5.6</span> <span class=\"toctext\">Inflammation</span></a></li>\n<li class=\"toclevel-2 tocsection-12\"><a href=\"#Diabetes,_non-alcoholic_fatty_liver_disease,_and_kidney_disease\"><span class=\"tocnumber\">5.7</span> <span class=\"toctext\">Diabetes, non-alcoholic fatty liver disease, and kidney disease</span></a></li>\n<li class=\"toclevel-2 tocsection-13\"><a href=\"#Pain\"><span class=\"tocnumber\">5.8</span> <span class=\"toctext\">Pain</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-14\"><a href=\"#References\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Structure\">Structure</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxyeicosatrienoic_acid&amp;action=edit&amp;section=1\" title=\"Edit section: Structure\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>EETS are <a href=\"/wiki/Epoxide\" title=\"Epoxide\">epoxide</a> eicosatrienoic acid metabolites of <a href=\"/wiki/Arachidonic_acid\" title=\"Arachidonic acid\">arachidonic acid</a> (a straight chain <a href=\"/wiki/Eicosatetraenoic_acid\" title=\"Eicosatetraenoic acid\">Eicosatetraenoic acid</a>, <a href=\"/wiki/Omega-6_fatty_acid\" title=\"Omega-6 fatty acid\">omega-6 fatty acid</a>).  Arachidonic acid has 4 cis <a href=\"/wiki/Double_bond\" title=\"Double bond\">double bonds</a> (see <a href=\"/wiki/Cis%E2%80%93trans_isomerism\" title=\"Cis\u2013trans isomerism\">Cis\u2013trans isomerism</a> which are abbreviated with the notation <i>Z</i> in the IUPAC <a href=\"/wiki/Chemical_nomenclature\" title=\"Chemical nomenclature\">Chemical nomenclature</a> used here. These double bonds are located between carbons 5-6, 8-9, 11-12, and 14-15; arachidonic acid is therefore 5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>-eicosatetraenoic acid. Cytochrome P450 epoxygenases attack these double bonds to form their respective eicosatrienoic acid epoxide regioisomers (see <a href=\"/wiki/Structural_isomer\" title=\"Structural isomer\">Structural isomer</a>, section on position isomerism (regioisomerism)) viz., 5,6-EET (i.e. 5,6-epoxy-8<i>Z</i>,11<i>Z</i>,14<i>Z</i>-eicosatrienoic acid), 8,9-EET (i.e. 5,6-epoxy-8<i>Z</i>,11<i>Z</i>,14<i>Z</i>-eicosatrienoic acid), 11,12-EET (i.e. 11,12-epoxy-5<i>Z</i>,8<i>Z</i>,14<i>Z</i>-eicosatrienoic acid), or, as drawn in the attached figure, 14,15-EET (i.e. 14,15-epoxy-5<i>Z</i>,8<i>Z</i>,11<i>Z</i>-eicosatrienoic acid). The enzymes generally form both <i>R</i>/<i>S</i> <a href=\"/wiki/Enantiomers\" class=\"mw-redirect\" title=\"Enantiomers\">enantiomers</a> at each former double bond position; for example, cytochrome P450 epoxidases metabolize arachidonic acid to a mixture of 14<i>R</i>,15<i>S</i>-EET and 14<i>S</i>,15<i>R</i>-EET.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_4-0\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-4\">&#91;4&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Production\">Production</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxyeicosatrienoic_acid&amp;action=edit&amp;section=2\" title=\"Edit section: Production\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The cytochrome P450 (CYP) superfamily of enzymes is distributed broadly throughout bacteria, <a href=\"/wiki/Archaea\" title=\"Archaea\">archaea</a>, fungi, plants, animals, and even viruses (see <a href=\"/wiki/Cytochrome_P450\" title=\"Cytochrome P450\">Cytochrome P450</a>).  The superfamily comprises more than 11,000 genes categorized into 1,000 families. Humans have 57 putatively active CYP genes and 58 CYP <a href=\"/wiki/Pseudogenes\" class=\"mw-redirect\" title=\"Pseudogenes\">pseudogenes</a>; only a relatively few of the active CYP genes code for EET-forming epoxygenases, i.e. protein enzymes with the capacity to attach atomic oxygen (see <a href=\"/wiki/Allotropes_of_oxygen#Atomic_oxygen\" title=\"Allotropes of oxygen\">Allotropes of oxygen#Atomic oxygen</a>) to the carbon-carbon double bonds of unsaturated long chain fatty acids such as arachidonic acid.<sup id=\"cite_ref-Pharmacol_Ther_2014_5-0\" class=\"reference\"><a href=\"#cite_note-Pharmacol_Ther_2014-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-ReferenceB_6-0\" class=\"reference\"><a href=\"#cite_note-ReferenceB-6\">&#91;6&#93;</a></sup> The CYP epoxygenases fall into several subfamilies including CYP1A, CYP2B, CYP2C, CYP2E, CYP2J, and within the CYP3A sub family, <a href=\"/wiki/CYP3A4\" title=\"CYP3A4\">CYP3A4</a>; in humans, <a href=\"/wiki/CYP2C8\" title=\"CYP2C8\">CYP2C8</a>, <a href=\"/wiki/CYP2C9\" title=\"CYP2C9\">CYP2C9</a>, <a href=\"/wiki/CYP2C19\" title=\"CYP2C19\">CYP2C19</a>, <a href=\"/wiki/CYP2J2\" title=\"CYP2J2\">CYP2J2</a>, and possibly <a href=\"/wiki/CYP2S1\" title=\"CYP2S1\">CYP2S1</a> <a href=\"/wiki/Isoforms\" class=\"mw-redirect\" title=\"Isoforms\">isoforms</a> are the main producers of EETs although <a href=\"/wiki/CYP2C9\" title=\"CYP2C9\">CYP2C9</a>, <a href=\"/wiki/CYP2C18\" title=\"CYP2C18\">CYP2C18</a>, <a href=\"/wiki/CYP3A4\" title=\"CYP3A4\">CYP3A4</a>, <a href=\"/wiki/CYP4A11\" title=\"CYP4A11\">CYP4A11</a>, <a href=\"/wiki/CYP4F8\" title=\"CYP4F8\">CYP4F8</a>, and <a href=\"/wiki/CYP4F12\" title=\"CYP4F12\">CYP4F12</a> are capable of producing the EETs and may do so in certain tissues.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_4-1\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-4\">&#91;4&#93;</a></sup><sup id=\"cite_ref-Pharmacol_Ther_2014_5-1\" class=\"reference\"><a href=\"#cite_note-Pharmacol_Ther_2014-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup><sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup> The CYP epoxygenases can epoxidize any of the double bounds in arachidonic acid but most of them are relatively selective in that they make appreciable amounts of only one or two EETs with 11,12-EET and 14,15-EET accounting for 67%-80% of the product made by the cited CYP epoxidases as well as the main EETs made by mammalian tissues.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_4-2\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-4\">&#91;4&#93;</a></sup>  CYP2C9, CYP2JP, and possibly the more recently characterized CYP2S1 appear to be the main produces of the EETs in humans with CYPP2C9 being the main EET producer in vascular endothelial cells and CYP2JP being highly expressed (although less catalytically active than CYP2C) in heart muscle, kidneys, pancreas, lung, and brain.<sup id=\"cite_ref-ReferenceA_9-0\" class=\"reference\"><a href=\"#cite_note-ReferenceA-9\">&#91;9&#93;</a></sup>  CYP2S1 is expressed in <a href=\"/wiki/Macrophages\" class=\"mw-redirect\" title=\"Macrophages\">macrophages</a>, liver, lung, intestine, and spleen and is abundant in human and mouse <a href=\"/wiki/Atherosclerosis\" title=\"Atherosclerosis\">atherosclerosis</a> (i.e. <a href=\"/wiki/Atheroma\" title=\"Atheroma\">Atheroma</a>) plaques as well as inflamed tonsils.<sup id=\"cite_ref-ReferenceB_6-1\" class=\"reference\"><a href=\"#cite_note-ReferenceB-6\">&#91;6&#93;</a></sup>\n</p><p>ETEs are commonly produced by the stimulation of specific cell types.  The stimulation causes arachidonic acid to be released from the <i>sn-2</i> position of cellular <a href=\"/wiki/Phospholipid\" title=\"Phospholipid\">phospholipids</a> through the action of  <a href=\"/wiki/Phospholipase_A2\" title=\"Phospholipase A2\">Phospholipase A2</a>-type enzymes and subsequent attack of the released arachidonic acid by a CYP epoxidase.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_4-3\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-4\">&#91;4&#93;</a></sup>  In a typical example of this mechanism, <a href=\"/wiki/Bradykinin\" title=\"Bradykinin\">bradykinin</a> or <a href=\"/wiki/Acetylcholine\" title=\"Acetylcholine\">acetylcholine</a> acting through their respective <a href=\"/wiki/Bradykinin_receptor_B2\" title=\"Bradykinin receptor B2\">Bradykinin receptor B2</a> and <a href=\"/wiki/Muscarinic_acetylcholine_receptor_M1\" title=\"Muscarinic acetylcholine receptor M1\">muscarinic acetylcholine receptor M1</a> or <a href=\"/wiki/Muscarinic_acetylcholine_receptor_M3\" title=\"Muscarinic acetylcholine receptor M3\">muscarinic acetylcholine receptor M3</a> stimulate vascular endothelial cells to make and release EETs.<sup id=\"cite_ref-ReferenceA_9-1\" class=\"reference\"><a href=\"#cite_note-ReferenceA-9\">&#91;9&#93;</a></sup>\n</p><p>The CYP epoxygenases, similar to essentially all CYP450 enzymes, are involved in the metabolism of diverse <a href=\"/wiki/Xenobiotics\" class=\"mw-redirect\" title=\"Xenobiotics\">xenobiotics</a> and natural compounds.  Since many of these same compounds also induce increases in the levels of the epoxygenases, CYP oxygenase levels and consequently EET levels in humans vary widely and are highly dependent on their recent consumption history.<sup id=\"cite_ref-Pharmacol_Ther_2014_5-2\" class=\"reference\"><a href=\"#cite_note-Pharmacol_Ther_2014-5\">&#91;5&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Metabolism_of_EETs\">Metabolism of EETs</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxyeicosatrienoic_acid&amp;action=edit&amp;section=3\" title=\"Edit section: Metabolism of EETs\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>In cells, the EETs are rapidly metabolized by a cytosolic <a href=\"/wiki/Soluble_epoxide_hydrolase\" class=\"mw-redirect\" title=\"Soluble epoxide hydrolase\">soluble epoxide hydrolase</a> (sEH) which adds water (H<sub>2</sub>O) across the epoxide to form their corresponding <a href=\"/wiki/Vicinal_(chemistry)\" title=\"Vicinal (chemistry)\">Vicinal (chemistry)</a> <a href=\"/wiki/Diol\" title=\"Diol\">diol</a> dihydroxyeicosatrienoic acids (diHETrEs or DHETs), i.e. sEH converts 14,15-ETE to 14,15-dihydroxy-eicosatrienoic acid (14,15-diHETrE), 11,12-ETE to 11,12-diHETrE, 8,9-ETE to 8,9-diHETrE, and 5,6-ETE to 5,6-diHETrE.<sup id=\"cite_ref-Gene_p_10_10-0\" class=\"reference\"><a href=\"#cite_note-Gene_p_10-10\">&#91;10&#93;</a></sup> The product diHETrEs, like their epoxy precursors, are <a href=\"/wiki/Enantiomer\" title=\"Enantiomer\">enantiomer</a> mixtures; for instance, sEH converts 14,15-ETE to a mixture of 14(<i>S</i>),15(<i>R</i>)-diHETrE and  14(<i>R</i>),15(<i>S</i>)-diHETrE.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_4-4\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-4\">&#91;4&#93;</a></sup>  However, 5,6-EET is a relatively poor substrate for sEH and in cells is more rapidly metabolized by <a href=\"/wiki/Cyclooxygenase-2\" class=\"mw-redirect\" title=\"Cyclooxygenase-2\">cyclooxygenase-2</a> to form 5,6-epoxy-prostaglandin F1\u03b1.<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup>   Since the diHETrE products are as a rule generally far less active than their epoxide precursors, the sEH pathway of EET metabolism is regarded as a critical EET-inactivating pathway.<sup id=\"cite_ref-Gene_p_10_10-1\" class=\"reference\"><a href=\"#cite_note-Gene_p_10-10\">&#91;10&#93;</a></sup><sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup>  In some instances, however, the diHETrEs have been found to possess appreciable activity as indicated in the Biological activities section below.\n</p><p>Membrane-bound <a href=\"/wiki/Microsomal_epoxide_hydrolase\" title=\"Microsomal epoxide hydrolase\">Microsomal epoxide hydrolase</a> (mEH or Epoxide hydrolase 1 [EC 3.2.2.9.]) can metabolize EETs to their dihydroxy products but is regarded as not contributing significantly to EET inactivation in vivo except perhaps in brain tissue where mEH activity levels far outstrip those of sEH.<sup id=\"cite_ref-Prostaglandins_Other_Lipid_Mediat_2014._p_18_13-0\" class=\"reference\"><a href=\"#cite_note-Prostaglandins_Other_Lipid_Mediat_2014._p_18-13\">&#91;13&#93;</a></sup><sup id=\"cite_ref-Annu_Rev_Pharmacol_Toxicol_p_27_14-0\" class=\"reference\"><a href=\"#cite_note-Annu_Rev_Pharmacol_Toxicol_p_27-14\">&#91;14&#93;</a></sup> Furthermore, two other human sEH, epoxide hydrolases 3 and 4 (see <a href=\"/wiki/Epoxide_hydrolase\" title=\"Epoxide hydrolase\">epoxide hydrolase</a>), have been defined but their role in attacking EETs (and other epoxides) in vivo has not yet been determined.  Besides these four epoxide hydrolase pathways, EETs may be acylated into phospholipids in an <a href=\"/wiki/Acylation\" title=\"Acylation\">Acylation</a>-like reaction.  This pathway may serve to limit the action of EETs or store them for future release.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_4-5\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-4\">&#91;4&#93;</a></sup>  EETs are also inactivated by being further metabolized though three other pathways: <a href=\"/wiki/Beta_oxidation\" title=\"Beta oxidation\">Beta oxidation</a>, <a href=\"/wiki/Omega_oxidation\" title=\"Omega oxidation\">Omega oxidation</a>, and elongation by enzymes involved in <a href=\"/wiki/Fatty_acid_synthesis\" title=\"Fatty acid synthesis\">Fatty acid synthesis</a>.<sup id=\"cite_ref-Prostaglandins_Other_Lipid_Mediat_2014._p_18_13-1\" class=\"reference\"><a href=\"#cite_note-Prostaglandins_Other_Lipid_Mediat_2014._p_18-13\">&#91;13&#93;</a></sup><sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup>  These alternate to sEH pathways of EET metabolism ensure that blockade of sEH with drugs can increase EET levels only moderately in vivo.<sup id=\"cite_ref-Annu_Rev_Pharmacol_Toxicol_p_27_14-1\" class=\"reference\"><a href=\"#cite_note-Annu_Rev_Pharmacol_Toxicol_p_27-14\">&#91;14&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Biological_effects\">Biological effects</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxyeicosatrienoic_acid&amp;action=edit&amp;section=4\" title=\"Edit section: Biological effects\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Generally, EETs cause:\n</p>\n<ul><li><a href=\"/wiki/Calcium\" title=\"Calcium\">Calcium</a> release from intracellular stores<sup id=\"cite_ref-boron108_1-1\" class=\"reference\"><a href=\"#cite_note-boron108-1\">&#91;1&#93;</a></sup></li>\n<li>Increased <a href=\"/wiki/Sodium-hydrogen_antiporter\" class=\"mw-redirect\" title=\"Sodium-hydrogen antiporter\">sodium-hydrogen antiporter</a> activity<sup id=\"cite_ref-boron108_1-2\" class=\"reference\"><a href=\"#cite_note-boron108-1\">&#91;1&#93;</a></sup></li>\n<li>Increased cell proliferation<sup id=\"cite_ref-boron108_1-3\" class=\"reference\"><a href=\"#cite_note-boron108-1\">&#91;1&#93;</a></sup></li>\n<li>Decreased <a href=\"/wiki/Cyclooxygenase\" title=\"Cyclooxygenase\">cyclooxygenase</a> activity<sup id=\"cite_ref-boron108_1-4\" class=\"reference\"><a href=\"#cite_note-boron108-1\">&#91;1&#93;</a></sup></li></ul>\n<p>Other effects are specific to certain cells or locations; EETs:\n</p>\n<ul><li>Are cardioprotective after <a href=\"/wiki/Myocardial_infarction\" title=\"Myocardial infarction\">ischemic heart attack</a> and reperfusion.<sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup></li>\n<li>Act in the <a href=\"/wiki/Corpus_cavernosum_penis\" title=\"Corpus cavernosum penis\">corpus cavernosum</a>  to maintain penile erection.<sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup></li>\n<li>Specific epoxidation of EET sites produces endogenous <a href=\"/wiki/PPAR%CE%B1\" class=\"mw-redirect\" title=\"PPAR\u03b1\">PPAR\u03b1</a> agonists.<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup></li>\n<li>Decrease release of <a href=\"/wiki/Somatostatin\" title=\"Somatostatin\">somatostatin</a>, <a href=\"/wiki/Insulin\" title=\"Insulin\">insulin</a> and <a href=\"/wiki/Glucagon\" title=\"Glucagon\">glucagon</a> from endocrine cells.<sup id=\"cite_ref-boron108_1-5\" class=\"reference\"><a href=\"#cite_note-boron108-1\">&#91;1&#93;</a></sup></li>\n<li>Stimulate blood vessel formation (<a href=\"/wiki/Angiogenesis\" title=\"Angiogenesis\">angiogenesis</a>.<sup id=\"cite_ref-boron108_1-6\" class=\"reference\"><a href=\"#cite_note-boron108-1\">&#91;1&#93;</a></sup></li>\n<li>Cause <a href=\"/wiki/Vasodilation\" title=\"Vasodilation\">Vasodilation</a> in the systemic arterial circulation.<sup id=\"cite_ref-boron108_1-7\" class=\"reference\"><a href=\"#cite_note-boron108-1\">&#91;1&#93;</a></sup></li>\n<li>Cause <a href=\"/wiki/Vasoconstriction\" title=\"Vasoconstriction\">Vasoconstriction</a> of the <a href=\"/wiki/Liver_sinusoid\" title=\"Liver sinusoid\">Liver sinusoidal</a> and pulmonary venous systems.<sup id=\"cite_ref-pmid26072731_19-0\" class=\"reference\"><a href=\"#cite_note-pmid26072731-19\">&#91;19&#93;</a></sup></li>\n<li>Increased risk of <a href=\"/wiki/Tumor_adhesion\" class=\"mw-redirect\" title=\"Tumor adhesion\">tumor adhesion</a> on <a href=\"/wiki/Endothelial_cells\" class=\"mw-redirect\" title=\"Endothelial cells\">endothelial cells</a><sup id=\"cite_ref-boron108_1-8\" class=\"reference\"><a href=\"#cite_note-boron108-1\">&#91;1&#93;</a></sup></li>\n<li>Decrease <a href=\"/wiki/Platelet_aggregation\" class=\"mw-redirect\" title=\"Platelet aggregation\">platelet aggregation</a> responses<sup id=\"cite_ref-boron108_1-9\" class=\"reference\"><a href=\"#cite_note-boron108-1\">&#91;1&#93;</a></sup></li>\n<li>Increase <a href=\"/wiki/Axon\" title=\"Axon\">axon</a> growth in neurons.<sup id=\"cite_ref-Prostaglandins_Other_Lipid_Mediat_2014._p_18_13-2\" class=\"reference\"><a href=\"#cite_note-Prostaglandins_Other_Lipid_Mediat_2014._p_18-13\">&#91;13&#93;</a></sup></li></ul>\n<p>Diol metabolites of the EETs, i.e. the diHETrEs (also termed DHETs), have relatively little or no activity compared to the EETs in most systems. However:\n</p>\n<ul><li>The <a href=\"/wiki/Chemotaxis\" title=\"Chemotaxis\">chemotaxis</a> response of human monocytes to <a href=\"/wiki/Monocyte\" title=\"Monocyte\">monocyte</a> chemotactic protein 1) in vivo and in vitro appears to depend on the generation of EETs and conversion of these EETs to diHETrEs.<sup id=\"cite_ref-Prostaglandins_Other_Lipid_Mediat_2014._p_18_13-3\" class=\"reference\"><a href=\"#cite_note-Prostaglandins_Other_Lipid_Mediat_2014._p_18-13\">&#91;13&#93;</a></sup></li>\n<li>Certain diHETrEs dilate human coronary arteries with efficacies approaching those of the EETs.<sup id=\"cite_ref-20\" class=\"reference\"><a href=\"#cite_note-20\">&#91;20&#93;</a></sup></li>\n<li>11,12-diHETrE but not 11,12-EET appears to support the maturation of the myelocyte cell line (i.e. support <a href=\"/wiki/Myelopoiesis\" title=\"Myelopoiesis\">Myelopoiesis</a>) in mice and to promote certain types of <a href=\"/wiki/Angiogenesis\" title=\"Angiogenesis\">angiogenesis</a> in mice and <a href=\"/wiki/Zebrafish\" title=\"Zebrafish\">Zebrafish</a>.<sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup></li>\n<li>In opposition of the anti-inflammatory actions of EETs, diHETrEs may have some pro-inflammatory actions.<sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup></li></ul>\n<h2><span class=\"mw-headline\" id=\"Clinical_significance\">Clinical significance</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxyeicosatrienoic_acid&amp;action=edit&amp;section=5\" title=\"Edit section: Clinical significance\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Regulation_of_blood_pressure\">Regulation of blood pressure</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxyeicosatrienoic_acid&amp;action=edit&amp;section=6\" title=\"Edit section: Regulation of blood pressure\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>With respect to the regulation of blood pressure as well as the kidneys' regulation of salt and water absorption (which contributes to blood pressure regulation), EETS are counterpoises to another CYP-derived arachidonic acid metabolite, <a href=\"/wiki/20-Hydroxyeicosatetraenoic_acid\" title=\"20-Hydroxyeicosatetraenoic acid\">20-Hydroxyeicosatetraenoic acid</a> (20-HETE).  In humans, the major CYPs making 20-HETE are <a href=\"/wiki/CYP4A11\" title=\"CYP4A11\">CYP4A11</a>, <a href=\"/wiki/CYP4F2\" title=\"CYP4F2\">CYP4F2</a>, and <a href=\"/wiki/CYP4F3\" title=\"CYP4F3\">CYP4F3</a>. In animal models, 20-HETE raises blood pressure by contracting arteries and stimulating the kidney to reabsorb salt and water to increase the intravascular volume (see <a href=\"/wiki/20-Hydroxyeicosatetraenoic_acid\" title=\"20-Hydroxyeicosatetraenoic acid\">20-Hydroxyeicosatetraenoic acid</a>). EETs have the opposite effects. They are one type of <a href=\"/wiki/Endothelium-Derived_Hyperpolarizing_Factor\" class=\"mw-redirect\" title=\"Endothelium-Derived Hyperpolarizing Factor\">Endothelium-Derived Hyperpolarizing Factor</a>, i.e. a substance and/or electrical signal synthesized or generated in and released from the vascular endothelium that hyperpolarize nearby vascular smooth muscle cells.  This causes these cells to relax and thereby lowers blood pressure. In animal (primarily rodent) models, EETs dilate smaller sized resistance arteries involved in causing hypertension as well as cardiac and renal arteries.  They cause smooth muscle hyperpolarization by opening vascular smooth muscle <a href=\"/wiki/Large-conductance_calcium-activated_potassium_channels\" class=\"mw-redirect\" title=\"Large-conductance calcium-activated potassium channels\">large-conductance calcium-activated potassium channels</a>, opening certain vascular smooth muscle <a href=\"/wiki/Transient_receptor_potential_channels\" class=\"mw-redirect\" title=\"Transient receptor potential channels\">transient receptor potential channels</a>, or facilitating the movement of excitatory signals through <a href=\"/wiki/Gap_junctions\" class=\"mw-redirect\" title=\"Gap junctions\">gap junctions</a> between endothelium and smooth muscles or between smooth muscles.<sup id=\"cite_ref-ReferenceB_6-2\" class=\"reference\"><a href=\"#cite_note-ReferenceB-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-ReferenceA_9-2\" class=\"reference\"><a href=\"#cite_note-ReferenceA-9\">&#91;9&#93;</a></sup>  The actual mechanism(s) involved in these EET-induced effects have not been fully elucidated although some studies implicate EET binding to an unidentified <a href=\"/wiki/Cell_surface_receptor\" title=\"Cell surface receptor\">Cell surface receptor</a> and/or <a href=\"/wiki/Gs_protein\" class=\"mw-redirect\" title=\"Gs protein\">Gs protein</a>-linked <a href=\"/wiki/G_protein%E2%80%93coupled_receptor\" class=\"mw-redirect\" title=\"G protein\u2013coupled receptor\">G protein\u2013coupled receptor</a> to initiate the signal pathway(s) leading to the cited channel and gap junction changes.<sup id=\"cite_ref-ReferenceB_6-3\" class=\"reference\"><a href=\"#cite_note-ReferenceB-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-ReferenceA_9-3\" class=\"reference\"><a href=\"#cite_note-ReferenceA-9\">&#91;9&#93;</a></sup> With respect to the kidney, studies in rodents find that 20-HETE increases sodium and water reabsorption while the EETs, which are made in the proximal tubules and cortical collecting ducts, reduce sodium ion and water transport at both sites by inhibiting kidney <a href=\"/wiki/Sodium%E2%80%93hydrogen_antiporter\" title=\"Sodium\u2013hydrogen antiporter\">Sodium\u2013hydrogen antiporter</a> (i.e. Na+/H+ exchanger) and/or <a href=\"/wiki/Epithelial_sodium_channel\" title=\"Epithelial sodium channel\">Epithelial sodium channels</a>.<sup id=\"cite_ref-ReferenceC_23-0\" class=\"reference\"><a href=\"#cite_note-ReferenceC-23\">&#91;23&#93;</a></sup> Mice lacking either of the EET-producing Cyp2c44 or Cyp4ac44 genes (by <a href=\"/wiki/Gene_knockout\" title=\"Gene knockout\">gene knockout</a>) develop hypertension when fed high sodium or high potassium diets.<sup id=\"cite_ref-ReferenceC_23-1\" class=\"reference\"><a href=\"#cite_note-ReferenceC-23\">&#91;23&#93;</a></sup> These and large number of other studies included in the cited references implicate the EETs in the control of at least certain forms of hypertension in rodents.\n</p><p>In humans, vascular endothelium production of EETs involves mainly CYP2C9 and numerous indirect studies have implicated CYP epoxygenase, possibly CYP2C9, in producing a product which causes vasodilation. These studies find that selective (but not entirely specific) CYP epoxygenase-inhibiting drugs reduce human vasodilation responses elicited by the vasodilators <a href=\"/wiki/Bradykinin\" title=\"Bradykinin\">bradykinin</a>, <a href=\"/wiki/Acetylcholine\" title=\"Acetylcholine\">acetylcholine</a>, and <a href=\"/wiki/Methacholine\" title=\"Methacholine\">methacholine</a>; this suggests that these vasodilators operate by stimulation the production of EETs.  Human studies also find that Caucasian but not African American subjects who have the Lys55Arg <a href=\"/wiki/Single_nucleotide_polymorphism\" class=\"mw-redirect\" title=\"Single nucleotide polymorphism\">single nucleotide polymorphism</a> variant in the polyunsaturated fatty epoxide-inactivating enzyme, sEH, express hyperactive sEH and show reduced vasodilation responses to bradykinin. Other studies find that women with <a href=\"/wiki/Pregnancy-induced_hypertension\" class=\"mw-redirect\" title=\"Pregnancy-induced hypertension\">pregnancy-induced hypertension</a> and subjects with <a href=\"/wiki/Renovascular_hypertension\" title=\"Renovascular hypertension\">Renovascular hypertension</a> exhibit low plasma ETE levels.<sup id=\"cite_ref-ReferenceA_9-4\" class=\"reference\"><a href=\"#cite_note-ReferenceA-9\">&#91;9&#93;</a></sup> Finally, 11,12-EET has been shown to relax the internal mammary artery in women, indicating that at least this EET has direct vasodilating actions in humans.<sup id=\"cite_ref-ReferenceA_9-5\" class=\"reference\"><a href=\"#cite_note-ReferenceA-9\">&#91;9&#93;</a></sup> On the other hand, several studies in humans with <a href=\"/wiki/Single_nucleotide_polymorphism\" class=\"mw-redirect\" title=\"Single nucleotide polymorphism\">single nucleotide polymorphism</a> in CYP epxoygenase genes have given negative or confusing results. The most common variant of CYP2J2, rs890293,<sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup> similarly contradictive or negative results are reported in studies on the rs11572082 (Arg1391Lys)<sup id=\"cite_ref-25\" class=\"reference\"><a href=\"#cite_note-25\">&#91;25&#93;</a></sup> variant of CYP2C8 and the rs1799853 (Arg144Cys)<sup id=\"cite_ref-urlrs1799853_at_chr10:96702047_in_CYP2C9_26-0\" class=\"reference\"><a href=\"#cite_note-urlrs1799853_at_chr10:96702047_in_CYP2C9-26\">&#91;26&#93;</a></sup> and rs1057910 (Ile359Leu)<sup id=\"cite_ref-urlrs1057910_at_chr10:96741053_in_CYP2C9_27-0\" class=\"reference\"><a href=\"#cite_note-urlrs1057910_at_chr10:96741053_in_CYP2C9-27\">&#91;27&#93;</a></sup> variants of CYP2C9, all of which code for an epoxygenase with reduced arachidonic acid-metabolizing and EET-forming activities.<sup id=\"cite_ref-pmid22173545_28-0\" class=\"reference\"><a href=\"#cite_note-pmid22173545-28\">&#91;28&#93;</a></sup>\n</p><p>While many of the cited studies suggest that one or more of the EETs released by vascular endothelial cells are responsible for the actions of the vasodilators and that deficiencies in EET production or excessive EET inactivation by sEH underlie certain types of hypertension in humans, they are not conclusive.  They do not exclude a possibility that other polyunsaturated fatty acid epoxides such as those derived from eicosatetraenoic, docosatetraenoic, or linoleic acids made by CYP2C9 or other CYP epoxygenases (see <a href=\"/wiki/Epoxygenase\" title=\"Epoxygenase\">epoxygenase</a>) contribute in small or large part to vasodilation responses and by this action promote blood flow to tissues and function in lowering high blood pressures.  Furthermore, the genetic studies conducted to date on SNP variants do not give strong support for an antihypertensive role for the EETs or EET-forming epoxygenases in humans.  Recently developed drugs which are metabolically stable analogs of the EETs and thereby mimic the EETs actions or, alternatively of drugs which inhibit sEH and thereby increase EET levels are in the <a href=\"/wiki/Pre-clinical_development\" title=\"Pre-clinical development\">Pre-clinical development</a> stage for treating human hypertension.<sup id=\"cite_ref-29\" class=\"reference\"><a href=\"#cite_note-29\">&#91;29&#93;</a></sup> Testing for their usefulness in treating human hypertension is made difficult because of: <b>1)</b> the large number of CYP epoxygenases along with their differing tissue distributions and sensitivities to drug inhibitors; <b>2)</b> the diversity of EETs made by the CYP epoxygenases, some of which differ in activities; <b>3)</b> the diversity of fatty acid substrates metabolized by the CYP epoxygenases some of which are converted to epoxides (e.g. the epoxide metabolites of linoleic, docosahexaenoic, eicosapentaenoic acids) with have different activities than the EETs or may even be overtly toxic to humans (see <a href=\"/wiki/Coronaric_acid\" title=\"Coronaric acid\">Coronaric acid</a>); <b>4)</b> the sEH-derived dihydroxy metabolites of the EETs some of which have potent vasodilating effects in the certain vascular networks in rodents and therefore potentially in humans; and <b>5)</b> the non-specificity and side effects of the latter drugs.<sup id=\"cite_ref-30\" class=\"reference\"><a href=\"#cite_note-30\">&#91;30&#93;</a></sup><sup id=\"cite_ref-31\" class=\"reference\"><a href=\"#cite_note-31\">&#91;31&#93;</a></sup><sup id=\"cite_ref-32\" class=\"reference\"><a href=\"#cite_note-32\">&#91;32&#93;</a></sup>\n</p><p>As indicated on the ClinicalTrials.gov web site, a <a href=\"/wiki/National_Institutes_of_Health\" title=\"National Institutes of Health\">National Institutes of Health</a>-sponsored clinical trial entitled \"Evaluation of Soluble Epoxide Hydrolase (s-EH) Inhibitor in Patients With Mild to Moderate Hypertension and Impaired Glucose Tolerance\" has not been completed or reported on although started in 2009.<sup id=\"cite_ref-33\" class=\"reference\"><a href=\"#cite_note-33\">&#91;33&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Heart_disease\">Heart disease</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxyeicosatrienoic_acid&amp;action=edit&amp;section=7\" title=\"Edit section: Heart disease\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>As indicated elsewhere on this page, EETs inhibit inflammation, inhibit <a href=\"/wiki/Blood_clot\" class=\"mw-redirect\" title=\"Blood clot\">blood clot</a> formation, inhibit <a href=\"/wiki/Platelet\" title=\"Platelet\">platelet</a> activation, dilate blood vessels including the <a href=\"/wiki/Coronary_arteries\" title=\"Coronary arteries\">coronary arteries</a>, reduce certain types of <a href=\"/wiki/Hypertension\" title=\"Hypertension\">hypertension</a>, stimulate the survival of vascular endothelial and cardiac muscle cells by inhibiting <a href=\"/wiki/Apoptosis\" title=\"Apoptosis\">apoptosis</a>, promote blood vessel growth (i.e. <a href=\"/wiki/Angiogenesis\" title=\"Angiogenesis\">angiogenesis</a>), and stimulate smooth muscle cell migration; these activities may protect the heart. Indeed, studies on in vivo animal and in vitro animal and human cell model systems indicate that the ETEs reduce <a href=\"/wiki/Infarct\" class=\"mw-redirect\" title=\"Infarct\">infarct</a> (i.e. injured tissue) size, reduce cardiac arrhythmias, and improve the strength of left ventricle contraction immediately after blockade of coronary artery blood flow in animal models of ischemia-<a href=\"/wiki/Reperfusion_injury\" title=\"Reperfusion injury\">reperfusion injury</a>; EETs also reduce the size of heart enlargement that occurs long after these experiment-induced injuries.<sup id=\"cite_ref-J_Mol_Cell_Cardiol_2014_34-0\" class=\"reference\"><a href=\"#cite_note-J_Mol_Cell_Cardiol_2014-34\">&#91;34&#93;</a></sup>\n</p><p>Humans with established <a href=\"/wiki/Coronary_artery_disease\" title=\"Coronary artery disease\">coronary artery disease</a> have higher levels of plasma EETs and higher ratios of 14,15-EET to 14,15-diHETrE (14,15-diHETrE is the less active or inactive metabolite 14,15-EET). This suggests that the EETs serve a protective role in this setting and that these plasma  changes were a result of a reduction in cardiac sEH activity.  Furthermore, <a href=\"/wiki/Coronary_artery_disease\" title=\"Coronary artery disease\">coronary artery disease</a> patients who had lower levels of EETs/14,15-di-ETE ratios exhibited evidence of a poorer prognosis based on the presence of poor prognostic indicators, cigarette smoking, obesity, old age, and elevation in inflammation markers.<sup id=\"cite_ref-Front_Pharmacol_2014_3-1\" class=\"reference\"><a href=\"#cite_note-Front_Pharmacol_2014-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-J_Mol_Cell_Cardiol_2014_34-1\" class=\"reference\"><a href=\"#cite_note-J_Mol_Cell_Cardiol_2014-34\">&#91;34&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Strokes_and_seizures\">Strokes and seizures</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxyeicosatrienoic_acid&amp;action=edit&amp;section=8\" title=\"Edit section: Strokes and seizures\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Indirect studies in animal models suggest that EETs have protective effects in <a href=\"/wiki/Stroke\" title=\"Stroke\">strokes</a> (i.e. cerbrovasular accidents).  Thus, sEH inhibitors and sEH-<a href=\"/wiki/Gene_knockout\" title=\"Gene knockout\">Gene knockout</a> have been shown to reduce the damage to brain that occurs in several different models of <a href=\"/wiki/Ischemic_stroke\" class=\"mw-redirect\" title=\"Ischemic stroke\">ischemic stroke</a>; this protective effect appears due to a reduction in systemic blood pressure and maintenance of blood flow to ischemic areas of the brain by arteriole dilation as a presumed consequence of inhibiting the degradation of EETs (and/or other fatty acid epoxides).<sup id=\"cite_ref-Huang_H_2015_35-0\" class=\"reference\"><a href=\"#cite_note-Huang_H_2015-35\">&#91;35&#93;</a></sup>  sEH-gene knockout mice were also protected from that brain damage that followed induced-<a href=\"/wiki/Subarachnoid_hemorrhage\" title=\"Subarachnoid hemorrhage\">subarachnoid hemorrhage</a>; this protective effect appeared due to a reduction in cerebral edema which was also presumable due to the prolongation of EET half-lives.<sup id=\"cite_ref-Huang_H_2015_35-1\" class=\"reference\"><a href=\"#cite_note-Huang_H_2015-35\">&#91;35&#93;</a></sup> 14,15-EET levels have been shown to be elevated in the <a href=\"/wiki/Cerebrospinal_fluid\" title=\"Cerebrospinal fluid\">cerebrospinal fluid</a> of humans suffering subarachnoid hemorrhage.<sup id=\"cite_ref-Huang_H_2015_35-2\" class=\"reference\"><a href=\"#cite_note-Huang_H_2015-35\">&#91;35&#93;</a></sup><sup id=\"cite_ref-36\" class=\"reference\"><a href=\"#cite_note-36\">&#91;36&#93;</a></sup>\n</p><p>sEH inhibitors and gene knockout also reduce the number and severity of <a href=\"/wiki/Epileptic_seizure\" title=\"Epileptic seizure\">Epileptic seizures</a> in several animal models; this effect is presumed due to the actions of EETs (and other epoxide fatty acids) in reducing cerebral blood flow changes, and reducing neuron production of <a href=\"/wiki/Neuroactive_steroid\" class=\"mw-redirect\" title=\"Neuroactive steroid\">Neuroactive steroids</a>, reducing neuroinflammation,<sup id=\"cite_ref-Huang_H_2015_35-3\" class=\"reference\"><a href=\"#cite_note-Huang_H_2015-35\">&#91;35&#93;</a></sup><sup id=\"cite_ref-37\" class=\"reference\"><a href=\"#cite_note-37\">&#91;37&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Portal_hypertension\">Portal hypertension</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxyeicosatrienoic_acid&amp;action=edit&amp;section=9\" title=\"Edit section: Portal hypertension\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Portal hypertension or hypertension in the venous <a href=\"/wiki/Hepatic_portal_system\" title=\"Hepatic portal system\">hepatic portal system</a> of blood flow is defined as an increase in portal pressure above normal values of 10 <a href=\"/wiki/Millimeter_of_mercury\" title=\"Millimeter of mercury\">Millimeter of mercury</a>.<sup id=\"cite_ref-pmid26072731_19-1\" class=\"reference\"><a href=\"#cite_note-pmid26072731-19\">&#91;19&#93;</a></sup> It is a serious, sometimes life-threatening complication of various diseases such as liver <a href=\"/wiki/Cirrhosis\" title=\"Cirrhosis\">cirrhosis</a>, <a href=\"/wiki/Liver_fibrosis\" class=\"mw-redirect\" title=\"Liver fibrosis\">liver fibrosis</a>, massive <a href=\"/wiki/Fatty_liver\" title=\"Fatty liver\">Fatty liver</a>, <a href=\"/wiki/Portal_vein_thrombosis\" title=\"Portal vein thrombosis\">portal vein thrombosis</a>, liver <a href=\"/wiki/Schistosomiasis\" title=\"Schistosomiasis\">schistosomiasis</a>, massive liver involvement in <a href=\"/wiki/Miliary_tuberculosis\" title=\"Miliary tuberculosis\">miliary tuberculosis</a> or <a href=\"/wiki/Sarcoidosis\" title=\"Sarcoidosis\">sarcoidosis</a>, and obstruction of the venous circuit at any level between liver and right heart (see <a href=\"/wiki/Portal_hypertension\" title=\"Portal hypertension\">Portal hypertension</a>).  Vascular contraction in the portal system is mediated by several agents: <a href=\"/wiki/Nitric_oxide\" title=\"Nitric oxide\">nitric oxide</a>, <a href=\"/wiki/Carbon_monoxide\" title=\"Carbon monoxide\">carbon monoxide</a>, <a href=\"/wiki/Prostacyclin\" title=\"Prostacyclin\">prostacyclin</a> I<sub>2</sub>, and <a href=\"/wiki/Endothelium-derived_hyperpolarizing_factor\" title=\"Endothelium-derived hyperpolarizing factor\">Endothelium-derived hyperpolarizing factors</a> (EDHFs). EDHFs include <a href=\"/wiki/Endothelin\" title=\"Endothelin\">endothelin</a>, <a href=\"/wiki/Angiotensin_II\" class=\"mw-redirect\" title=\"Angiotensin II\">angiotensin II</a>, <a href=\"/wiki/Thromboxane_A2\" title=\"Thromboxane A2\">thromboxane A2</a>, certain <a href=\"/wiki/Leukotriene\" title=\"Leukotriene\">leukotrienes</a>, and the EETs.  In portal hypertension, portal vein endothelium appears to be dysfunctional in that it overproduces EDHFs.<sup id=\"cite_ref-Prostaglandins_Other_Lipid_Mediat_2011_38-0\" class=\"reference\"><a href=\"#cite_note-Prostaglandins_Other_Lipid_Mediat_2011-38\">&#91;38&#93;</a></sup> The EETs, particularly 11,12-EET, have a quite different effect on the <a href=\"/wiki/Liver_sinusoid\" title=\"Liver sinusoid\">Liver sinusoidal</a> veins than on arteries of the <a href=\"/wiki/Systemic_circulation\" class=\"mw-redirect\" title=\"Systemic circulation\">systemic circulation</a>: they constrict the sinusoids.<sup id=\"cite_ref-39\" class=\"reference\"><a href=\"#cite_note-39\">&#91;39&#93;</a></sup>  Levels of EETs in the plasma and liver of patients with cirrhosis and portal hypertension are reportedly elevated compared to normal subjects.<sup id=\"cite_ref-pmid26072731_19-2\" class=\"reference\"><a href=\"#cite_note-pmid26072731-19\">&#91;19&#93;</a></sup><sup id=\"cite_ref-Prostaglandins_Other_Lipid_Mediat_2011_38-1\" class=\"reference\"><a href=\"#cite_note-Prostaglandins_Other_Lipid_Mediat_2011-38\">&#91;38&#93;</a></sup><sup id=\"cite_ref-pmid21856435_40-0\" class=\"reference\"><a href=\"#cite_note-pmid21856435-40\">&#91;40&#93;</a></sup>  These and other findings have led to the proposal that portal endothelium-derived EETs, perhaps acting in cooperation with another EDHF, endothelin, contribute to portal hypertension.<sup id=\"cite_ref-pmid26072731_19-3\" class=\"reference\"><a href=\"#cite_note-pmid26072731-19\">&#91;19&#93;</a></sup><sup id=\"cite_ref-pmid21856435_40-1\" class=\"reference\"><a href=\"#cite_note-pmid21856435-40\">&#91;40&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Cancer\">Cancer</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxyeicosatrienoic_acid&amp;action=edit&amp;section=10\" title=\"Edit section: Cancer\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The forced over-expression of CYP2J2 in or the addition of an EET to cultured human Tca-8113 oral squamous cancer cells, lung cancer <a href=\"/wiki/A549_cell\" title=\"A549 cell\">A549 cells</a> and <a href=\"/w/index.php?title=NCL-H446&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"NCL-H446 (page does not exist)\">NCL-H446</a> cells, <a href=\"/wiki/HepG2\" class=\"mw-redirect\" title=\"HepG2\">HepG2</a> liver cancer cells, <a href=\"/w/index.php?title=LS-174&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"LS-174 (page does not exist)\">LS-174</a> colon cancer cells, <a href=\"/w/index.php?title=SiHa&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"SiHa (page does not exist)\">SiHa</a> uterine cervix cancer cells, <a href=\"/wiki/U251\" class=\"mw-redirect\" title=\"U251\">U251</a> <a href=\"/wiki/Glioblastoma\" title=\"Glioblastoma\">glioblastoma</a> cancer cells, <a href=\"/w/index.php?title=ScaBER&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"ScaBER (page does not exist)\">ScaBER</a> urinary bladder cancer cells, and <a href=\"/wiki/K562\" class=\"mw-redirect\" title=\"K562\">K562</a> <a href=\"/wiki/Erythroleukemia\" class=\"mw-redirect\" title=\"Erythroleukemia\">erythroleukemia</a> and <a href=\"/wiki/HL-60\" class=\"mw-redirect\" title=\"HL-60\">HL-60</a> <a href=\"/wiki/Promyelocyte\" title=\"Promyelocyte\">promyelocyte</a> leukemic blood cancer cells caused an increase in their survival and proliferation.<sup id=\"cite_ref-pmid15930289_41-0\" class=\"reference\"><a href=\"#cite_note-pmid15930289-41\">&#91;41&#93;</a></sup><sup id=\"cite_ref-pmid22009066_42-0\" class=\"reference\"><a href=\"#cite_note-pmid22009066-42\">&#91;42&#93;</a></sup>  \nPutative inhibitors of CYP2J2 inhibit the growth in culture of several human cancer cell lines that express relatively high levels of CYP2J2 viz., Tca-8113 cells, <a href=\"/wiki/HeLa\" title=\"HeLa\">HeLa</a> uterine cervix cell lines, <a href=\"/wiki/A549_(cell_line)\" class=\"mw-redirect\" title=\"A549 (cell line)\">A549</a> cells, <a href=\"/wiki/MDA-MB-435\" class=\"mw-redirect\" title=\"MDA-MB-435\">MDA-MB-435</a> breast cells, and <a href=\"/wiki/HepG2\" class=\"mw-redirect\" title=\"HepG2\">HepG2</a> cells but they had no significant inhibitory effects on two cell lines that expressed little or no CYP2J2.<sup id=\"cite_ref-43\" class=\"reference\"><a href=\"#cite_note-43\">&#91;43&#93;</a></sup> \nA putative inhibitor of CYPJ2 also inhibited the growth of human <a href=\"/wiki/K562\" class=\"mw-redirect\" title=\"K562\">K562</a> erythroleukemia in a <a href=\"/wiki/Severe_combined_immunodeficiency_(non-human)#mice\" title=\"Severe combined immunodeficiency (non-human)\">mice</a> model as well as the growth of mouse el4 lymphoma cells in mice that were forced to overexpress CYP2J2 cells in their vascular epithelium.  \nForced expression of CYP2J2 also enhanced, while forced inhibition of its expression (using <a href=\"/wiki/Small_interfering_RNA\" title=\"Small interfering RNA\">Small interfering RNA</a>) reduced, the survival, growth, and metastasis of  <a href=\"/wiki/MDA-MB-231\" class=\"mw-redirect\" title=\"MDA-MB-231\">MDA-MB-231</a> human breast carcinoma cells in the mouse model and likewise enhanced or reduced, respectively, the survival and growth of these cells in culture.<sup id=\"cite_ref-44\" class=\"reference\"><a href=\"#cite_note-44\">&#91;44&#93;</a></sup>  \nFurther studies found that the expression of CYP2J2 was in increased in the malignant cells, relative to the nearby normal cells, in the following specimens taken from humans suffering <a href=\"/wiki/Squamous-cell_carcinoma\" class=\"mw-redirect\" title=\"Squamous-cell carcinoma\">squamous-cell carcinoma</a> and <a href=\"/wiki/Adenocarcinoma\" title=\"Adenocarcinoma\">adenocarcinoma</a> types of <a href=\"/wiki/Esophageal_cancer\" title=\"Esophageal cancer\">esophageal cancer</a> and <a href=\"/wiki/Lung_cancer\" title=\"Lung cancer\">lung cancer</a>, <a href=\"/wiki/Small_cell_lung_carcinoma\" class=\"mw-redirect\" title=\"Small cell lung carcinoma\">small cell lung carcinoma</a>, <a href=\"/wiki/Breast_cancer\" title=\"Breast cancer\">breast cancer</a>, <a href=\"/wiki/Stomach_cancer\" title=\"Stomach cancer\">stomach cancer</a>, <a href=\"/wiki/Liver_cancer\" title=\"Liver cancer\">liver cancer</a>, and <a href=\"/wiki/Colon_adenocarcinoma\" class=\"mw-redirect\" title=\"Colon adenocarcinoma\">colon adenocarcinoma</a>; \nthis CYP was also highly expressed in the malignant cells of patients with acute leukemia, chronic leukemia, and lymphoma.<sup id=\"cite_ref-Adv_Drug_Deliv_Rev_2011_45-0\" class=\"reference\"><a href=\"#cite_note-Adv_Drug_Deliv_Rev_2011-45\">&#91;45&#93;</a></sup>  \nAs a group, patients with these cancers exhibited increased levels of EETs in their urine and blood samples.<sup id=\"cite_ref-Adv_Drug_Deliv_Rev_2011_45-1\" class=\"reference\"><a href=\"#cite_note-Adv_Drug_Deliv_Rev_2011-45\">&#91;45&#93;</a></sup>\n</p><p>Studies of the CYP epoxygenases have not been restricted to the CYP2J subfamily. \nReduction in the expression of CYP3A4 or CYP2C using small interfering RNA inhibits the growth of cultured <a href=\"/wiki/MCF7\" class=\"mw-redirect\" title=\"MCF7\">MCF7</a>, <a href=\"/wiki/T47D\" class=\"mw-redirect\" title=\"T47D\">T47D</a>, and MDA-MB-231 human breast cancer cells; in these studies 14,15-EET stimulated the proliferation of cultured <a href=\"/wiki/MCF7\" class=\"mw-redirect\" title=\"MCF7\">MCF7</a> cells, reduction in the expression of CYP3A4 by small interference RNA methods, inhibited these cells from proliferating, and 14,15-ETE reversed the effect of CYP3A4 interference; \nin other studies, the forced overexpression of CYP3A4 stimulated the growth of human liver cancer (<a href=\"/wiki/Hepatoma\" class=\"mw-redirect\" title=\"Hepatoma\">hepatoma</a>) cell line, Hep3 .<sup id=\"cite_ref-pmid22009066_42-1\" class=\"reference\"><a href=\"#cite_note-pmid22009066-42\">&#91;42&#93;</a></sup><sup id=\"cite_ref-46\" class=\"reference\"><a href=\"#cite_note-46\">&#91;46&#93;</a></sup>  \nIn human breast cancer, not only CYP2J2 but also CYP2C8 and CYP2C9 levels appear elevated while sEH levels appear reduced in malignant compared to nearby normal tissues; associated with this finding, the levels of 14,15-EET as well as the levels of 14,15-EET plus 14,15-dihydroxy-EET were significantly elevated in the cancerous compared to noncancerous cells and the levels of CYP2C8 and CYP2C9 proteins correlated positively and sEH levels correlated negatively with the tumor cells rate of proliferation as accessed by their <a href=\"/wiki/Ki67\" class=\"mw-redirect\" title=\"Ki67\">Ki67</a> levels while CYP2J2 levels correlated positively with poorer prognosis as predicted tumor histological grade and tumor size.<sup id=\"cite_ref-Adv_Pharmacol_2015_47-0\" class=\"reference\"><a href=\"#cite_note-Adv_Pharmacol_2015-47\">&#91;47&#93;</a></sup>\n</p><p>The cited findings suggest that various CYP epoxygenases along with the epoxide metabolites which they make promote the growth and spread of diverse types of cancer in animals and humans.  Their effects may reflect the ability of the epoxide metabolites to stimulate the proliferation and survival of the target cancer cells but perhaps also to stimulate these cells to trigger new capillary formation (see <a href=\"/wiki/Angiogenesis#Tumor_angiogenesis\" title=\"Angiogenesis\">angiogenesis#Tumor angiogenesis</a>), invade new tissues, and <a href=\"/wiki/Metastasize\" class=\"mw-redirect\" title=\"Metastasize\">metastasize</a>.<sup id=\"cite_ref-ReferenceB_6-4\" class=\"reference\"><a href=\"#cite_note-ReferenceB-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-pmid22009066_42-2\" class=\"reference\"><a href=\"#cite_note-pmid22009066-42\">&#91;42&#93;</a></sup><sup id=\"cite_ref-Adv_Pharmacol_2015_47-1\" class=\"reference\"><a href=\"#cite_note-Adv_Pharmacol_2015-47\">&#91;47&#93;</a></sup>\n</p><p>A series of drugs derived from <a href=\"/wiki/Terfenadine\" title=\"Terfenadine\">Terfenadine</a> have been shown to inhibit CYP2J2 and to suppress the proliferation and cause the <a href=\"/wiki/Apoptosis\" title=\"Apoptosis\">apoptosis</a> of various types of human cancer cell lines in culture as well as in animal models.<sup id=\"cite_ref-Adv_Pharmacol_2015_47-2\" class=\"reference\"><a href=\"#cite_note-Adv_Pharmacol_2015-47\">&#91;47&#93;</a></sup> However, clinical studies targeting CYP epoxygenases and EETs and to successfully suppress cancer in humans have not been reported.\n</p>\n<h3><span class=\"mw-headline\" id=\"Inflammation\">Inflammation</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxyeicosatrienoic_acid&amp;action=edit&amp;section=11\" title=\"Edit section: Inflammation\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In vitro and animal model studies indicate that the EETs possess <a href=\"/wiki/Anti-inflammatory\" title=\"Anti-inflammatory\">anti-inflammatory</a> activity that is directed toward reducing, resolving, and limiting the damage caused by inflammation.  Most of these studies have focused on circulating <a href=\"/wiki/Leukocytes\" class=\"mw-redirect\" title=\"Leukocytes\">leukocytes</a>, blood vessel endothelium, and the occlusion of blood vessels due to pathological blood clotting. EETs <b>a)</b> inhibit vascular endothelial cells from expressing <a href=\"/wiki/Cell_adhesion_molecule\" title=\"Cell adhesion molecule\">Cell adhesion molecules</a> such as <a href=\"/wiki/VCAM-1\" title=\"VCAM-1\">VCAM-1</a>, <a href=\"/wiki/ICAM-1\" title=\"ICAM-1\">ICAM-1</a>, and <a href=\"/wiki/E-selectin\" title=\"E-selectin\">E-selectin</a> thereby limiting circulating <a href=\"/wiki/Leukocytes\" class=\"mw-redirect\" title=\"Leukocytes\">leukocytes</a> from adhering to blood vessel endothelium and migrating across this endothelium into tissues; <b>2)</b> inhibit the expression and activity of <a href=\"/wiki/Cyclooxygenase-2\" class=\"mw-redirect\" title=\"Cyclooxygenase-2\">cyclooxygenase-2</a> in blood <a href=\"/wiki/Monocytes\" class=\"mw-redirect\" title=\"Monocytes\">monocytes</a> thereby reducing their production of pro-inflammatory metabolites of arachidonic acid such as <a href=\"/wiki/Prostaglandin_E2\" title=\"Prostaglandin E2\">prostaglandin E2</a>; <b>3)</b> inhibit platelet aggregation thereby reducing <a href=\"/wiki/Thrombus\" title=\"Thrombus\">thrombus</a> (i.e. blood clot) formation; <b>4)</b> promote <a href=\"/wiki/Fibrinolysis\" title=\"Fibrinolysis\">fibrinolysis</a> thereby dissolving blood clots; and <b>5)</b> inhibit vascular smooth muscle cell proliferation thereby reducing blood vessel <a href=\"/wiki/Hypertrophy\" title=\"Hypertrophy\">hypertrophy</a> and narrowing.<sup id=\"cite_ref-Front_Pharmacol_2014_3-2\" class=\"reference\"><a href=\"#cite_note-Front_Pharmacol_2014-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-48\" class=\"reference\"><a href=\"#cite_note-48\">&#91;48&#93;</a></sup>\n</p>\n<h3><span id=\"Diabetes.2C_non-alcoholic_fatty_liver_disease.2C_and_kidney_disease\"></span><span class=\"mw-headline\" id=\"Diabetes,_non-alcoholic_fatty_liver_disease,_and_kidney_disease\">Diabetes, non-alcoholic fatty liver disease, and kidney disease</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxyeicosatrienoic_acid&amp;action=edit&amp;section=12\" title=\"Edit section: Diabetes, non-alcoholic fatty liver disease, and kidney disease\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>EETs, pharmacological inhibition of sEH, and/or inhibition of sEH expression enhance insulin actions on animal tissues in vitro and have protective effects in ameliorating insulin resistance as well as many of the neurological and kidney complications of diabetes in various animal models of diabetes; the studies suggest that the EETs have beneficial effects in <a href=\"/wiki/Type_I_diabetes\" class=\"mw-redirect\" title=\"Type I diabetes\">Type I diabetes</a> as well as <a href=\"/wiki/Type_II_diabetes\" class=\"mw-redirect\" title=\"Type II diabetes\">Type II diabetes</a>.<sup id=\"cite_ref-pmid26621325_49-0\" class=\"reference\"><a href=\"#cite_note-pmid26621325-49\">&#91;49&#93;</a></sup>  These interventions also gave beneficial results in animal models of <a href=\"/wiki/Non-alcoholic_fatty_liver_disease\" title=\"Non-alcoholic fatty liver disease\">non-alcoholic fatty liver disease</a> and certain types inflammation-related kidney diseases including chronic kidney disease, renal ischemia-reperfusion injury, and <a href=\"/wiki/Polycystic_kidney_disease\" title=\"Polycystic kidney disease\">polycystic kidney disease</a>.<sup id=\"cite_ref-ReferenceC_23-2\" class=\"reference\"><a href=\"#cite_note-ReferenceC-23\">&#91;23&#93;</a></sup><sup id=\"cite_ref-50\" class=\"reference\"><a href=\"#cite_note-50\">&#91;50&#93;</a></sup><sup id=\"cite_ref-pmid26621325_49-1\" class=\"reference\"><a href=\"#cite_note-pmid26621325-49\">&#91;49&#93;</a></sup>  The protective role of EETs in these animal model diseases may reflect, at least in part, their anti-inflammatory actions.<sup id=\"cite_ref-pmid26621325_49-2\" class=\"reference\"><a href=\"#cite_note-pmid26621325-49\">&#91;49&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Pain\">Pain</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxyeicosatrienoic_acid&amp;action=edit&amp;section=13\" title=\"Edit section: Pain\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>EETs have been shown to have anti-hyperalgesic and pain-relieving activity in several animal models of pain including <a href=\"/wiki/Nociception\" title=\"Nociception\">Nociception</a> resulting from tissue injury, <a href=\"/wiki/Inflammation\" title=\"Inflammation\">inflammation</a>, and <a href=\"/wiki/Peripheral_neuropathy\" title=\"Peripheral neuropathy\">Peripheral neuropathy</a> (also see <a href=\"/wiki/Neuropathic_pain\" title=\"Neuropathic pain\">Neuropathic pain</a>) including pain secondary to experimentally induced <a href=\"/wiki/Diabetes\" class=\"mw-redirect\" title=\"Diabetes\">Diabetes</a> in mice.<sup id=\"cite_ref-Prostaglandins_Other_Lipid_Mediat_2014._p_18_13-4\" class=\"reference\"><a href=\"#cite_note-Prostaglandins_Other_Lipid_Mediat_2014._p_18-13\">&#91;13&#93;</a></sup><sup id=\"cite_ref-pmid22280237_51-0\" class=\"reference\"><a href=\"#cite_note-pmid22280237-51\">&#91;51&#93;</a></sup><sup id=\"cite_ref-pmid26621325_49-3\" class=\"reference\"><a href=\"#cite_note-pmid26621325-49\">&#91;49&#93;</a></sup>  The epoxides of omega-3 fatty acids appear far stronger and more involved in the relief of pain than the EETs (see <a href=\"/wiki/Epoxydocosapentaenoic_acid\" title=\"Epoxydocosapentaenoic acid\">epoxydocosapentaenoic acid</a>).<sup id=\"cite_ref-Prostaglandins_Other_Lipid_Mediat_2014._p_18_13-5\" class=\"reference\"><a href=\"#cite_note-Prostaglandins_Other_Lipid_Mediat_2014._p_18-13\">&#91;13&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxyeicosatrienoic_acid&amp;action=edit&amp;section=14\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-boron108-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-boron108_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-boron108_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-boron108_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-boron108_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-boron108_1-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-boron108_1-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-boron108_1-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-boron108_1-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-boron108_1-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-boron108_1-9\"><sup><i><b>j</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">Boron WF (2003). <i>Medical Physiology: A Cellular And Molecular Approach</i>. Elsevier/Saunders. p.&#160;108. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/1-4160-2328-3\" title=\"Special:BookSources/1-4160-2328-3\">1-4160-2328-3</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Medical+Physiology%3A+A+Cellular+And+Molecular+Approach&amp;rft.pages=108&amp;rft.pub=Elsevier%2FSaunders&amp;rft.date=2003&amp;rft.isbn=1-4160-2328-3&amp;rft.aulast=Boron&amp;rft.aufirst=Walter+F.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Spector AA, Fang X, Snyder GD, Weintraub NL (Jan 2004). \"Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function\". <i>Progress in Lipid Research</i>. <b>43</b> (1): 55\u201390. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0163-7827%2803%2900049-3\">10.1016/S0163-7827(03)00049-3</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14636671\">14636671</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Progress+in+Lipid+Research&amp;rft.atitle=Epoxyeicosatrienoic+acids+%28EETs%29%3A+metabolism+and+biochemical+function&amp;rft.volume=43&amp;rft.issue=1&amp;rft.pages=55-90&amp;rft.date=2004-01&amp;rft_id=info%3Adoi%2F10.1016%2FS0163-7827%2803%2900049-3&amp;rft_id=info%3Apmid%2F14636671&amp;rft.aulast=Spector&amp;rft.aufirst=AA&amp;rft.au=Fang%2C+X&amp;rft.au=Snyder%2C+GD&amp;rft.au=Weintraub%2C+NL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Front_Pharmacol_2014-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Front_Pharmacol_2014_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Front_Pharmacol_2014_3-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Front_Pharmacol_2014_3-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Tacconelli S, Patrignani P (2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4226225\">\"Inside epoxyeicosatrienoic acids and cardiovascular disease\"</a>. <i>Frontiers in Pharmacology</i>. <b>5</b>: 239. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3389/fphar.2014.00239\">10.3389/fphar.2014.00239</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4226225\">4226225</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25426071\">25426071</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Pharmacology&amp;rft.atitle=Inside+epoxyeicosatrienoic+acids+and+cardiovascular+disease&amp;rft.volume=5&amp;rft.pages=239&amp;rft.date=2014&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4226225&amp;rft_id=info%3Apmid%2F25426071&amp;rft_id=info%3Adoi%2F10.3389%2Ffphar.2014.00239&amp;rft.aulast=Tacconelli&amp;rft.aufirst=S&amp;rft.au=Patrignani%2C+P&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4226225&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Biochim_Biophys_Acta_2014-4\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_4-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_4-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_4-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_4-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_4-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_4-5\"><sup><i><b>f</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Spector AA, Kim HY (Apr 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4314516\">\"Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism\"</a>. <i>Biochimica et Biophysica Acta</i>. <b>1851</b> (4): 356\u201365. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bbalip.2014.07.020\">10.1016/j.bbalip.2014.07.020</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4314516\">4314516</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25093613\">25093613</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochimica+et+Biophysica+Acta&amp;rft.atitle=Cytochrome+P450+epoxygenase+pathway+of+polyunsaturated+fatty+acid+metabolism&amp;rft.volume=1851&amp;rft.issue=4&amp;rft.pages=356-65&amp;rft.date=2015-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4314516&amp;rft_id=info%3Apmid%2F25093613&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbalip.2014.07.020&amp;rft.aulast=Spector&amp;rft.aufirst=AA&amp;rft.au=Kim%2C+HY&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4314516&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Pharmacol_Ther_2014-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Pharmacol_Ther_2014_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Pharmacol_Ther_2014_5-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Pharmacol_Ther_2014_5-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Shahabi P, Siest G, Meyer UA, Visvikis-Siest S (Nov 2014). \"Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders\". <i>Pharmacology &amp; Therapeutics</i>. <b>144</b> (2): 134\u201361. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.pharmthera.2014.05.011\">10.1016/j.pharmthera.2014.05.011</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24882266\">24882266</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacology+%26+Therapeutics&amp;rft.atitle=Human+cytochrome+P450+epoxygenases%3A+variability+in+expression+and+role+in+inflammation-related+disorders&amp;rft.volume=144&amp;rft.issue=2&amp;rft.pages=134-61&amp;rft.date=2014-11&amp;rft_id=info%3Adoi%2F10.1016%2Fj.pharmthera.2014.05.011&amp;rft_id=info%3Apmid%2F24882266&amp;rft.aulast=Shahabi&amp;rft.aufirst=P&amp;rft.au=Siest%2C+G&amp;rft.au=Meyer%2C+UA&amp;rft.au=Visvikis-Siest%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ReferenceB-6\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ReferenceB_6-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ReferenceB_6-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-ReferenceB_6-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-ReferenceB_6-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-ReferenceB_6-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fleming I (2014). \"The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease\". <i>Pharmacological Reviews</i>. <b>66</b> (4): 1106\u201340. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1124/pr.113.007781\">10.1124/pr.113.007781</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25244930\">25244930</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacological+Reviews&amp;rft.atitle=The+pharmacology+of+the+cytochrome+P450+epoxygenase%2Fsoluble+epoxide+hydrolase+axis+in+the+vasculature+and+cardiovascular+disease&amp;rft.volume=66&amp;rft.issue=4&amp;rft.pages=1106-40&amp;rft.date=2014&amp;rft_id=info%3Adoi%2F10.1124%2Fpr.113.007781&amp;rft_id=info%3Apmid%2F25244930&amp;rft.aulast=Fleming&amp;rft.aufirst=I&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Panigrahy D, Greene ER, Pozzi A, Wang DW, Zeldin DC (2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3804913\">\"EET signaling in cancer\"</a>. <i>Cancer Metastasis Reviews</i>. <b>30</b> (3\u20134): 525\u201340. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s10555-011-9315-y\">10.1007/s10555-011-9315-y</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3804913\">3804913</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22009066\">22009066</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Metastasis+Reviews&amp;rft.atitle=EET+signaling+in+cancer&amp;rft.volume=30&amp;rft.issue=3%E2%80%934&amp;rft.pages=525-40&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3804913&amp;rft_id=info%3Apmid%2F22009066&amp;rft_id=info%3Adoi%2F10.1007%2Fs10555-011-9315-y&amp;rft.aulast=Panigrahy&amp;rft.aufirst=D&amp;rft.au=Greene%2C+ER&amp;rft.au=Pozzi%2C+A&amp;rft.au=Wang%2C+DW&amp;rft.au=Zeldin%2C+DC&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3804913&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ayajiki, K; Fujioka, H; Toda, N; Okada, S; Minamiyama, Y; Imaoka, S; Funae, Y; Watanabe, S; Nakamura, A; Okamura, T (2003). \"Mediation of arachidonic acid metabolite(s) produced by endothelial cytochrome P-450 3A4 in monkey arterial relaxation\". <i>Hypertension Research</i>. <b>26</b> (3): 237\u201343. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1291/hypres.26.237\">10.1291/hypres.26.237</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12675279\">12675279</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hypertension+Research&amp;rft.atitle=Mediation+of+arachidonic+acid+metabolite%28s%29+produced+by+endothelial+cytochrome+P-450+3A4+in+monkey+arterial+relaxation&amp;rft.volume=26&amp;rft.issue=3&amp;rft.pages=237-43&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1291%2Fhypres.26.237&amp;rft_id=info%3Apmid%2F12675279&amp;rft.aulast=Ayajiki&amp;rft.aufirst=K&amp;rft.au=Fujioka%2C+H&amp;rft.au=Toda%2C+N&amp;rft.au=Okada%2C+S&amp;rft.au=Minamiyama%2C+Y&amp;rft.au=Imaoka%2C+S&amp;rft.au=Funae%2C+Y&amp;rft.au=Watanabe%2C+S&amp;rft.au=Nakamura%2C+A&amp;rft.au=Okamura%2C+T&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ReferenceA-9\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ReferenceA_9-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ReferenceA_9-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-ReferenceA_9-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-ReferenceA_9-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-ReferenceA_9-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-ReferenceA_9-5\"><sup><i><b>f</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Yang L, M\u00e4ki-Pet\u00e4j\u00e4 K, Cheriyan J, McEniery C, Wilkinson IB (Jul 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4500322\">\"The role of epoxyeicosatrienoic acids in the cardiovascular system\"</a>. <i>British Journal of Clinical Pharmacology</i>. <b>80</b> (1): 28\u201344. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/bcp.12603\">10.1111/bcp.12603</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4500322\">4500322</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25655310\">25655310</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Journal+of+Clinical+Pharmacology&amp;rft.atitle=The+role+of+epoxyeicosatrienoic+acids+in+the+cardiovascular+system&amp;rft.volume=80&amp;rft.issue=1&amp;rft.pages=28-44&amp;rft.date=2015-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4500322&amp;rft_id=info%3Apmid%2F25655310&amp;rft_id=info%3Adoi%2F10.1111%2Fbcp.12603&amp;rft.aulast=Yang&amp;rft.aufirst=L&amp;rft.au=M%C3%A4ki-Pet%C3%A4j%C3%A4%2C+K&amp;rft.au=Cheriyan%2C+J&amp;rft.au=McEniery%2C+C&amp;rft.au=Wilkinson%2C+IB&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4500322&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Gene_p_10-10\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Gene_p_10_10-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Gene_p_10_10-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Harris TR, Hammock BD (Sep 2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3733540\">\"Soluble epoxide hydrolase: gene structure, expression and deletion\"</a>. <i>Gene</i>. <b>526</b> (2): 61\u201374. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.gene.2013.05.008\">10.1016/j.gene.2013.05.008</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3733540\">3733540</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23701967\">23701967</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gene&amp;rft.atitle=Soluble+epoxide+hydrolase%3A+gene+structure%2C+expression+and+deletion&amp;rft.volume=526&amp;rft.issue=2&amp;rft.pages=61-74&amp;rft.date=2013-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3733540&amp;rft_id=info%3Apmid%2F23701967&amp;rft_id=info%3Adoi%2F10.1016%2Fj.gene.2013.05.008&amp;rft.aulast=Harris&amp;rft.aufirst=TR&amp;rft.au=Hammock%2C+BD&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3733540&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fr\u00f6mel T, Fleming I (May 2015). \"Whatever happened to the epoxyeicosatrienoic Acid-like endothelium-derived hyperpolarizing factor? The identification of novel classes of lipid mediators and their role in vascular homeostasis\". <i>Antioxidants &amp; Redox Signaling</i>. <b>22</b> (14): 1273\u201392. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1089/ars.2014.6150\">10.1089/ars.2014.6150</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25330284\">25330284</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Antioxidants+%26+Redox+Signaling&amp;rft.atitle=Whatever+happened+to+the+epoxyeicosatrienoic+Acid-like+endothelium-derived+hyperpolarizing+factor%3F+The+identification+of+novel+classes+of+lipid+mediators+and+their+role+in+vascular+homeostasis&amp;rft.volume=22&amp;rft.issue=14&amp;rft.pages=1273-92&amp;rft.date=2015-05&amp;rft_id=info%3Adoi%2F10.1089%2Fars.2014.6150&amp;rft_id=info%3Apmid%2F25330284&amp;rft.aulast=Fr%C3%B6mel&amp;rft.aufirst=T&amp;rft.au=Fleming%2C+I&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bellien J, Joannides R (Mar 2013). \"Epoxyeicosatrienoic acid pathway in human health and diseases\". <i>Journal of Cardiovascular Pharmacology</i>. <b>61</b> (3): 188\u201396. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/FJC.0b013e318273b007\">10.1097/FJC.0b013e318273b007</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23011468\">23011468</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Cardiovascular+Pharmacology&amp;rft.atitle=Epoxyeicosatrienoic+acid+pathway+in+human+health+and+diseases&amp;rft.volume=61&amp;rft.issue=3&amp;rft.pages=188-96&amp;rft.date=2013-03&amp;rft_id=info%3Adoi%2F10.1097%2FFJC.0b013e318273b007&amp;rft_id=info%3Apmid%2F23011468&amp;rft.aulast=Bellien&amp;rft.aufirst=J&amp;rft.au=Joannides%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Prostaglandins_Other_Lipid_Mediat_2014._p_18-13\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Prostaglandins_Other_Lipid_Mediat_2014._p_18_13-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Prostaglandins_Other_Lipid_Mediat_2014._p_18_13-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Prostaglandins_Other_Lipid_Mediat_2014._p_18_13-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Prostaglandins_Other_Lipid_Mediat_2014._p_18_13-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Prostaglandins_Other_Lipid_Mediat_2014._p_18_13-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Prostaglandins_Other_Lipid_Mediat_2014._p_18_13-5\"><sup><i><b>f</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wagner K, Vito S, Inceoglu B, Hammock BD (Oct 2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4254344\">\"The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling\"</a>. <i>Prostaglandins &amp; Other Lipid Mediators</i>. 113-115: 2\u201312. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.prostaglandins.2014.09.001\">10.1016/j.prostaglandins.2014.09.001</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4254344\">4254344</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25240260\">25240260</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Prostaglandins+%26+Other+Lipid+Mediators&amp;rft.atitle=The+role+of+long+chain+fatty+acids+and+their+epoxide+metabolites+in+nociceptive+signaling&amp;rft.volume=113-115&amp;rft.pages=2-12&amp;rft.date=2014-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4254344&amp;rft_id=info%3Apmid%2F25240260&amp;rft_id=info%3Adoi%2F10.1016%2Fj.prostaglandins.2014.09.001&amp;rft.aulast=Wagner&amp;rft.aufirst=K&amp;rft.au=Vito%2C+S&amp;rft.au=Inceoglu%2C+B&amp;rft.au=Hammock%2C+BD&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4254344&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Annu_Rev_Pharmacol_Toxicol_p_27-14\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Annu_Rev_Pharmacol_Toxicol_p_27_14-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Annu_Rev_Pharmacol_Toxicol_p_27_14-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Morisseau, C; Hammock, B. D. (2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3578707\">\"Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health\"</a>. <i>Annual Review of Pharmacology and Toxicology</i>. <b>53</b>: 37\u201358. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1146/annurev-pharmtox-011112-140244\">10.1146/annurev-pharmtox-011112-140244</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3578707\">3578707</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23020295\">23020295</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annual+Review+of+Pharmacology+and+Toxicology&amp;rft.atitle=Impact+of+soluble+epoxide+hydrolase+and+epoxyeicosanoids+on+human+health&amp;rft.volume=53&amp;rft.pages=37-58&amp;rft.date=2013&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3578707&amp;rft_id=info%3Apmid%2F23020295&amp;rft_id=info%3Adoi%2F10.1146%2Fannurev-pharmtox-011112-140244&amp;rft.aulast=Morisseau&amp;rft.aufirst=C&amp;rft.au=Hammock%2C+B.+D.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3578707&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Thomson SJ, Askari A, Bishop-Bailey D (2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3405717\">\"Anti-inflammatory effects of epoxyeicosatrienoic acids\"</a>. <i>International Journal of Vascular Medicine</i>. <b>2012</b>: 605101. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1155/2012/605101\">10.1155/2012/605101</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3405717\">3405717</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22848834\">22848834</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Vascular+Medicine&amp;rft.atitle=Anti-inflammatory+effects+of+epoxyeicosatrienoic+acids&amp;rft.volume=2012&amp;rft.pages=605101&amp;rft.date=2012&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3405717&amp;rft_id=info%3Apmid%2F22848834&amp;rft_id=info%3Adoi%2F10.1155%2F2012%2F605101&amp;rft.aulast=Thomson&amp;rft.aufirst=SJ&amp;rft.au=Askari%2C+A&amp;rft.au=Bishop-Bailey%2C+D&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3405717&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Nithipatikom K, Moore JM, Isbell MA, Falck JR, Gross GJ (Aug 2006). <a rel=\"nofollow\" class=\"external text\" href=\"http://ajpheart.physiology.org/cgi/pmidlookup?view=long&amp;pmid=16473964\">\"Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury\"</a>. <i>American Journal of Physiology. Heart and Circulatory Physiology</i>. <b>291</b> (2): H537\u201342. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1152/ajpheart.00071.2006\">10.1152/ajpheart.00071.2006</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16473964\">16473964</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Physiology.+Heart+and+Circulatory+Physiology&amp;rft.atitle=Epoxyeicosatrienoic+acids+in+cardioprotection%3A+ischemic+versus+reperfusion+injury&amp;rft.volume=291&amp;rft.issue=2&amp;rft.pages=H537-42&amp;rft.date=2006-08&amp;rft_id=info%3Adoi%2F10.1152%2Fajpheart.00071.2006&amp;rft_id=info%3Apmid%2F16473964&amp;rft.aulast=Nithipatikom&amp;rft.aufirst=K&amp;rft.au=Moore%2C+JM&amp;rft.au=Isbell%2C+MA&amp;rft.au=Falck%2C+JR&amp;rft.au=Gross%2C+GJ&amp;rft_id=http%3A%2F%2Fajpheart.physiology.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D16473964&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Jin L, Foss CE, Zhao X, Mills TM, Wang MH, McCluskey LP, Yaddanapud GS, Falck JR, Imig JD, Webb RC (Mar 2006). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.fasebj.org/cgi/pmidlookup?view=long&amp;pmid=16415108\">\"Cytochrome P450 epoxygenases provide a novel mechanism for penile erection\"</a>. <i>FASEB Journal</i>. <b>20</b> (3): 539\u201341. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1096/fj.05-4341fje\">10.1096/fj.05-4341fje</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16415108\">16415108</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FASEB+Journal&amp;rft.atitle=Cytochrome+P450+epoxygenases+provide+a+novel+mechanism+for+penile+erection&amp;rft.volume=20&amp;rft.issue=3&amp;rft.pages=539-41&amp;rft.date=2006-03&amp;rft_id=info%3Adoi%2F10.1096%2Ffj.05-4341fje&amp;rft_id=info%3Apmid%2F16415108&amp;rft.aulast=Jin&amp;rft.aufirst=L&amp;rft.au=Foss%2C+CE&amp;rft.au=Zhao%2C+X&amp;rft.au=Mills%2C+TM&amp;rft.au=Wang%2C+MH&amp;rft.au=McCluskey%2C+LP&amp;rft.au=Yaddanapud%2C+GS&amp;rft.au=Falck%2C+JR&amp;rft.au=Imig%2C+JD&amp;rft.au=Webb%2C+RC&amp;rft_id=http%3A%2F%2Fwww.fasebj.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D16415108&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ng VY, Huang Y, Reddy LM, Falck JR, Lin ET, Kroetz DL (Jul 2007). \"Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha\". <i>Drug Metabolism and Disposition</i>. <b>35</b> (7): 1126\u201334. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1124/dmd.106.013839\">10.1124/dmd.106.013839</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17431031\">17431031</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drug+Metabolism+and+Disposition&amp;rft.atitle=Cytochrome+P450+eicosanoids+are+activators+of+peroxisome+proliferator-activated+receptor+alpha&amp;rft.volume=35&amp;rft.issue=7&amp;rft.pages=1126-34&amp;rft.date=2007-07&amp;rft_id=info%3Adoi%2F10.1124%2Fdmd.106.013839&amp;rft_id=info%3Apmid%2F17431031&amp;rft.aulast=Ng&amp;rft.aufirst=VY&amp;rft.au=Huang%2C+Y&amp;rft.au=Reddy%2C+LM&amp;rft.au=Falck%2C+JR&amp;rft.au=Lin%2C+ET&amp;rft.au=Kroetz%2C+DL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid26072731-19\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid26072731_19-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid26072731_19-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid26072731_19-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid26072731_19-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sacerdoti D, Pesce P, Di Pascoli M, Brocco S, Cecchetto L, Bolognesi M (Jul 2015). \"Arachidonic acid metabolites and endothelial dysfunction of portal hypertension\". <i>Prostaglandins &amp; Other Lipid Mediators</i>. <b>120</b>: 80\u201390. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.prostaglandins.2015.05.008\">10.1016/j.prostaglandins.2015.05.008</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26072731\">26072731</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Prostaglandins+%26+Other+Lipid+Mediators&amp;rft.atitle=Arachidonic+acid+metabolites+and+endothelial+dysfunction+of+portal+hypertension&amp;rft.volume=120&amp;rft.pages=80-90&amp;rft.date=2015-07&amp;rft_id=info%3Adoi%2F10.1016%2Fj.prostaglandins.2015.05.008&amp;rft_id=info%3Apmid%2F26072731&amp;rft.aulast=Sacerdoti&amp;rft.aufirst=D&amp;rft.au=Pesce%2C+P&amp;rft.au=Di+Pascoli%2C+M&amp;rft.au=Brocco%2C+S&amp;rft.au=Cecchetto%2C+L&amp;rft.au=Bolognesi%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Thomson SJ, Askari A, Bishop-Bailey D (2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3405717\">\"Anti-inflammatory effects of epoxyeicosatrienoic acids\"</a>. <i>International Journal of Vascular Medicine</i>. <b>2012</b>: 605101. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1155/2012/605101\">10.1155/2012/605101</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3405717\">3405717</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22848834\">22848834</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Vascular+Medicine&amp;rft.atitle=Anti-inflammatory+effects+of+epoxyeicosatrienoic+acids&amp;rft.volume=2012&amp;rft.pages=605101&amp;rft.date=2012&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3405717&amp;rft_id=info%3Apmid%2F22848834&amp;rft_id=info%3Adoi%2F10.1155%2F2012%2F605101&amp;rft.aulast=Thomson&amp;rft.aufirst=SJ&amp;rft.au=Askari%2C+A&amp;rft.au=Bishop-Bailey%2C+D&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3405717&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fleming I (Oct 2014). \"The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease\". <i>Pharmacological Reviews</i>. <b>66</b> (4): 1106\u201340. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1124/pr.113.007781\">10.1124/pr.113.007781</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25244930\">25244930</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacological+Reviews&amp;rft.atitle=The+pharmacology+of+the+cytochrome+P450+epoxygenase%2Fsoluble+epoxide+hydrolase+axis+in+the+vasculature+and+cardiovascular+disease&amp;rft.volume=66&amp;rft.issue=4&amp;rft.pages=1106-40&amp;rft.date=2014-10&amp;rft_id=info%3Adoi%2F10.1124%2Fpr.113.007781&amp;rft_id=info%3Apmid%2F25244930&amp;rft.aulast=Fleming&amp;rft.aufirst=I&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Morisseau C, Hammock BD. <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3578707\">\"Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health\"</a>. <i>Annual Review of Pharmacology and Toxicology</i>. <b>53</b>: 37\u201358. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1146/annurev-pharmtox-011112-140244\">10.1146/annurev-pharmtox-011112-140244</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3578707\">3578707</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23020295\">23020295</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annual+Review+of+Pharmacology+and+Toxicology&amp;rft.atitle=Impact+of+soluble+epoxide+hydrolase+and+epoxyeicosanoids+on+human+health&amp;rft.volume=53&amp;rft.pages=37-58&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3578707&amp;rft_id=info%3Apmid%2F23020295&amp;rft_id=info%3Adoi%2F10.1146%2Fannurev-pharmtox-011112-140244&amp;rft.aulast=Morisseau&amp;rft.aufirst=C&amp;rft.au=Hammock%2C+BD&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3578707&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ReferenceC-23\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ReferenceC_23-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ReferenceC_23-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-ReferenceC_23-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fan F, Muroya Y, Roman RJ (Jan 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4260681\">\"Cytochrome P450 eicosanoids in hypertension and renal disease\"</a>. <i>Current Opinion in Nephrology and Hypertension</i>. <b>24</b> (1): 37\u201346. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/MNH.0000000000000088\">10.1097/MNH.0000000000000088</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4260681\">4260681</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25427230\">25427230</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Nephrology+and+Hypertension&amp;rft.atitle=Cytochrome+P450+eicosanoids+in+hypertension+and+renal+disease&amp;rft.volume=24&amp;rft.issue=1&amp;rft.pages=37-46&amp;rft.date=2015-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4260681&amp;rft_id=info%3Apmid%2F25427230&amp;rft_id=info%3Adoi%2F10.1097%2FMNH.0000000000000088&amp;rft.aulast=Fan&amp;rft.aufirst=F&amp;rft.au=Muroya%2C+Y&amp;rft.au=Roman%2C+RJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4260681&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bellien J, Joannides R (Mar 2013). \"Epoxyeicosatrienoic acid pathway in human health and diseases\". <i>Journal of Cardiovascular Pharmacology</i>. <b>61</b> (3): 188\u201396. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/FJC.0b013e318273b007\">10.1097/FJC.0b013e318273b007</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23011468\">23011468</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Cardiovascular+Pharmacology&amp;rft.atitle=Epoxyeicosatrienoic+acid+pathway+in+human+health+and+diseases&amp;rft.volume=61&amp;rft.issue=3&amp;rft.pages=188-96&amp;rft.date=2013-03&amp;rft_id=info%3Adoi%2F10.1097%2FFJC.0b013e318273b007&amp;rft_id=info%3Apmid%2F23011468&amp;rft.aulast=Bellien&amp;rft.aufirst=J&amp;rft.au=Joannides%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"https://www.pharmgkb.org/variant/rs11572082\">https://www.pharmgkb.org/variant/rs11572082</a></span>\n</li>\n<li id=\"cite_note-urlrs1799853_at_chr10:96702047_in_CYP2C9-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-urlrs1799853_at_chr10:96702047_in_CYP2C9_26-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.pharmgkb.org/variant/rs1799853?previousQuery=rs1799853\">\"rs1799853 at chr10:96702047 in CYP2C9\"</a>. <i>PharmGKB</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=PharmGKB&amp;rft.atitle=rs1799853+at+chr10%3A96702047+in+CYP2C9&amp;rft_id=https%3A%2F%2Fwww.pharmgkb.org%2Fvariant%2Frs1799853%3FpreviousQuery%3Drs1799853&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-urlrs1057910_at_chr10:96741053_in_CYP2C9-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-urlrs1057910_at_chr10:96741053_in_CYP2C9_27-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.pharmgkb.org/variant/rs1057910?previousQuery=rs1057910\">\"rs1057910 at chr10:96741053 in CYP2C9\"</a>. <i>PharmGKB</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=PharmGKB&amp;rft.atitle=rs1057910+at+chr10%3A96741053+in+CYP2C9&amp;rft_id=https%3A%2F%2Fwww.pharmgkb.org%2Fvariant%2Frs1057910%3FpreviousQuery%3Drs1057910&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid22173545-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid22173545_28-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fava C, Ricci M, Melander O, Minuz P (2012). \"Hypertension, cardiovascular risk and polymorphisms in genes controlling the cytochrome P450 pathway of arachidonic acid: A sex-specific relation?\". <i>Prostaglandins &amp; Other Lipid Mediators</i>. <b>98</b> (3-4): 75\u201385. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.prostaglandins.2011.11.007\">10.1016/j.prostaglandins.2011.11.007</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22173545\">22173545</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Prostaglandins+%26+Other+Lipid+Mediators&amp;rft.atitle=Hypertension%2C+cardiovascular+risk+and+polymorphisms+in+genes+controlling+the+cytochrome+P450+pathway+of+arachidonic+acid%3A+A+sex-specific+relation%3F&amp;rft.volume=98&amp;rft.issue=3-4&amp;rft.pages=75-85&amp;rft.date=2012&amp;rft_id=info%3Adoi%2F10.1016%2Fj.prostaglandins.2011.11.007&amp;rft_id=info%3Apmid%2F22173545&amp;rft.aulast=Fava&amp;rft.aufirst=C&amp;rft.au=Ricci%2C+M&amp;rft.au=Melander%2C+O&amp;rft.au=Minuz%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-29\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bellien J, Joannides R (Mar 2013). \"Epoxyeicosatrienoic acid pathway in human health and diseases\". <i>Journal of Cardiovascular Pharmacology</i>. <b>61</b> (3): 188\u201396. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/FJC.0b013e318273b007\">10.1097/FJC.0b013e318273b007</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23011468\">23011468</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Cardiovascular+Pharmacology&amp;rft.atitle=Epoxyeicosatrienoic+acid+pathway+in+human+health+and+diseases&amp;rft.volume=61&amp;rft.issue=3&amp;rft.pages=188-96&amp;rft.date=2013-03&amp;rft_id=info%3Adoi%2F10.1097%2FFJC.0b013e318273b007&amp;rft_id=info%3Apmid%2F23011468&amp;rft.aulast=Bellien&amp;rft.aufirst=J&amp;rft.au=Joannides%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-30\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Konkel A, Schunck WH (Jan 2011). \"Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids\". <i>Biochimica et Biophysica Acta</i>. <b>1814</b> (1): 210\u201322. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bbapap.2010.09.009\">10.1016/j.bbapap.2010.09.009</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20869469\">20869469</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochimica+et+Biophysica+Acta&amp;rft.atitle=Role+of+cytochrome+P450+enzymes+in+the+bioactivation+of+polyunsaturated+fatty+acids&amp;rft.volume=1814&amp;rft.issue=1&amp;rft.pages=210-22&amp;rft.date=2011-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbapap.2010.09.009&amp;rft_id=info%3Apmid%2F20869469&amp;rft.aulast=Konkel&amp;rft.aufirst=A&amp;rft.au=Schunck%2C+WH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-31\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bellien J, Joannides R (Mar 2013). \"Epoxyeicosatrienoic acid pathway in human health and diseases\". <i>Journal of Cardiovascular Pharmacology</i>. <b>61</b> (3): 188\u201396. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/FJC.0b013e318273b007\">10.1097/FJC.0b013e318273b007</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23011468\">23011468</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Cardiovascular+Pharmacology&amp;rft.atitle=Epoxyeicosatrienoic+acid+pathway+in+human+health+and+diseases&amp;rft.volume=61&amp;rft.issue=3&amp;rft.pages=188-96&amp;rft.date=2013-03&amp;rft_id=info%3Adoi%2F10.1097%2FFJC.0b013e318273b007&amp;rft_id=info%3Apmid%2F23011468&amp;rft.aulast=Bellien&amp;rft.aufirst=J&amp;rft.au=Joannides%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-32\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-32\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lazaar AL, Yang L, Boardley RL, Goyal NS, Robertson J, Baldwin SJ, Newby DE, Wilkinson IB, Tal-Singer R, Mayer RJ, Cheriyan J (Dec 2015). \"Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor\". <i>British Journal of Clinical Pharmacology</i>. <b>81</b>: 971\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/bcp.12855\">10.1111/bcp.12855</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26620151\">26620151</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Journal+of+Clinical+Pharmacology&amp;rft.atitle=Pharmacokinetics%2C+pharmacodynamics+and+adverse+event+profile+of+GSK2256294%2C+a+novel+soluble+epoxide+hydrolase+inhibitor&amp;rft.volume=81&amp;rft.pages=971-9&amp;rft.date=2015-12&amp;rft_id=info%3Adoi%2F10.1111%2Fbcp.12855&amp;rft_id=info%3Apmid%2F26620151&amp;rft.aulast=Lazaar&amp;rft.aufirst=AL&amp;rft.au=Yang%2C+L&amp;rft.au=Boardley%2C+RL&amp;rft.au=Goyal%2C+NS&amp;rft.au=Robertson%2C+J&amp;rft.au=Baldwin%2C+SJ&amp;rft.au=Newby%2C+DE&amp;rft.au=Wilkinson%2C+IB&amp;rft.au=Tal-Singer%2C+R&amp;rft.au=Mayer%2C+RJ&amp;rft.au=Cheriyan%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-33\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-33\">^</a></b></span> <span class=\"reference-text\">Clinical trial number <i><a rel=\"nofollow\" class=\"external text\" href=\"https://www.clinicaltrials.gov/show/NCT00847899\">NCT00847899</a></i> for \"Evaluation of Soluble Epoxide Hydrolase (s-EH) Inhibitor in Patients With Mild to Moderate Hypertension and Impaired Glucose Tolerance\" at <a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></span>\n</li>\n<li id=\"cite_note-J_Mol_Cell_Cardiol_2014-34\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-J_Mol_Cell_Cardiol_2014_34-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-J_Mol_Cell_Cardiol_2014_34-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Oni-Orisan A, Alsaleh N, Lee CR, Seubert JM (Sep 2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4115045\">\"Epoxyeicosatrienoic acids and cardioprotection: the road to translation\"</a>. <i>Journal of Molecular and Cellular Cardiology</i>. <b>74</b>: 199\u2013208. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.yjmcc.2014.05.016\">10.1016/j.yjmcc.2014.05.016</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4115045\">4115045</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24893205\">24893205</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Molecular+and+Cellular+Cardiology&amp;rft.atitle=Epoxyeicosatrienoic+acids+and+cardioprotection%3A+the+road+to+translation&amp;rft.volume=74&amp;rft.pages=199-208&amp;rft.date=2014-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4115045&amp;rft_id=info%3Apmid%2F24893205&amp;rft_id=info%3Adoi%2F10.1016%2Fj.yjmcc.2014.05.016&amp;rft.aulast=Oni-Orisan&amp;rft.aufirst=A&amp;rft.au=Alsaleh%2C+N&amp;rft.au=Lee%2C+CR&amp;rft.au=Seubert%2C+JM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4115045&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Huang_H_2015-35\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Huang_H_2015_35-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Huang_H_2015_35-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Huang_H_2015_35-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Huang_H_2015_35-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Huang H, Al-Shabrawey M, Wang MH (Jan 2016). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4779674\">\"Cyclooxygenase- and cytochrome P450-derived eicosanoids in stroke\"</a>. <i>Prostaglandins &amp; Other Lipid Mediators</i>. <b>122</b>: 45\u201353. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.prostaglandins.2015.12.007\">10.1016/j.prostaglandins.2015.12.007</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4779674\">4779674</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26747234\">26747234</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Prostaglandins+%26+Other+Lipid+Mediators&amp;rft.atitle=Cyclooxygenase-+and+cytochrome+P450-derived+eicosanoids+in+stroke&amp;rft.volume=122&amp;rft.pages=45-53&amp;rft.date=2016-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4779674&amp;rft_id=info%3Apmid%2F26747234&amp;rft_id=info%3Adoi%2F10.1016%2Fj.prostaglandins.2015.12.007&amp;rft.aulast=Huang&amp;rft.aufirst=H&amp;rft.au=Al-Shabrawey%2C+M&amp;rft.au=Wang%2C+MH&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4779674&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-36\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Siler DA, Berlow YA, Kukino A, Davis CM, Nelson JW, Grafe MR, Ono H, Cetas JS, Pike M, Alkayed NJ (Jul 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4480190\">\"Soluble Epoxide Hydrolase in Hydrocephalus, Cerebral Edema, and Vascular Inflammation After Subarachnoid Hemorrhage\"</a>. <i>Stroke: A Journal of Cerebral Circulation</i>. <b>46</b> (7): 1916\u201322. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1161/STROKEAHA.114.008560\">10.1161/STROKEAHA.114.008560</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4480190\">4480190</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25991416\">25991416</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Stroke%3A+A+Journal+of+Cerebral+Circulation&amp;rft.atitle=Soluble+Epoxide+Hydrolase+in+Hydrocephalus%2C+Cerebral+Edema%2C+and+Vascular+Inflammation+After+Subarachnoid+Hemorrhage&amp;rft.volume=46&amp;rft.issue=7&amp;rft.pages=1916-22&amp;rft.date=2015-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4480190&amp;rft_id=info%3Apmid%2F25991416&amp;rft_id=info%3Adoi%2F10.1161%2FSTROKEAHA.114.008560&amp;rft.aulast=Siler&amp;rft.aufirst=DA&amp;rft.au=Berlow%2C+YA&amp;rft.au=Kukino%2C+A&amp;rft.au=Davis%2C+CM&amp;rft.au=Nelson%2C+JW&amp;rft.au=Grafe%2C+MR&amp;rft.au=Ono%2C+H&amp;rft.au=Cetas%2C+JS&amp;rft.au=Pike%2C+M&amp;rft.au=Alkayed%2C+NJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4480190&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-37\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-37\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hung YW, Hung SW, Wu YC, Wong LK, Lai MT, Shih YH, Lee TS, Lin YY (Jan 2015). \"Soluble epoxide hydrolase activity regulates inflammatory responses and seizure generation in two mouse models of temporal lobe epilepsy\". <i>Brain, Behavior, and Immunity</i>. <b>43</b>: 118\u201329. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bbi.2014.07.016\">10.1016/j.bbi.2014.07.016</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25135858\">25135858</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Brain%2C+Behavior%2C+and+Immunity&amp;rft.atitle=Soluble+epoxide+hydrolase+activity+regulates+inflammatory+responses+and+seizure+generation+in+two+mouse+models+of+temporal+lobe+epilepsy&amp;rft.volume=43&amp;rft.pages=118-29&amp;rft.date=2015-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbi.2014.07.016&amp;rft_id=info%3Apmid%2F25135858&amp;rft.aulast=Hung&amp;rft.aufirst=YW&amp;rft.au=Hung%2C+SW&amp;rft.au=Wu%2C+YC&amp;rft.au=Wong%2C+LK&amp;rft.au=Lai%2C+MT&amp;rft.au=Shih%2C+YH&amp;rft.au=Lee%2C+TS&amp;rft.au=Lin%2C+YY&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Prostaglandins_Other_Lipid_Mediat_2011-38\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Prostaglandins_Other_Lipid_Mediat_2011_38-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Prostaglandins_Other_Lipid_Mediat_2011_38-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sacerdoti D, Mania D, Jiang H, Pesce P, Gaiani S, Gatta A, Bolognesi M (2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4547526\">\"Increased EETs participate in peripheral endothelial dysfunction of cirrhosis\"</a>. <i>Prostaglandins &amp; Other Lipid Mediators</i>. <b>98</b> (3-4): 129\u201332. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.prostaglandins.2011.12.008\">10.1016/j.prostaglandins.2011.12.008</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4547526\">4547526</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22245571\">22245571</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Prostaglandins+%26+Other+Lipid+Mediators&amp;rft.atitle=Increased+EETs+participate+in+peripheral+endothelial+dysfunction+of+cirrhosis&amp;rft.volume=98&amp;rft.issue=3-4&amp;rft.pages=129-32&amp;rft.date=2012&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4547526&amp;rft_id=info%3Apmid%2F22245571&amp;rft_id=info%3Adoi%2F10.1016%2Fj.prostaglandins.2011.12.008&amp;rft.aulast=Sacerdoti&amp;rft.aufirst=D&amp;rft.au=Mania%2C+D&amp;rft.au=Jiang%2C+H&amp;rft.au=Pesce%2C+P&amp;rft.au=Gaiani%2C+S&amp;rft.au=Gatta%2C+A&amp;rft.au=Bolognesi%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4547526&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-39\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-39\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sacerdoti D, Gatta A, McGiff JC (Oct 2003). \"Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology\". <i>Prostaglandins &amp; Other Lipid Mediators</i>. <b>72</b> (1-2): 51\u201371. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/s1098-8823%2803%2900077-7\">10.1016/s1098-8823(03)00077-7</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14626496\">14626496</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Prostaglandins+%26+Other+Lipid+Mediators&amp;rft.atitle=Role+of+cytochrome+P450-dependent+arachidonic+acid+metabolites+in+liver+physiology+and+pathophysiology&amp;rft.volume=72&amp;rft.issue=1-2&amp;rft.pages=51-71&amp;rft.date=2003-10&amp;rft_id=info%3Adoi%2F10.1016%2Fs1098-8823%2803%2900077-7&amp;rft_id=info%3Apmid%2F14626496&amp;rft.aulast=Sacerdoti&amp;rft.aufirst=D&amp;rft.au=Gatta%2C+A&amp;rft.au=McGiff%2C+JC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid21856435-40\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid21856435_40-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid21856435_40-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sacerdoti D, Jiang H, Gaiani S, McGiff JC, Gatta A, Bolognesi M (2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4540347\">\"11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension\"</a>. <i>Prostaglandins &amp; Other Lipid Mediators</i>. <b>96</b> (1-4): 72\u20135. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.prostaglandins.2011.08.002\">10.1016/j.prostaglandins.2011.08.002</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4540347\">4540347</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21856435\">21856435</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Prostaglandins+%26+Other+Lipid+Mediators&amp;rft.atitle=11%2C12-EET+increases+porto-sinusoidal+resistance+and+may+play+a+role+in+endothelial+dysfunction+of+portal+hypertension&amp;rft.volume=96&amp;rft.issue=1-4&amp;rft.pages=72-5&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4540347&amp;rft_id=info%3Apmid%2F21856435&amp;rft_id=info%3Adoi%2F10.1016%2Fj.prostaglandins.2011.08.002&amp;rft.aulast=Sacerdoti&amp;rft.aufirst=D&amp;rft.au=Jiang%2C+H&amp;rft.au=Gaiani%2C+S&amp;rft.au=McGiff%2C+JC&amp;rft.au=Gatta%2C+A&amp;rft.au=Bolognesi%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4540347&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid15930289-41\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid15930289_41-0\">^</a></b></span> <span class=\"reference-text\">\n<cite class=\"citation journal\">Jiang JG, Chen CL, Card JW, Yang S, Chen JX, Fu XN, Ning YG, Xiao X, Zeldin DC, Wang DW (2005). \"Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors\". <i>Cancer Research</i>. <b>65</b> (11): 4707\u201315. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1158/0008-5472.CAN-04-4173\">10.1158/0008-5472.CAN-04-4173</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15930289\">15930289</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Research&amp;rft.atitle=Cytochrome+P450+2J2+promotes+the+neoplastic+phenotype+of+carcinoma+cells+and+is+up-regulated+in+human+tumors&amp;rft.volume=65&amp;rft.issue=11&amp;rft.pages=4707-15&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1158%2F0008-5472.CAN-04-4173&amp;rft_id=info%3Apmid%2F15930289&amp;rft.aulast=Jiang&amp;rft.aufirst=JG&amp;rft.au=Chen%2C+CL&amp;rft.au=Card%2C+JW&amp;rft.au=Yang%2C+S&amp;rft.au=Chen%2C+JX&amp;rft.au=Fu%2C+XN&amp;rft.au=Ning%2C+YG&amp;rft.au=Xiao%2C+X&amp;rft.au=Zeldin%2C+DC&amp;rft.au=Wang%2C+DW&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid22009066-42\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid22009066_42-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid22009066_42-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid22009066_42-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\">\n<cite class=\"citation journal\">Panigrahy D, Greene ER, Pozzi A, Wang DW, Zeldin DC (2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3804913\">\"EET signaling in cancer\"</a>. <i>Cancer Metastasis Reviews</i>. <b>30</b> (3\u20134): 525\u201340. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s10555-011-9315-y\">10.1007/s10555-011-9315-y</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3804913\">3804913</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22009066\">22009066</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Metastasis+Reviews&amp;rft.atitle=EET+signaling+in+cancer&amp;rft.volume=30&amp;rft.issue=3%E2%80%934&amp;rft.pages=525-40&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3804913&amp;rft_id=info%3Apmid%2F22009066&amp;rft_id=info%3Adoi%2F10.1007%2Fs10555-011-9315-y&amp;rft.aulast=Panigrahy&amp;rft.aufirst=D&amp;rft.au=Greene%2C+ER&amp;rft.au=Pozzi%2C+A&amp;rft.au=Wang%2C+DW&amp;rft.au=Zeldin%2C+DC&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3804913&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-43\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-43\">^</a></b></span> <span class=\"reference-text\">\n<cite class=\"citation journal\">Chen, C; Li, G; Liao, W; Wu, J; Liu, L; Ma, D; Zhou, J; Elbekai, R. H.; Edin, M. L.; Zeldin, D. C.; Wang, D. W. (2009). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2683771\">\"Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo\"</a>. <i>Journal of Pharmacology and Experimental Therapeutics</i>. <b>329</b> (3): 908\u201318. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1124/jpet.109.152017\">10.1124/jpet.109.152017</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2683771\">2683771</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19289568\">19289568</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Pharmacology+and+Experimental+Therapeutics&amp;rft.atitle=Selective+inhibitors+of+CYP2J2+related+to+terfenadine+exhibit+strong+activity+against+human+cancers+in+vitro+and+in+vivo&amp;rft.volume=329&amp;rft.issue=3&amp;rft.pages=908-18&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2683771&amp;rft_id=info%3Apmid%2F19289568&amp;rft_id=info%3Adoi%2F10.1124%2Fjpet.109.152017&amp;rft.aulast=Chen&amp;rft.aufirst=C&amp;rft.au=Li%2C+G&amp;rft.au=Liao%2C+W&amp;rft.au=Wu%2C+J&amp;rft.au=Liu%2C+L&amp;rft.au=Ma%2C+D&amp;rft.au=Zhou%2C+J&amp;rft.au=Elbekai%2C+R.+H.&amp;rft.au=Edin%2C+M.+L.&amp;rft.au=Zeldin%2C+D.+C.&amp;rft.au=Wang%2C+D.+W.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2683771&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-44\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-44\">^</a></b></span> <span class=\"reference-text\">\n<cite class=\"citation journal\">Chen, C; Wei, X; Rao, X; Wu, J; Yang, S; Chen, F; Ma, D; Zhou, J; Dackor, R. T.; Zeldin, D. C.; Wang, D. W. (2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3033713\">\"Cytochrome P450 2J2 is highly expressed in hematologic malignant diseases and promotes tumor cell growth\"</a>. <i>Journal of Pharmacology and Experimental Therapeutics</i>. <b>336</b> (2): 344\u201355. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1124/jpet.110.174805\">10.1124/jpet.110.174805</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3033713\">3033713</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21030485\">21030485</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Pharmacology+and+Experimental+Therapeutics&amp;rft.atitle=Cytochrome+P450+2J2+is+highly+expressed+in+hematologic+malignant+diseases+and+promotes+tumor+cell+growth&amp;rft.volume=336&amp;rft.issue=2&amp;rft.pages=344-55&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3033713&amp;rft_id=info%3Apmid%2F21030485&amp;rft_id=info%3Adoi%2F10.1124%2Fjpet.110.174805&amp;rft.aulast=Chen&amp;rft.aufirst=C&amp;rft.au=Wei%2C+X&amp;rft.au=Rao%2C+X&amp;rft.au=Wu%2C+J&amp;rft.au=Yang%2C+S&amp;rft.au=Chen%2C+F&amp;rft.au=Ma%2C+D&amp;rft.au=Zhou%2C+J&amp;rft.au=Dackor%2C+R.+T.&amp;rft.au=Zeldin%2C+D.+C.&amp;rft.au=Wang%2C+D.+W.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3033713&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Adv_Drug_Deliv_Rev_2011-45\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Adv_Drug_Deliv_Rev_2011_45-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Adv_Drug_Deliv_Rev_2011_45-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">\n<cite class=\"citation journal\">Xu, X; Zhang, X. A.; Wang, D. W. (2011). \"The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases\". <i>Advanced Drug Delivery Reviews</i>. <b>63</b> (8): 597\u2013609. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.addr.2011.03.006\">10.1016/j.addr.2011.03.006</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21477627\">21477627</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Advanced+Drug+Delivery+Reviews&amp;rft.atitle=The+roles+of+CYP450+epoxygenases+and+metabolites%2C+epoxyeicosatrienoic+acids%2C+in+cardiovascular+and+malignant+diseases&amp;rft.volume=63&amp;rft.issue=8&amp;rft.pages=597-609&amp;rft.date=2011&amp;rft_id=info%3Adoi%2F10.1016%2Fj.addr.2011.03.006&amp;rft_id=info%3Apmid%2F21477627&amp;rft.aulast=Xu&amp;rft.aufirst=X&amp;rft.au=Zhang%2C+X.+A.&amp;rft.au=Wang%2C+D.+W.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-46\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-46\">^</a></b></span> <span class=\"reference-text\">\n<cite class=\"citation journal\">Mitra, R; Guo, Z; Milani, M; Mesaros, C; Rodriguez, M; Nguyen, J; Luo, X; Clarke, D; Lamba, J; Schuetz, E; Donner, D. B.; Puli, N; Falck, J. R.; Capdevila, J; Gupta, K; Blair, I. A.; Potter, D. A. (2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3093829\">\"CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (\u00b1)-14,15-epoxyeicosatrienoic acid (EET)\"</a>. <i>Journal of Biological Chemistry</i>. <b>286</b> (20): 17543\u201359. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1074/jbc.M110.198515\">10.1074/jbc.M110.198515</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3093829\">3093829</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21402692\">21402692</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Biological+Chemistry&amp;rft.atitle=CYP3A4+mediates+growth+of+estrogen+receptor-positive+breast+cancer+cells+in+part+by+inducing+nuclear+translocation+of+phospho-Stat3+through+biosynthesis+of+%28%C2%B1%29-14%2C15-epoxyeicosatrienoic+acid+%28EET%29&amp;rft.volume=286&amp;rft.issue=20&amp;rft.pages=17543-59&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3093829&amp;rft_id=info%3Apmid%2F21402692&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M110.198515&amp;rft.aulast=Mitra&amp;rft.aufirst=R&amp;rft.au=Guo%2C+Z&amp;rft.au=Milani%2C+M&amp;rft.au=Mesaros%2C+C&amp;rft.au=Rodriguez%2C+M&amp;rft.au=Nguyen%2C+J&amp;rft.au=Luo%2C+X&amp;rft.au=Clarke%2C+D&amp;rft.au=Lamba%2C+J&amp;rft.au=Schuetz%2C+E&amp;rft.au=Donner%2C+D.+B.&amp;rft.au=Puli%2C+N&amp;rft.au=Falck%2C+J.+R.&amp;rft.au=Capdevila%2C+J&amp;rft.au=Gupta%2C+K&amp;rft.au=Blair%2C+I.+A.&amp;rft.au=Potter%2C+D.+A.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3093829&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Adv_Pharmacol_2015-47\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Adv_Pharmacol_2015_47-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Adv_Pharmacol_2015_47-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Adv_Pharmacol_2015_47-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">Chen C, Wang DW (2015). \"Cytochrome P450-CYP2 Family-Epoxygenase Role in Inflammation and Cancer\".  In Hardwick JP. <i>Cytochrome P450 Function and Pharmacological Roles in Inflammation and Cancer</i>. Advances in Pharmacology. <b>74</b>. pp.&#160;193\u2013221. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/bs.apha.2015.04.005\">10.1016/bs.apha.2015.04.005</a>. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/9780128031193\" title=\"Special:BookSources/9780128031193\">9780128031193</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26233908\">26233908</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Cytochrome+P450-CYP2+Family-Epoxygenase+Role+in+Inflammation+and+Cancer&amp;rft.btitle=Cytochrome+P450+Function+and+Pharmacological+Roles+in+Inflammation+and+Cancer&amp;rft.series=Advances+in+Pharmacology&amp;rft.pages=193-221&amp;rft.date=2015&amp;rft_id=info%3Apmid%2F26233908&amp;rft_id=info%3Adoi%2F10.1016%2Fbs.apha.2015.04.005&amp;rft.isbn=9780128031193&amp;rft.aulast=Chen&amp;rft.aufirst=C&amp;rft.au=Wang%2C+DW&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-48\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-48\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Thomson SJ, Askari A, Bishop-Bailey D (2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3405717\">\"Anti-inflammatory effects of epoxyeicosatrienoic acids\"</a>. <i>International Journal of Vascular Medicine</i>. <b>2012</b>: 605101. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1155/2012/605101\">10.1155/2012/605101</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3405717\">3405717</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22848834\">22848834</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Vascular+Medicine&amp;rft.atitle=Anti-inflammatory+effects+of+epoxyeicosatrienoic+acids&amp;rft.volume=2012&amp;rft.pages=605101&amp;rft.date=2012&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3405717&amp;rft_id=info%3Apmid%2F22848834&amp;rft_id=info%3Adoi%2F10.1155%2F2012%2F605101&amp;rft.aulast=Thomson&amp;rft.aufirst=SJ&amp;rft.au=Askari%2C+A&amp;rft.au=Bishop-Bailey%2C+D&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3405717&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid26621325-49\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid26621325_49-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid26621325_49-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid26621325_49-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid26621325_49-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">He J, Wang C, Zhu Y, Ai D (Dec 2015). \"Soluble epoxide hydrolase: A potential target for metabolic diseases\". <i>Journal of Diabetes</i>. <b>8</b>: 305\u201313. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/1753-0407.12358\">10.1111/1753-0407.12358</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26621325\">26621325</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Diabetes&amp;rft.atitle=Soluble+epoxide+hydrolase%3A+A+potential+target+for+metabolic+diseases&amp;rft.volume=8&amp;rft.pages=305-13&amp;rft.date=2015-12&amp;rft_id=info%3Adoi%2F10.1111%2F1753-0407.12358&amp;rft_id=info%3Apmid%2F26621325&amp;rft.aulast=He&amp;rft.aufirst=J&amp;rft.au=Wang%2C+C&amp;rft.au=Zhu%2C+Y&amp;rft.au=Ai%2C+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-50\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-50\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sacerdoti D, Gatta A, McGiff JC (Oct 2003). \"Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology\". <i>Prostaglandins &amp; Other Lipid Mediators</i>. <b>72</b> (1-2): 51\u201371. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/s1098-8823%2803%2900077-7\">10.1016/s1098-8823(03)00077-7</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14626496\">14626496</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Prostaglandins+%26+Other+Lipid+Mediators&amp;rft.atitle=Role+of+cytochrome+P450-dependent+arachidonic+acid+metabolites+in+liver+physiology+and+pathophysiology&amp;rft.volume=72&amp;rft.issue=1-2&amp;rft.pages=51-71&amp;rft.date=2003-10&amp;rft_id=info%3Adoi%2F10.1016%2Fs1098-8823%2803%2900077-7&amp;rft_id=info%3Apmid%2F14626496&amp;rft.aulast=Sacerdoti&amp;rft.aufirst=D&amp;rft.au=Gatta%2C+A&amp;rft.au=McGiff%2C+JC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid22280237-51\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid22280237_51-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Pillarisetti S, Khanna I (2012). \"Targeting soluble epoxide hydrolase for inflammation and pain - an overview of pharmacology and the inhibitors\". <i>Inflammation &amp; Allergy Drug Targets</i>. <b>11</b> (2): 143\u201358. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2174/187152812800392823\">10.2174/187152812800392823</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22280237\">22280237</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Inflammation+%26+Allergy+Drug+Targets&amp;rft.atitle=Targeting+soluble+epoxide+hydrolase+for+inflammation+and+pain+-+an+overview+of+pharmacology+and+the+inhibitors&amp;rft.volume=11&amp;rft.issue=2&amp;rft.pages=143-58&amp;rft.date=2012&amp;rft_id=info%3Adoi%2F10.2174%2F187152812800392823&amp;rft_id=info%3Apmid%2F22280237&amp;rft.aulast=Pillarisetti&amp;rft.aufirst=S&amp;rft.au=Khanna%2C+I&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxyeicosatrienoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Nuclear_receptor_modulators\" style=\"padding:3px\"><table class=\"nowraplinks hlist collapsible collapsed navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Nuclear_receptor_modulators\" title=\"Template:Nuclear receptor modulators\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Nuclear_receptor_modulators\" title=\"Template talk:Nuclear receptor modulators\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Nuclear_receptor_modulators&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Nuclear_receptor_modulators\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Nuclear_receptor\" title=\"Nuclear receptor\">Nuclear receptor</a> <a href=\"/wiki/Receptor_modulator\" title=\"Receptor modulator\">modulators</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/Aryl_hydrocarbon_receptor\" title=\"Aryl hydrocarbon receptor\"><abbr title=\"Aryl hydrocarbon receptor\">AhR</abbr></a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i>Agonists:</i> <a href=\"/wiki/Arachidonic_acid\" title=\"Arachidonic acid\">Arachidonic acid</a> <a href=\"/wiki/Metabolite\" title=\"Metabolite\">metabolites</a> (e.g., <a href=\"/wiki/Lipoxin_A4\" class=\"mw-redirect\" title=\"Lipoxin A4\">lipoxin A4</a>, <a href=\"/wiki/Prostaglandin_G2\" title=\"Prostaglandin G2\">prostaglandin G2</a>)</li>\n<li><a href=\"/wiki/Carotenoid\" title=\"Carotenoid\">Dietary carotenoids</a></li>\n<li><a href=\"/wiki/Flutamide\" title=\"Flutamide\">Flutamide</a></li>\n<li><a href=\"/wiki/Halogen\" title=\"Halogen\">Halogenated</a> <a href=\"/wiki/Aromatic_hydrocarbon\" title=\"Aromatic hydrocarbon\">aromatic hydrocarbons</a> (e.g., <a href=\"/wiki/Polychlorinated_dibenzodioxin\" class=\"mw-redirect\" title=\"Polychlorinated dibenzodioxin\">polychlorinated dibenzodioxins</a> (e.g., <a href=\"/wiki/2,3,7,8-Tetrachlorodibenzodioxin\" title=\"2,3,7,8-Tetrachlorodibenzodioxin\">TCDD</a>), <a href=\"/wiki/Dibenzofuran\" title=\"Dibenzofuran\">dibenzofurans</a>, <a href=\"/wiki/Biphenyl\" title=\"Biphenyl\">biphenyls</a>)</li>\n<li><a href=\"/wiki/Low-density_lipoprotein\" title=\"Low-density lipoprotein\">Modified low-density lipoproteins</a></li>\n<li><a href=\"/wiki/Polycyclic_aromatic_hydrocarbon\" title=\"Polycyclic aromatic hydrocarbon\">Polycyclic aromatic hydrocarbons</a> (e.g., <a href=\"/wiki/3-methylcholanthrene\" class=\"mw-redirect\" title=\"3-methylcholanthrene\">3-methylcholanthrene</a>, <a href=\"/wiki/Benzo(a)pyrene\" title=\"Benzo(a)pyrene\">benzo[a]pyrene</a>, <a href=\"/wiki/Benzanthracene\" class=\"mw-redirect\" title=\"Benzanthracene\">benzanthracenes</a>, <a href=\"/wiki/Benzoflavone\" class=\"mw-redirect\" title=\"Benzoflavone\">benzoflavones</a> (e.g., <a href=\"/wiki/Beta-naphthoflavone\" class=\"mw-redirect\" title=\"Beta-naphthoflavone\">beta-naphthoflavone</a>))</li>\n<li><a href=\"/w/index.php?title=Tapinarof&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Tapinarof (page does not exist)\">Tapinarof (benvitimod)</a></li>\n<li><a href=\"/wiki/Tetrapyrole\" class=\"mw-redirect\" title=\"Tetrapyrole\">Tetrapyroles</a> (e.g., <a href=\"/wiki/Bilirubin\" title=\"Bilirubin\">bilirubin</a>)</li>\n<li><a href=\"/wiki/Tryptophan\" title=\"Tryptophan\">Tryptophan</a> <a href=\"/wiki/Chemical_derivative\" class=\"mw-redirect\" title=\"Chemical derivative\">derivatives</a> (e.g., <a href=\"/wiki/Indigo_dye\" title=\"Indigo dye\">indigo dye</a>, <a href=\"/wiki/Indirubin\" title=\"Indirubin\">indirubin</a>)</li></ul>\n<ul><li><i>Antagonists:</i> <a href=\"/w/index.php?title=7-Ketocholesterol&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"7-Ketocholesterol (page does not exist)\">7-Ketocholesterol</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/Constitutive_androstane_receptor\" title=\"Constitutive androstane receptor\"><abbr title=\"Constitutive androstane receptor\">CAR</abbr></a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">See <a href=\"/wiki/Template:Xenobiotic-sensing_receptor_modulators\" title=\"Template:Xenobiotic-sensing receptor modulators\">here</a> instead.</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/Estrogen-related_receptor\" title=\"Estrogen-related receptor\"><abbr title=\"Estrogen-related receptor\">ERR</abbr></a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:3em;;text-align:center;\"><a href=\"/wiki/Estrogen-related_receptor_alpha\" title=\"Estrogen-related receptor alpha\"><abbr title=\"Estrogen-related receptor alpha\">ERR\u03b1</abbr></a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i>Agonists:</i> <a href=\"/w/index.php?title=6,3%E2%80%B2,4%E2%80%B2-Trihydroxyflavone&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"6,3\u2032,4\u2032-Trihydroxyflavone (page does not exist)\">6,3\u2032,4\u2032-Trihydroxyflavone</a></li>\n<li><a href=\"/wiki/Biochanin_A\" title=\"Biochanin A\">Biochanin A</a></li>\n<li><a href=\"/wiki/Cholesterol\" title=\"Cholesterol\">Cholesterol</a></li>\n<li><a href=\"/wiki/Daidzein\" title=\"Daidzein\">Daidzein</a></li>\n<li><a href=\"/wiki/Genistein\" title=\"Genistein\">Genistein</a></li></ul>\n<ul><li><i>Antagonists:</i> <a href=\"/wiki/Diethylstilbestrol\" title=\"Diethylstilbestrol\">Diethylstilbestrol</a></li>\n<li><a href=\"/wiki/XCT790\" class=\"mw-redirect\" title=\"XCT790\">XCT-790</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:3em;;text-align:center;\"><a href=\"/wiki/Estrogen-related_receptor_beta\" title=\"Estrogen-related receptor beta\"><abbr title=\"Estrogen-related receptor beta\">ERR\u03b2</abbr></a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i>Agonists:</i> <a href=\"/w/index.php?title=DY-131&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"DY-131 (page does not exist)\">DY-131 (GSK-9089)</a></li>\n<li><a href=\"/w/index.php?title=GSK-4716&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"GSK-4716 (page does not exist)\">GSK-4716 (GW-4716)</a></li></ul>\n<ul><li><i>Antagonists:</i> <a href=\"/wiki/Afimoxifene\" title=\"Afimoxifene\">4-Hydroxytamoxifen (afimoxifene)</a></li>\n<li><a href=\"/wiki/Diethylstilbestrol\" title=\"Diethylstilbestrol\">Diethylstilbestrol</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:3em;;text-align:center;\"><a href=\"/wiki/Estrogen-related_receptor_gamma\" title=\"Estrogen-related receptor gamma\"><abbr title=\"Estrogen-related receptor gamma\">ERR\u03b3</abbr></a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i>Agonists:</i> <a href=\"/wiki/Bisphenol_A\" title=\"Bisphenol A\">Bisphenol A</a></li>\n<li><a href=\"/w/index.php?title=DY-131&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"DY-131 (page does not exist)\">DY-131 (GSK-9089)</a></li>\n<li><a href=\"/w/index.php?title=GSK-4716&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"GSK-4716 (page does not exist)\">GSK-4716 (GW-4716)</a></li></ul>\n<ul><li><i>Antagonists:</i> <a href=\"/wiki/Afimoxifene\" title=\"Afimoxifene\">4-Hydroxytamoxifen (afimoxifene)</a></li>\n<li><a href=\"/wiki/Diethylstilbestrol\" title=\"Diethylstilbestrol\">Diethylstilbestrol</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/Farnesoid_X_receptor\" title=\"Farnesoid X receptor\"><abbr title=\"Farnesoid X receptor\">FXR</abbr></a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i>Agonists:</i> <a href=\"/wiki/Bile_acid\" title=\"Bile acid\">Bile acids</a></li>\n<li><a href=\"/wiki/Cafestol\" title=\"Cafestol\">Cafestol</a></li>\n<li><a href=\"/wiki/Chenodeoxycholic_acid\" title=\"Chenodeoxycholic acid\">Chenodeoxycholic acid</a></li>\n<li><a href=\"/w/index.php?title=Cilofexor&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Cilofexor (page does not exist)\">Cilofexor</a></li>\n<li><a href=\"/wiki/Fexaramine\" title=\"Fexaramine\">Fexaramine</a></li>\n<li><a href=\"/w/index.php?title=GW-4064&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"GW-4064 (page does not exist)\">GW-4064</a></li>\n<li><a href=\"/w/index.php?title=Nidufexor&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Nidufexor (page does not exist)\">Nidufexor</a></li>\n<li><a href=\"/wiki/Obeticholic_acid\" title=\"Obeticholic acid\">Obeticholic acid</a></li>\n<li><a href=\"/w/index.php?title=Tropifexor&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Tropifexor (page does not exist)\">Tropifexor</a></li></ul>\n<ul><li><i>Antagonists:</i> <a href=\"/wiki/Guggulsterone\" title=\"Guggulsterone\">Guggulsterone</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/Liver_X_receptor\" title=\"Liver X receptor\"><abbr title=\"Liver X receptor\">LXR</abbr></a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i>Agonists:</i> <a href=\"/wiki/22R-Hydroxycholesterol\" title=\"22R-Hydroxycholesterol\">22R-Hydroxycholesterol</a></li>\n<li><a href=\"/w/index.php?title=24S-Hydroxycholesterol&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"24S-Hydroxycholesterol (page does not exist)\">24S-Hydroxycholesterol</a></li>\n<li><a href=\"/wiki/27-Hydroxycholesterol\" title=\"27-Hydroxycholesterol\">27-Hydroxycholesterol</a></li>\n<li><a href=\"/w/index.php?title=Cholestenoic_acid&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Cholestenoic acid (page does not exist)\">Cholestenoic acid</a></li>\n<li><a href=\"/w/index.php?title=N,N-Dimethyl-3%CE%B2-hydroxycholenamide&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"N,N-Dimethyl-3\u03b2-hydroxycholenamide (page does not exist)\">DMHCA</a></li>\n<li><a href=\"/w/index.php?title=GW-3965&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"GW-3965 (page does not exist)\">GW-3965</a></li>\n<li><a href=\"/w/index.php?title=Hypocholamide&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Hypocholamide (page does not exist)\">Hypocholamide</a></li>\n<li><a href=\"/w/index.php?title=T-0901317&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"T-0901317 (page does not exist)\">T-0901317</a></li></ul>\n<ul><li><i>Antagonists:</i> <a href=\"/wiki/Efavirenz\" title=\"Efavirenz\">Efavirenz</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/Peroxisome_proliferator-activated_receptor\" title=\"Peroxisome proliferator-activated receptor\"><abbr title=\"Peroxisome proliferator-activated receptor\">PPAR</abbr></a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">See <a href=\"/wiki/Template:PPAR_modulators\" title=\"Template:PPAR modulators\">here</a> instead.</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/Pregnane_X_receptor\" title=\"Pregnane X receptor\"><abbr title=\"Pregnane X receptor\">PXR</abbr></a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">See <a href=\"/wiki/Template:Xenobiotic-sensing_receptor_modulators\" title=\"Template:Xenobiotic-sensing receptor modulators\">here</a> instead.</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/Retinoid_receptor\" title=\"Retinoid receptor\">Retinoid</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">See <a href=\"/wiki/Template:Retinoid_receptor_modulators\" title=\"Template:Retinoid receptor modulators\">here</a> instead.</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/Steroid_hormone_receptor\" title=\"Steroid hormone receptor\"><abbr title=\"Steroid hormone receptor\">SHR</abbr></a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:3em;;text-align:center;\"><a href=\"/wiki/Androgen_receptor\" title=\"Androgen receptor\"><abbr title=\"Androgen receptor\">AR</abbr></a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">See <a href=\"/wiki/Template:Androgen_receptor_modulators\" title=\"Template:Androgen receptor modulators\">here</a> instead.</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:3em;;text-align:center;\"><a href=\"/wiki/Estrogen_receptor\" title=\"Estrogen receptor\"><abbr title=\"Estrogen receptor\">ER</abbr></a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">See <a href=\"/wiki/Template:Estrogen_receptor_modulators\" title=\"Template:Estrogen receptor modulators\">here</a> instead.</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:3em;;text-align:center;\"><a href=\"/wiki/Progesterone_receptor\" title=\"Progesterone receptor\"><abbr title=\"Progesterone receptor\">PR</abbr></a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">See <a href=\"/wiki/Template:Progesterone_receptor_modulators\" title=\"Template:Progesterone receptor modulators\">here</a> instead.</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:3em;;text-align:center;\"><a href=\"/wiki/Glucocorticoid_receptor\" title=\"Glucocorticoid receptor\"><abbr title=\"Glucocorticoid receptor\">GR</abbr></a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">See <a href=\"/wiki/Template:Glucocorticoid_receptor_modulators\" title=\"Template:Glucocorticoid receptor modulators\">here</a> instead.</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:3em;;text-align:center;\"><a href=\"/wiki/Mineralocorticoid_receptor\" title=\"Mineralocorticoid receptor\"><abbr title=\"Mineralocorticoid receptor\">MR</abbr></a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">See <a href=\"/wiki/Template:Mineralocorticoid_receptor_modulators\" title=\"Template:Mineralocorticoid receptor modulators\">here</a> instead.</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/Thyroid_hormone_receptor\" title=\"Thyroid hormone receptor\"><abbr title=\"Thyroid hormone receptor\">THR</abbr></a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li>See <a href=\"/wiki/Template:Thyroid_hormone_receptor_modulators\" title=\"Template:Thyroid hormone receptor modulators\">here</a> instead.</li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/Vitamin_D_receptor\" class=\"mw-redirect\" title=\"Vitamin D receptor\"><abbr title=\"Vitamin D receptor\">VDR</abbr></a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">See <a href=\"/wiki/Template:Vitamin_D_receptor_modulators\" title=\"Template:Vitamin D receptor modulators\">here</a> instead.</div></td></tr><tr><td class=\"navbox-abovebelow\" colspan=\"2\"><div>\n<dl><dt>See also</dt>\n<dd><i><a href=\"/wiki/Template:Receptor_modulators\" title=\"Template:Receptor modulators\">Receptor/signaling modulators</a></i></dd>\n<dd><i><a href=\"/wiki/Template:Leukotriene_signaling_modulators\" title=\"Template:Leukotriene signaling modulators\">Leukotriene signaling modulators</a></i></dd>\n<dd><i><a href=\"/wiki/Template:Prostanoid_signaling_modulators\" title=\"Template:Prostanoid signaling modulators\">Prostanoid signaling modulators</a></i></dd></dl>\n</div></td></tr></tbody></table></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"TRP_channel_modulators\" style=\"padding:3px\"><table class=\"nowraplinks collapsible collapsed navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Transient_receptor_potential_channel_modulators\" title=\"Template:Transient receptor potential channel modulators\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Transient_receptor_potential_channel_modulators\" title=\"Template talk:Transient receptor potential channel modulators\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Transient_receptor_potential_channel_modulators&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"TRP_channel_modulators\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Transient_receptor_potential_channel\" title=\"Transient receptor potential channel\"><abbr title=\"Transient receptor potential\">TRP</abbr> channel</a> <a href=\"/wiki/Channel_modulator\" title=\"Channel modulator\">modulators</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/Transient_receptor_potential_ankyrin_channel\" class=\"mw-redirect\" title=\"Transient receptor potential ankyrin channel\"><abbr title=\"Transient receptor potential ankyrin channel\">TRPA</abbr></a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\">Activators</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/4-Hydroxynonenal\" title=\"4-Hydroxynonenal\">4-Hydroxynonenal</a></li>\n<li><a href=\"/wiki/4-Oxo-2-nonenal\" title=\"4-Oxo-2-nonenal\">4-Oxo-2-nonenal</a></li>\n<li><a href=\"/wiki/4,5-EET\" class=\"mw-redirect\" title=\"4,5-EET\">4,5-EET</a></li>\n<li><a href=\"/wiki/12S-HpETE\" class=\"mw-redirect\" title=\"12S-HpETE\">12S-HpETE</a></li>\n<li><a href=\"/wiki/15-Deoxy-%CE%9412,14-prostaglandin_J2\" class=\"mw-redirect\" title=\"15-Deoxy-\u039412,14-prostaglandin J2\">15-Deoxy-\u0394<sup>12,14</sup>-prostaglandin J2</a></li>\n<li><a href=\"/wiki/Sanshool\" class=\"mw-redirect\" title=\"Sanshool\">\u03b1-Sanshool</a> (<a href=\"/wiki/Ginger\" title=\"Ginger\">ginger</a>, <a href=\"/wiki/Sichuan_pepper\" title=\"Sichuan pepper\">Sichuan</a> and <a href=\"/wiki/Melegueta_pepper\" class=\"mw-redirect\" title=\"Melegueta pepper\">melegueta peppers</a>)</li>\n<li><a href=\"/wiki/Acrolein\" title=\"Acrolein\">Acrolein</a></li>\n<li><a href=\"/wiki/Allicin\" title=\"Allicin\">Allicin</a> (<a href=\"/wiki/Garlic\" title=\"Garlic\">garlic</a>)</li>\n<li><a href=\"/wiki/Allyl_isothiocyanate\" title=\"Allyl isothiocyanate\">Allyl isothiocyanate</a> (<a href=\"/wiki/Mustard_plant\" title=\"Mustard plant\">mustard</a>, <a href=\"/wiki/Radish\" title=\"Radish\">radish</a>, <a href=\"/wiki/Horseradish\" title=\"Horseradish\">horseradish</a>, <a href=\"/wiki/Wasabi\" title=\"Wasabi\">wasabi</a>)</li>\n<li><a href=\"/wiki/AM404\" title=\"AM404\">AM404</a></li>\n<li><a href=\"/wiki/Bradykinin\" title=\"Bradykinin\">Bradykinin</a></li>\n<li><a href=\"/wiki/Cannabichromene\" title=\"Cannabichromene\">Cannabichromene</a> (<a href=\"/wiki/Cannabis\" title=\"Cannabis\">cannabis</a>)</li>\n<li><a href=\"/wiki/Cannabidiol\" title=\"Cannabidiol\">Cannabidiol</a> (<a href=\"/wiki/Cannabis\" title=\"Cannabis\">cannabis</a>)</li>\n<li><a href=\"/wiki/Cannabigerol\" title=\"Cannabigerol\">Cannabigerol</a> (<a href=\"/wiki/Cannabis\" title=\"Cannabis\">cannabis</a>)</li>\n<li><a href=\"/wiki/Cinnamaldehyde\" title=\"Cinnamaldehyde\">Cinnamaldehyde</a> (<a href=\"/wiki/Cinnamon\" title=\"Cinnamon\">cinnamon</a>)</li>\n<li><a href=\"/wiki/CR_gas\" title=\"CR gas\">CR gas (dibenzoxazepine; DBO)</a></li>\n<li><a href=\"/wiki/CS_gas\" title=\"CS gas\">CS gas (2-chlorobenzal malononitrile)</a></li>\n<li><a href=\"/wiki/Curcumin\" title=\"Curcumin\">Curcumin</a> (<a href=\"/wiki/Turmeric\" title=\"Turmeric\">turmeric</a>)</li>\n<li><a href=\"/w/index.php?title=Dehydroligustilide&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Dehydroligustilide (page does not exist)\">Dehydroligustilide</a> (<a href=\"/wiki/Celery\" title=\"Celery\">celery</a>)</li>\n<li><a href=\"/wiki/Diallyl_disulfide\" title=\"Diallyl disulfide\">Diallyl disulfide</a></li>\n<li><a href=\"/wiki/Dicentrine\" title=\"Dicentrine\">Dicentrine</a> (<i><a href=\"/wiki/Lindera\" title=\"Lindera\">Lindera</a></i> spp.)</li>\n<li><a href=\"/w/index.php?title=Farnesyl_thiosalicylic_acid&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Farnesyl thiosalicylic acid (page does not exist)\">Farnesyl thiosalicylic acid</a></li>\n<li><a href=\"/wiki/Formalin\" class=\"mw-redirect\" title=\"Formalin\">Formalin</a></li>\n<li><a href=\"/wiki/Gingerol\" title=\"Gingerol\">Gingerols</a> (<a href=\"/wiki/Ginger\" title=\"Ginger\">ginger</a>)</li>\n<li><a href=\"/wiki/Hepoxilin_A3\" class=\"mw-redirect\" title=\"Hepoxilin A3\">Hepoxilin A3</a></li>\n<li><a href=\"/wiki/Hepoxilin_B3\" class=\"mw-redirect\" title=\"Hepoxilin B3\">Hepoxilin B3</a></li>\n<li><a href=\"/wiki/Hydrogen_peroxide\" title=\"Hydrogen peroxide\">Hydrogen peroxide</a></li>\n<li><a href=\"/wiki/Icilin\" title=\"Icilin\">Icilin</a></li>\n<li><a href=\"/wiki/Isothiocyanate\" title=\"Isothiocyanate\">Isothiocyanate</a></li>\n<li><a href=\"/w/index.php?title=Ligustilide&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Ligustilide (page does not exist)\">Ligustilide</a> (<a href=\"/wiki/Celery\" title=\"Celery\">celery</a>, <i><a href=\"/wiki/Angelica_acutiloba\" title=\"Angelica acutiloba\">Angelica acutiloba</a></i>)</li>\n<li><a href=\"/wiki/Linalool\" title=\"Linalool\">Linalool</a> (<a href=\"/wiki/Sichuan_pepper\" title=\"Sichuan pepper\">Sichuan pepper</a>, <a href=\"/wiki/Thyme\" title=\"Thyme\">thyme</a>)</li>\n<li><a href=\"/wiki/Methylglyoxal\" title=\"Methylglyoxal\">Methylglyoxal</a></li>\n<li><a href=\"/wiki/Methyl_salicylate\" title=\"Methyl salicylate\">Methyl salicylate</a> (<a href=\"/wiki/Wintergreen\" title=\"Wintergreen\">wintergreen</a>)</li>\n<li><a href=\"/wiki/N-Methylmaleimide\" title=\"N-Methylmaleimide\">N-Methylmaleimide</a></li>\n<li><a href=\"/wiki/Nicotine\" title=\"Nicotine\">Nicotine</a> (<a href=\"/wiki/Tobacco\" title=\"Tobacco\">tobacco</a>)</li>\n<li><a href=\"/wiki/Oleocanthal\" title=\"Oleocanthal\">Oleocanthal</a> (<a href=\"/wiki/Olive_oil\" title=\"Olive oil\">olive oil</a>)</li>\n<li><a href=\"/wiki/Paclitaxel\" title=\"Paclitaxel\">Paclitaxel</a> (<a href=\"/wiki/Pacific_yew\" class=\"mw-redirect\" title=\"Pacific yew\">Pacific yew</a>)</li>\n<li><a href=\"/wiki/Paracetamol\" title=\"Paracetamol\">Paracetamol (acetaminophen)</a></li>\n<li><a href=\"/wiki/PF-4840154\" title=\"PF-4840154\">PF-4840154</a></li>\n<li><a href=\"/wiki/Phenacyl_chloride\" title=\"Phenacyl chloride\">Phenacyl chloride</a></li>\n<li><a href=\"/wiki/Polygodial\" title=\"Polygodial\">Polygodial</a> (<a href=\"/wiki/Dorrigo_pepper\" class=\"mw-redirect\" title=\"Dorrigo pepper\">Dorrigo pepper</a>)</li>\n<li><a href=\"/wiki/Shogaol\" title=\"Shogaol\">Shogaols</a> (<a href=\"/wiki/Ginger\" title=\"Ginger\">ginger</a>, <a href=\"/wiki/Sichuan_pepper\" title=\"Sichuan pepper\">Sichuan</a> and <a href=\"/wiki/Melegueta_pepper\" class=\"mw-redirect\" title=\"Melegueta pepper\">melegueta peppers</a>)</li>\n<li><a href=\"/wiki/Tear_gas\" title=\"Tear gas\">Tear gases</a></li>\n<li><a href=\"/wiki/Tetrahydrocannabinol\" title=\"Tetrahydrocannabinol\">Tetrahydrocannabinol</a> (<a href=\"/wiki/Cannabis\" title=\"Cannabis\">cannabis</a>)</li>\n<li><a href=\"/wiki/Thiopropanal_S-oxide\" class=\"mw-redirect\" title=\"Thiopropanal S-oxide\">Thiopropanal S-oxide</a> (<a href=\"/wiki/Onion\" title=\"Onion\">onion</a>)</li>\n<li><a href=\"/wiki/Umbellulone\" title=\"Umbellulone\">Umbellulone</a> (<i>Umbellularia californica</i>)</li>\n<li><a href=\"/wiki/WIN_55,212-2\" title=\"WIN 55,212-2\">WIN 55,212-2</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\">Blockers</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/w/index.php?title=Dehydroligustilide&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Dehydroligustilide (page does not exist)\">Dehydroligustilide</a> (<a href=\"/wiki/Celery\" title=\"Celery\">celery</a>)</li>\n<li><a href=\"/wiki/Nicotine\" title=\"Nicotine\">Nicotine</a> (<a href=\"/wiki/Tobacco\" title=\"Tobacco\">tobacco</a>)</li>\n<li><a href=\"/wiki/Ruthenium_red\" title=\"Ruthenium red\">Ruthenium red</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/Transient_receptor_potential_canonical_channel\" class=\"mw-redirect\" title=\"Transient receptor potential canonical channel\"><abbr title=\"Transient receptor potential canonical channel\">TRPC</abbr></a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\">Activators</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Adhyperforin\" title=\"Adhyperforin\">Adhyperforin</a> (<a href=\"/wiki/St_John%27s_wort\" class=\"mw-redirect\" title=\"St John&#39;s wort\">St John's wort</a>)</li>\n<li><a href=\"/wiki/Diacyl_glycerol\" class=\"mw-redirect\" title=\"Diacyl glycerol\">Diacyl glycerol</a></li>\n<li><a href=\"/w/index.php?title=GSK1702934A&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"GSK1702934A (page does not exist)\">GSK1702934A</a></li>\n<li><a href=\"/wiki/Hyperforin\" title=\"Hyperforin\">Hyperforin</a> (<a href=\"/wiki/St_John%27s_wort\" class=\"mw-redirect\" title=\"St John&#39;s wort\">St John's wort</a>)</li>\n<li><a href=\"/wiki/Substance_P\" title=\"Substance P\">Substance P</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\">Blockers</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/w/index.php?title=3%E2%80%B2-5-Dichlorodiphenylamine-2-carboxylic_acid&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"3\u2032-5-Dichlorodiphenylamine-2-carboxylic acid (page does not exist)\">DCDPC</a></li>\n<li><a href=\"/wiki/Dehydroepiandrosterone_sulfate\" title=\"Dehydroepiandrosterone sulfate\">DHEA-S</a></li>\n<li><a href=\"/wiki/Flufenamic_acid\" title=\"Flufenamic acid\">Flufenamic acid</a></li>\n<li><a href=\"/w/index.php?title=GSK417651A&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"GSK417651A (page does not exist)\">GSK417651A</a></li>\n<li><a href=\"/w/index.php?title=GSK2293017A&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"GSK2293017A (page does not exist)\">GSK2293017A</a></li>\n<li><a href=\"/wiki/Meclofenamic_acid\" title=\"Meclofenamic acid\">Meclofenamic acid</a></li>\n<li><a href=\"/wiki/N-(p-amylcinnamoyl)anthranilic_acid\" title=\"N-(p-amylcinnamoyl)anthranilic acid\">N-(p-amylcinnamoyl)anthranilic acid</a></li>\n<li><a href=\"/wiki/Niflumic_acid\" title=\"Niflumic acid\">Niflumic acid</a></li>\n<li><a href=\"/wiki/Pregnenolone_sulfate\" title=\"Pregnenolone sulfate\">Pregnenolone sulfate</a></li>\n<li><a href=\"/wiki/Progesterone\" title=\"Progesterone\">Progesterone</a></li>\n<li><a href=\"/w/index.php?title=Pyr3&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Pyr3 (page does not exist)\">Pyr3</a></li>\n<li><a href=\"/wiki/Tolfenamic_acid\" title=\"Tolfenamic acid\">Tolfenamic acid</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/Transient_receptor_potential_melastatin_channel\" class=\"mw-redirect\" title=\"Transient receptor potential melastatin channel\"><abbr title=\"Transient receptor potential melastatin channel\">TRPM</abbr></a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\">Activators</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Adenosine_diphosphate_ribose\" title=\"Adenosine diphosphate ribose\">ADP-ribose</a></li>\n<li><a href=\"/w/index.php?title=BCTC_(drug)&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"BCTC (drug) (page does not exist)\">BCTC</a></li>\n<li><a href=\"/wiki/Calcium\" title=\"Calcium\">Calcium</a> (intracellular)</li>\n<li><a href=\"/wiki/Cold\" title=\"Cold\">Cold</a></li>\n<li><a href=\"/w/index.php?title=Coolact_P&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Coolact P (page does not exist)\">Coolact P</a></li>\n<li><a href=\"/w/index.php?title=Cooling_Agent_10&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Cooling Agent 10 (page does not exist)\">Cooling Agent 10</a></li>\n<li><a href=\"/w/index.php?title=CPS-369&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"CPS-369 (page does not exist)\">CPS-369</a></li>\n<li><a href=\"/wiki/Eucalyptol\" title=\"Eucalyptol\">Eucalyptol</a> (<a href=\"/wiki/Eucalyptus\" title=\"Eucalyptus\">eucalyptus</a>)</li>\n<li><a href=\"/w/index.php?title=Frescolat_MGA&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Frescolat MGA (page does not exist)\">Frescolat MGA</a></li>\n<li><a href=\"/w/index.php?title=Frescolat_ML&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Frescolat ML (page does not exist)\">Frescolat ML</a></li>\n<li><a href=\"/wiki/Geraniol\" title=\"Geraniol\">Geraniol</a></li>\n<li><a href=\"/wiki/Hydroxycitronellal\" title=\"Hydroxycitronellal\">Hydroxycitronellal</a></li>\n<li><a href=\"/wiki/Icilin\" title=\"Icilin\">Icilin</a></li>\n<li><a href=\"/wiki/Linalool\" title=\"Linalool\">Linalool</a></li>\n<li><a href=\"/wiki/Menthol\" title=\"Menthol\">Menthol</a> (<a href=\"/wiki/Mentha\" title=\"Mentha\">mint</a>)</li>\n<li><a href=\"/w/index.php?title=PMD_38&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"PMD 38 (page does not exist)\">PMD 38</a></li>\n<li><a href=\"/wiki/Pregnenolone_sulfate\" title=\"Pregnenolone sulfate\">Pregnenolone sulfate</a></li>\n<li><a href=\"/w/index.php?title=Rutamarin&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Rutamarin (page does not exist)\">Rutamarin</a> (<i><a href=\"/wiki/Ruta_graveolens\" title=\"Ruta graveolens\">Ruta graveolens</a></i>)</li>\n<li><a href=\"/wiki/Steviol_glycoside\" title=\"Steviol glycoside\">Steviol glycosides</a> (e.g., <a href=\"/wiki/Stevioside\" title=\"Stevioside\">stevioside</a>) (<i><a href=\"/wiki/Stevia_rebaudiana\" title=\"Stevia rebaudiana\">Stevia rebaudiana</a></i>)</li>\n<li>Sweet <a href=\"/wiki/Taste\" title=\"Taste\">tastants</a> (e.g., <a href=\"/wiki/Glucose\" title=\"Glucose\">glucose</a>, <a href=\"/wiki/Fructose\" title=\"Fructose\">fructose</a>, <a href=\"/wiki/Sucrose\" title=\"Sucrose\">sucrose</a>; indirectly)</li>\n<li><a href=\"/w/index.php?title=Thio-BCTC&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Thio-BCTC (page does not exist)\">Thio-BCTC</a></li>\n<li><a href=\"/wiki/WS-3\" class=\"mw-redirect\" title=\"WS-3\">WS-3</a></li>\n<li><a href=\"/w/index.php?title=WS-12&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"WS-12 (page does not exist)\">WS-12</a></li>\n<li><a href=\"/w/index.php?title=WS-23&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"WS-23 (page does not exist)\">WS-23</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\">Blockers</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Capsazepine\" title=\"Capsazepine\">Capsazepine</a></li>\n<li><a href=\"/wiki/Clotrimazole\" title=\"Clotrimazole\">Clotrimazole</a></li>\n<li><a href=\"/w/index.php?title=3%E2%80%B2-5-Dichlorodiphenylamine-2-carboxylic_acid&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"3\u2032-5-Dichlorodiphenylamine-2-carboxylic acid (page does not exist)\">DCDPC</a></li>\n<li><a href=\"/w/index.php?title=Elismetrep&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Elismetrep (page does not exist)\">Elismetrep</a></li>\n<li><a href=\"/wiki/Flufenamic_acid\" title=\"Flufenamic acid\">Flufenamic acid</a></li>\n<li><a href=\"/wiki/Meclofenamic_acid\" title=\"Meclofenamic acid\">Meclofenamic acid</a></li>\n<li><a href=\"/wiki/Mefenamic_acid\" title=\"Mefenamic acid\">Mefenamic acid</a></li>\n<li><a href=\"/wiki/N-(p-amylcinnamoyl)anthranilic_acid\" title=\"N-(p-amylcinnamoyl)anthranilic acid\">N-(p-amylcinnamoyl)anthranilic acid</a></li>\n<li><a href=\"/wiki/Nicotine\" title=\"Nicotine\">Nicotine</a> (<a href=\"/wiki/Tobacco\" title=\"Tobacco\">tobacco</a>)</li>\n<li><a href=\"/wiki/Niflumic_acid\" title=\"Niflumic acid\">Niflumic acid</a></li>\n<li><a href=\"/wiki/Ruthenium_red\" title=\"Ruthenium red\">Ruthenium red</a></li>\n<li><a href=\"/w/index.php?title=Rutamarin&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Rutamarin (page does not exist)\">Rutamarin</a> (<i><a href=\"/wiki/Ruta_graveolens\" title=\"Ruta graveolens\">Ruta graveolens</a></i>)</li>\n<li><a href=\"/wiki/Tolfenamic_acid\" title=\"Tolfenamic acid\">Tolfenamic acid</a></li>\n<li><a href=\"/wiki/Triphenylphosphine_oxide\" title=\"Triphenylphosphine oxide\">TPPO</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/Transient_receptor_potential_mucolipin_channel\" class=\"mw-redirect\" title=\"Transient receptor potential mucolipin channel\"><abbr title=\"Transient receptor potential mucolipin channel\">TRPML</abbr></a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\">Activators</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/w/index.php?title=MK6-83&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"MK6-83 (page does not exist)\">MK6-83</a></li>\n<li><a href=\"/wiki/Phosphatidylinositol_3,5-bisphosphate\" title=\"Phosphatidylinositol 3,5-bisphosphate\">PI(3,5)P<sub>2</sub></a></li>\n<li><a href=\"/w/index.php?title=SF-22&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"SF-22 (page does not exist)\">SF-22</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/Transient_receptor_potential_polycystin_channel\" class=\"mw-redirect\" title=\"Transient receptor potential polycystin channel\"><abbr title=\"Transient receptor potential polycystin channel\">TRPP</abbr></a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\">Activators</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Triptolide\" title=\"Triptolide\">Triptolide</a> (<i><a href=\"/wiki/Tripterygium_wilfordii\" title=\"Tripterygium wilfordii\">Tripterygium wilfordii</a></i>)</li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\">Blockers</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Ruthenium_red\" title=\"Ruthenium red\">Ruthenium red</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\"><a href=\"/wiki/Transient_receptor_potential_vanilloid_channel\" class=\"mw-redirect\" title=\"Transient receptor potential vanilloid channel\"><abbr title=\"Transient receptor potential vanilloid channel\">TRPV</abbr></a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\">Activators</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/2-Aminoethoxydiphenyl_borate\" title=\"2-Aminoethoxydiphenyl borate\">2-APB</a></li>\n<li><a href=\"/wiki/5%27,6%27-Epoxyeicosatrienoic_acid\" class=\"mw-redirect\" title=\"5&#39;,6&#39;-Epoxyeicosatrienoic acid\">5',6'-EET</a></li>\n<li><a href=\"/wiki/9-Hydroxyoctadecadienoic_acid\" title=\"9-Hydroxyoctadecadienoic acid\">9-HODE</a></li>\n<li><a href=\"/wiki/9-oxoODE\" class=\"mw-redirect\" title=\"9-oxoODE\">9-oxoODE</a></li>\n<li><a href=\"/wiki/12S-HETE\" class=\"mw-redirect\" title=\"12S-HETE\">12S-HETE</a></li>\n<li><a href=\"/wiki/12S-HpETE\" class=\"mw-redirect\" title=\"12S-HpETE\">12S-HpETE</a></li>\n<li><a href=\"/wiki/13-Hydroxyoctadecadienoic_acid\" title=\"13-Hydroxyoctadecadienoic acid\">13-HODE</a></li>\n<li><a href=\"/wiki/13-oxoODE\" class=\"mw-redirect\" title=\"13-oxoODE\">13-oxoODE</a></li>\n<li><a href=\"/wiki/20-Hydroxyeicosatetraenoic_acid\" title=\"20-Hydroxyeicosatetraenoic acid\">20-HETE</a></li>\n<li><a href=\"/wiki/Sanshool\" class=\"mw-redirect\" title=\"Sanshool\">\u03b1-Sanshool</a> (<a href=\"/wiki/Ginger\" title=\"Ginger\">ginger</a>, <a href=\"/wiki/Sichuan_pepper\" title=\"Sichuan pepper\">Sichuan</a> and <a href=\"/wiki/Melegueta_pepper\" class=\"mw-redirect\" title=\"Melegueta pepper\">melegueta peppers</a>)</li>\n<li><a href=\"/wiki/Allicin\" title=\"Allicin\">Allicin</a> (<a href=\"/wiki/Garlic\" title=\"Garlic\">garlic</a>)</li>\n<li><a href=\"/wiki/AM404\" title=\"AM404\">AM404</a></li>\n<li><a href=\"/wiki/Anandamide\" title=\"Anandamide\">Anandamide</a></li>\n<li><a href=\"/w/index.php?title=Bisandrographolide&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Bisandrographolide (page does not exist)\">Bisandrographolide</a> (<i><a href=\"/wiki/Andrographis_paniculata\" title=\"Andrographis paniculata\">Andrographis paniculata</a></i>)</li>\n<li><a href=\"/wiki/Camphor\" title=\"Camphor\">Camphor</a> (<a href=\"/wiki/Camphor_laurel\" class=\"mw-redirect\" title=\"Camphor laurel\">camphor laurel</a>, <a href=\"/wiki/Rosemary\" title=\"Rosemary\">rosemary</a>, <a href=\"/wiki/Camphorweed\" title=\"Camphorweed\">camphorweed</a>, <a href=\"/wiki/African_blue_basil\" title=\"African blue basil\">African blue basil</a>, <a href=\"/wiki/Ocimum_kilimandscharicum\" title=\"Ocimum kilimandscharicum\">camphor basil</a>)</li>\n<li><a href=\"/wiki/Cannabidiol\" title=\"Cannabidiol\">Cannabidiol</a> (<a href=\"/wiki/Cannabis\" title=\"Cannabis\">cannabis</a>)</li>\n<li><a href=\"/wiki/Cannabidivarin\" title=\"Cannabidivarin\">Cannabidivarin</a> (<a href=\"/wiki/Cannabis\" title=\"Cannabis\">cannabis</a>)</li>\n<li><a href=\"/wiki/Capsaicin\" title=\"Capsaicin\">Capsaicin</a> (<a href=\"/wiki/Chili_pepper\" title=\"Chili pepper\">chili pepper</a>)</li>\n<li><a href=\"/wiki/Carvacrol\" title=\"Carvacrol\">Carvacrol</a> (<a href=\"/wiki/Oregano\" title=\"Oregano\">oregano</a>, <a href=\"/wiki/Thyme\" title=\"Thyme\">thyme</a>, <a href=\"/wiki/Lepidium\" title=\"Lepidium\">pepperwort</a>, <a href=\"/wiki/Wild_bergamot\" class=\"mw-redirect\" title=\"Wild bergamot\">wild bergamot</a>, others)</li>\n<li><a href=\"/wiki/Dehydroepiandrosterone\" title=\"Dehydroepiandrosterone\">DHEA</a></li>\n<li><a href=\"/wiki/Diacyl_glycerol\" class=\"mw-redirect\" title=\"Diacyl glycerol\">Diacyl glycerol</a></li>\n<li><a href=\"/wiki/Dihydrocapsaicin\" title=\"Dihydrocapsaicin\">Dihydrocapsaicin</a> (<a href=\"/wiki/Chili_pepper\" title=\"Chili pepper\">chili pepper</a>)</li>\n<li><a href=\"/wiki/Estradiol\" title=\"Estradiol\">Estradiol</a></li>\n<li><a href=\"/wiki/Eugenol\" title=\"Eugenol\">Eugenol</a> (<a href=\"/wiki/Basil\" title=\"Basil\">basil</a>, <a href=\"/wiki/Clove\" title=\"Clove\">clove</a>)</li>\n<li><a href=\"/wiki/Evodiamine\" title=\"Evodiamine\">Evodiamine</a> (<i><a href=\"/wiki/Euodia_ruticarpa\" class=\"mw-redirect\" title=\"Euodia ruticarpa\">Euodia ruticarpa</a></i>)</li>\n<li><a href=\"/wiki/Gingerol\" title=\"Gingerol\">Gingerols</a> (<a href=\"/wiki/Ginger\" title=\"Ginger\">ginger</a>)</li>\n<li><a href=\"/w/index.php?title=GSK1016790A&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"GSK1016790A (page does not exist)\">GSK1016790A</a></li>\n<li><a href=\"/wiki/Heat\" title=\"Heat\">Heat</a></li>\n<li><a href=\"/wiki/Hepoxilin_A3\" class=\"mw-redirect\" title=\"Hepoxilin A3\">Hepoxilin A3</a></li>\n<li><a href=\"/wiki/Hepoxilin_B3\" class=\"mw-redirect\" title=\"Hepoxilin B3\">Hepoxilin B3</a></li>\n<li><a href=\"/wiki/Homocapsaicin\" title=\"Homocapsaicin\">Homocapsaicin</a> (<a href=\"/wiki/Chili_pepper\" title=\"Chili pepper\">chili pepper</a>)</li>\n<li><a href=\"/wiki/Homodihydrocapsaicin\" title=\"Homodihydrocapsaicin\">Homodihydrocapsaicin</a> (<a href=\"/wiki/Chili_pepper\" title=\"Chili pepper\">chili pepper</a>)</li>\n<li><a href=\"/wiki/Incensole\" title=\"Incensole\">Incensole</a> (<a href=\"/wiki/Incense\" title=\"Incense\">incense</a>)</li>\n<li><a href=\"/wiki/Lysophosphatidic_acid\" title=\"Lysophosphatidic acid\">Lysophosphatidic acid</a></li>\n<li>Low <a href=\"/wiki/PH\" title=\"PH\">pH</a> (acidic conditions)</li>\n<li><a href=\"/wiki/Menthol\" title=\"Menthol\">Menthol</a> (<a href=\"/wiki/Mentha\" title=\"Mentha\">mint</a>)</li>\n<li><a href=\"/wiki/N-Arachidonoyl_dopamine\" title=\"N-Arachidonoyl dopamine\">N-Arachidonoyl dopamine</a></li>\n<li><a href=\"/w/index.php?title=N-Oleoyldopamine&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"N-Oleoyldopamine (page does not exist)\">N-Oleoyldopamine</a></li>\n<li><a href=\"/wiki/N-Oleoylethanolamide\" class=\"mw-redirect\" title=\"N-Oleoylethanolamide\">N-Oleoylethanolamide</a></li>\n<li><a href=\"/wiki/Nonivamide\" title=\"Nonivamide\">Nonivamide (PAVA)</a> (<a href=\"/wiki/PAVA_spray\" title=\"PAVA spray\">PAVA spray</a>)</li>\n<li><a href=\"/wiki/Nordihydrocapsaicin\" title=\"Nordihydrocapsaicin\">Nordihydrocapsaicin</a> (<a href=\"/wiki/Chili_pepper\" title=\"Chili pepper\">chili pepper</a>)</li>\n<li><a href=\"/wiki/Paclitaxel\" title=\"Paclitaxel\">Paclitaxel</a> (<a href=\"/wiki/Pacific_yew\" class=\"mw-redirect\" title=\"Pacific yew\">Pacific yew</a>)</li>\n<li><a href=\"/wiki/Paracetamol\" title=\"Paracetamol\">Paracetamol (acetaminophen)</a></li>\n<li><a href=\"/wiki/Phorbol_esters\" title=\"Phorbol esters\">Phorbol esters</a> (e.g., <a href=\"/w/index.php?title=4%CE%B1-phorbol_12,13-didecanoate&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"4\u03b1-phorbol 12,13-didecanoate (page does not exist)\">4\u03b1-PDD</a>)</li>\n<li><a href=\"/wiki/Piperine\" title=\"Piperine\">Piperine</a> (<a href=\"/wiki/Black_pepper\" title=\"Black pepper\">black pepper</a>, <a href=\"/wiki/Long_pepper\" title=\"Long pepper\">long pepper</a>)</li>\n<li><a href=\"/wiki/Polygodial\" title=\"Polygodial\">Polygodial</a> (<a href=\"/wiki/Dorrigo_pepper\" class=\"mw-redirect\" title=\"Dorrigo pepper\">Dorrigo pepper</a>)</li>\n<li><a href=\"/wiki/Probenecid\" title=\"Probenecid\">Probenecid</a></li>\n<li><a href=\"/wiki/Proton\" title=\"Proton\">Protons</a></li>\n<li><a href=\"/wiki/RhTx\" title=\"RhTx\">RhTx</a></li>\n<li><a href=\"/w/index.php?title=Rutamarin&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Rutamarin (page does not exist)\">Rutamarin</a> (<i><a href=\"/wiki/Ruta_graveolens\" title=\"Ruta graveolens\">Ruta graveolens</a></i>)</li>\n<li><a href=\"/wiki/Resiniferatoxin\" title=\"Resiniferatoxin\">Resiniferatoxin</a> (RTX) (<i><a href=\"/wiki/Euphorbia_resinifera\" title=\"Euphorbia resinifera\">Euphorbia resinifera</a>/<a href=\"/wiki/Euphorbia_poissonii\" title=\"Euphorbia poissonii\">pooissonii</a></i>)</li>\n<li><a href=\"/wiki/Shogaol\" title=\"Shogaol\">Shogaols</a> (<a href=\"/wiki/Ginger\" title=\"Ginger\">ginger</a>, <a href=\"/wiki/Sichuan_pepper\" title=\"Sichuan pepper\">Sichuan</a> and <a href=\"/wiki/Melegueta_pepper\" class=\"mw-redirect\" title=\"Melegueta pepper\">melegueta peppers</a>)</li>\n<li><a href=\"/wiki/Tetrahydrocannabivarin\" title=\"Tetrahydrocannabivarin\">Tetrahydrocannabivarin</a> (<a href=\"/wiki/Cannabis\" title=\"Cannabis\">cannabis</a>)</li>\n<li><a href=\"/wiki/Thymol\" title=\"Thymol\">Thymol</a> (<a href=\"/wiki/Thyme\" title=\"Thyme\">thyme</a>, <a href=\"/wiki/Oregano\" title=\"Oregano\">oregano</a>)</li>\n<li><a href=\"/wiki/Tinyatoxin\" title=\"Tinyatoxin\">Tinyatoxin</a> (<i><a href=\"/wiki/Euphorbia_resinifera\" title=\"Euphorbia resinifera\">Euphorbia resinifera</a>/<a href=\"/wiki/Euphorbia_poissonii\" title=\"Euphorbia poissonii\">pooissonii</a></i>)</li>\n<li><a href=\"/wiki/Tramadol\" title=\"Tramadol\">Tramadol</a></li>\n<li><a href=\"/wiki/Vanillin\" title=\"Vanillin\">Vanillin</a> (<a href=\"/wiki/Vanilla\" title=\"Vanilla\">vanilla</a>)</li>\n<li><a href=\"/wiki/Zucapsaicin\" title=\"Zucapsaicin\">Zucapsaicin</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align:center;\">Blockers</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Spinasterol\" title=\"Spinasterol\">\u03b1-Spinasterol</a> (<i><a href=\"/wiki/Vernonia\" title=\"Vernonia\">Vernonia tweediana</a></i>)</li>\n<li><a href=\"/w/index.php?title=AMG-517&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"AMG-517 (page does not exist)\">AMG-517</a></li>\n<li><a href=\"/w/index.php?title=Asivatrep&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Asivatrep (page does not exist)\">Asivatrep</a></li>\n<li><a href=\"/w/index.php?title=BCTC_(drug)&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"BCTC (drug) (page does not exist)\">BCTC</a></li>\n<li><a href=\"/wiki/Cannabigerol\" title=\"Cannabigerol\">Cannabigerol</a> (<a href=\"/wiki/Cannabis\" title=\"Cannabis\">cannabis</a>)</li>\n<li><a href=\"/w/index.php?title=Cannabigerolic_acid&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Cannabigerolic acid (page does not exist)\">Cannabigerolic acid</a> (<a href=\"/wiki/Cannabis\" title=\"Cannabis\">cannabis</a>)</li>\n<li><a href=\"/w/index.php?title=Cannabigerovarin&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Cannabigerovarin (page does not exist)\">Cannabigerovarin</a> (<a href=\"/wiki/Cannabis\" title=\"Cannabis\">cannabis</a>)</li>\n<li><a href=\"/wiki/Cannabinol\" title=\"Cannabinol\">Cannabinol</a> (<a href=\"/wiki/Cannabis\" title=\"Cannabis\">cannabis</a>)</li>\n<li><a href=\"/wiki/Capsazepine\" title=\"Capsazepine\">Capsazepine</a></li>\n<li><a href=\"/w/index.php?title=3%E2%80%B2-5-Dichlorodiphenylamine-2-carboxylic_acid&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"3\u2032-5-Dichlorodiphenylamine-2-carboxylic acid (page does not exist)\">DCDPC</a></li>\n<li><a href=\"/wiki/Dehydroepiandrosterone\" title=\"Dehydroepiandrosterone\">DHEA</a></li>\n<li><a href=\"/wiki/Dehydroepiandrosterone_sulfate\" title=\"Dehydroepiandrosterone sulfate\">DHEA-S</a></li>\n<li><a href=\"/wiki/Flufenamic_acid\" title=\"Flufenamic acid\">Flufenamic acid</a></li>\n<li><a href=\"/w/index.php?title=GRC-6211&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"GRC-6211 (page does not exist)\">GRC-6211</a></li>\n<li><a href=\"/w/index.php?title=HC-067047&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"HC-067047 (page does not exist)\">HC-067047</a></li>\n<li><a href=\"/wiki/Lanthanum\" title=\"Lanthanum\">Lanthanum</a></li>\n<li><a href=\"/wiki/Meclofenamic_acid\" title=\"Meclofenamic acid\">Meclofenamic acid</a></li>\n<li><a href=\"/wiki/N-(p-amylcinnamoyl)anthranilic_acid\" title=\"N-(p-amylcinnamoyl)anthranilic acid\">N-(p-amylcinnamoyl)anthranilic acid</a></li>\n<li><a href=\"/w/index.php?title=NGD-8243&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"NGD-8243 (page does not exist)\">NGD-8243</a></li>\n<li><a href=\"/wiki/Niflumic_acid\" title=\"Niflumic acid\">Niflumic acid</a></li>\n<li><a href=\"/wiki/Pregnenolone_sulfate\" title=\"Pregnenolone sulfate\">Pregnenolone sulfate</a></li>\n<li><a href=\"/w/index.php?title=RN-1734&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"RN-1734 (page does not exist)\">RN-1734</a></li>\n<li><a href=\"/w/index.php?title=RN-9893&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"RN-9893 (page does not exist)\">RN-9893</a></li>\n<li><a href=\"/wiki/Ruthenium_red\" title=\"Ruthenium red\">Ruthenium red</a></li>\n<li><a href=\"/w/index.php?title=SB-705498&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"SB-705498 (page does not exist)\">SB-705498</a></li>\n<li><a href=\"/w/index.php?title=Tivanisiran&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Tivanisiran (page does not exist)\">Tivanisiran</a></li>\n<li><a href=\"/wiki/Tolfenamic_acid\" title=\"Tolfenamic acid\">Tolfenamic acid</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><td class=\"navbox-abovebelow\" colspan=\"2\"><div><i><b>See also:</b> <a href=\"/wiki/Template:Receptor_modulators\" title=\"Template:Receptor modulators\">Receptor/signaling modulators</a> \u2022 <a href=\"/wiki/Template:Ion_channel_modulators\" title=\"Template:Ion channel modulators\">Ion channel modulators</a></i></div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw2239\nCached time: 20180921234907\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.684 seconds\nReal time usage: 0.730 seconds\nPreprocessor visited node count: 4059/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 226021/2097152 bytes\nTemplate argument size: 2754/2097152 bytes\nHighest expansion depth: 11/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 100990/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.291/10.000 seconds\nLua memory usage: 3.19 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  445.893      1 -total\n 83.43%  372.016      1 Template:Reflist\n 53.04%  236.505     45 Template:Cite_journal\n 20.41%   91.004     10 Template:Navbox\n 10.71%   47.748      1 Template:Nuclear_receptor_modulators\n 10.12%   45.139      2 Template:Cite_book\n  7.06%   31.484     24 Template:Abbrlink\n  6.57%   29.303     25 Template:Abbr\n  5.82%   25.953      1 Template:Transient_receptor_potential_channel_modulators\n  1.51%    6.743      2 Template:Cite_web\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:4367754-0!canonical and timestamp 20180921234906 and revision id 845144300\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","*":"Metabolic_pathways"},{"sortkey":"","*":"Cytochrome_P450"},{"sortkey":"","*":"Eicosanoids"},{"sortkey":"","*":"Epoxides"},{"sortkey":"","*":"Cell_biology"},{"sortkey":"","*":"Immunology"},{"sortkey":"","*":"Inflammations"},{"sortkey":"","*":"Blood_pressure"},{"sortkey":"","*":"Human_physiology"},{"sortkey":"","*":"Animal_physiology"}],"links":[{"ns":0,"exists":"","*":"12S-HETE"},{"ns":0,"exists":"","*":"12S-HpETE"},{"ns":0,"exists":"","*":"13-Hydroxyoctadecadienoic acid"},{"ns":0,"exists":"","*":"13-oxoODE"},{"ns":0,"exists":"","*":"15-Deoxy-\u039412,14-prostaglandin J2"},{"ns":0,"exists":"","*":"2,3,7,8-Tetrachlorodibenzodioxin"},{"ns":0,"exists":"","*":"2-Aminoethoxydiphenyl borate"},{"ns":0,"exists":"","*":"20-Hydroxyeicosatetraenoic acid"},{"ns":0,"exists":"","*":"22R-Hydroxycholesterol"},{"ns":0,"exists":"","*":"27-Hydroxycholesterol"},{"ns":0,"exists":"","*":"3-methylcholanthrene"},{"ns":0,"exists":"","*":"4,5-EET"},{"ns":0,"exists":"","*":"4-Hydroxynonenal"},{"ns":0,"exists":"","*":"4-Oxo-2-nonenal"},{"ns":0,"exists":"","*":"5',6'-Epoxyeicosatrienoic acid"},{"ns":0,"exists":"","*":"9-Hydroxyoctadecadienoic acid"},{"ns":0,"exists":"","*":"9-oxoODE"},{"ns":0,"exists":"","*":"A549 (cell line)"},{"ns":0,"exists":"","*":"A549 cell"},{"ns":0,"exists":"","*":"AM404"},{"ns":0,"exists":"","*":"Acetylcholine"},{"ns":0,"exists":"","*":"Acrolein"},{"ns":0,"exists":"","*":"Acylation"},{"ns":0,"exists":"","*":"Adenocarcinoma"},{"ns":0,"exists":"","*":"Adenosine diphosphate ribose"},{"ns":0,"exists":"","*":"Adhyperforin"},{"ns":0,"exists":"","*":"Afimoxifene"},{"ns":0,"exists":"","*":"African blue basil"},{"ns":0,"exists":"","*":"Allicin"},{"ns":0,"exists":"","*":"Allotropes of oxygen"},{"ns":0,"exists":"","*":"Allyl isothiocyanate"},{"ns":0,"exists":"","*":"Anandamide"},{"ns":0,"exists":"","*":"Androgen receptor"},{"ns":0,"exists":"","*":"Andrographis paniculata"},{"ns":0,"exists":"","*":"Angelica acutiloba"},{"ns":0,"exists":"","*":"Angiogenesis"},{"ns":0,"exists":"","*":"Angiotensin II"},{"ns":0,"exists":"","*":"Anti-inflammatory"},{"ns":0,"exists":"","*":"Apoptosis"},{"ns":0,"exists":"","*":"Arachidonic acid"},{"ns":0,"exists":"","*":"Archaea"},{"ns":0,"exists":"","*":"Aromatic hydrocarbon"},{"ns":0,"exists":"","*":"Aryl hydrocarbon receptor"},{"ns":0,"exists":"","*":"Atheroma"},{"ns":0,"exists":"","*":"Atherosclerosis"},{"ns":0,"exists":"","*":"Autocrine signalling"},{"ns":0,"exists":"","*":"Axon"},{"ns":0,"exists":"","*":"Basil"},{"ns":0,"exists":"","*":"Benzanthracene"},{"ns":0,"exists":"","*":"Benzo(a)pyrene"},{"ns":0,"exists":"","*":"Benzoflavone"},{"ns":0,"exists":"","*":"Beta-naphthoflavone"},{"ns":0,"exists":"","*":"Beta oxidation"},{"ns":0,"exists":"","*":"Bile acid"},{"ns":0,"exists":"","*":"Bilirubin"},{"ns":0,"exists":"","*":"Biochanin A"},{"ns":0,"exists":"","*":"Biphenyl"},{"ns":0,"exists":"","*":"Bisphenol A"},{"ns":0,"exists":"","*":"Black pepper"},{"ns":0,"exists":"","*":"Blood clot"},{"ns":0,"exists":"","*":"Bradykinin"},{"ns":0,"exists":"","*":"Bradykinin receptor B2"},{"ns":0,"exists":"","*":"Brain stroke"},{"ns":0,"exists":"","*":"Breast cancer"},{"ns":0,"exists":"","*":"CR gas"},{"ns":0,"exists":"","*":"CS gas"},{"ns":0,"exists":"","*":"CYP2C18"},{"ns":0,"exists":"","*":"CYP2C19"},{"ns":0,"exists":"","*":"CYP2C8"},{"ns":0,"exists":"","*":"CYP2C9"},{"ns":0,"exists":"","*":"CYP2J2"},{"ns":0,"exists":"","*":"CYP2S1"},{"ns":0,"exists":"","*":"CYP3A4"},{"ns":0,"exists":"","*":"CYP4A11"},{"ns":0,"exists":"","*":"CYP4F12"},{"ns":0,"exists":"","*":"CYP4F2"},{"ns":0,"exists":"","*":"CYP4F3"},{"ns":0,"exists":"","*":"CYP4F8"},{"ns":0,"exists":"","*":"Cafestol"},{"ns":0,"exists":"","*":"Calcium"},{"ns":0,"exists":"","*":"Camphor"},{"ns":0,"exists":"","*":"Camphor laurel"},{"ns":0,"exists":"","*":"Camphorweed"},{"ns":0,"exists":"","*":"Cannabichromene"},{"ns":0,"exists":"","*":"Cannabidiol"},{"ns":0,"exists":"","*":"Cannabidivarin"},{"ns":0,"exists":"","*":"Cannabigerol"},{"ns":0,"exists":"","*":"Cannabinol"},{"ns":0,"exists":"","*":"Cannabis"},{"ns":0,"exists":"","*":"Capsaicin"},{"ns":0,"exists":"","*":"Capsazepine"},{"ns":0,"exists":"","*":"Carbon monoxide"},{"ns":0,"exists":"","*":"Cardiovascular diseases"},{"ns":0,"exists":"","*":"Carotenoid"},{"ns":0,"exists":"","*":"Carvacrol"},{"ns":0,"exists":"","*":"Celery"},{"ns":0,"exists":"","*":"Cell adhesion molecule"},{"ns":0,"exists":"","*":"Cell surface receptor"},{"ns":0,"exists":"","*":"Cerebrospinal fluid"},{"ns":0,"exists":"","*":"Channel modulator"},{"ns":0,"exists":"","*":"Chemical derivative"},{"ns":0,"exists":"","*":"Chemical nomenclature"},{"ns":0,"exists":"","*":"Chemotaxis"},{"ns":0,"exists":"","*":"Chenodeoxycholic acid"},{"ns":0,"exists":"","*":"Chili pepper"},{"ns":0,"exists":"","*":"Cholesterol"},{"ns":0,"exists":"","*":"Cinnamaldehyde"},{"ns":0,"exists":"","*":"Cinnamon"},{"ns":0,"exists":"","*":"Cirrhosis"},{"ns":0,"exists":"","*":"Cis\u2013trans isomerism"},{"ns":0,"exists":"","*":"ClinicalTrials.gov"},{"ns":0,"exists":"","*":"Clotrimazole"},{"ns":0,"exists":"","*":"Clove"},{"ns":0,"exists":"","*":"Cold"},{"ns":0,"exists":"","*":"Colon adenocarcinoma"},{"ns":0,"exists":"","*":"Constitutive androstane receptor"},{"ns":0,"exists":"","*":"Coronaric acid"},{"ns":0,"exists":"","*":"Coronary arteries"},{"ns":0,"exists":"","*":"Coronary artery disease"},{"ns":0,"exists":"","*":"Corpus cavernosum penis"},{"ns":0,"exists":"","*":"Curcumin"},{"ns":0,"exists":"","*":"Cyclooxygenase"},{"ns":0,"exists":"","*":"Cyclooxygenase-2"},{"ns":0,"exists":"","*":"Cytochrome P450"},{"ns":0,"exists":"","*":"Daidzein"},{"ns":0,"exists":"","*":"Dehydroepiandrosterone"},{"ns":0,"exists":"","*":"Dehydroepiandrosterone sulfate"},{"ns":0,"exists":"","*":"Diabetes"},{"ns":0,"exists":"","*":"Diacyl glycerol"},{"ns":0,"exists":"","*":"Diallyl disulfide"},{"ns":0,"exists":"","*":"Dibenzofuran"},{"ns":0,"exists":"","*":"Dicentrine"},{"ns":0,"exists":"","*":"Diethylstilbestrol"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Dihydrocapsaicin"},{"ns":0,"exists":"","*":"Diol"},{"ns":0,"exists":"","*":"Dorrigo pepper"},{"ns":0,"exists":"","*":"Double bond"},{"ns":0,"exists":"","*":"E-selectin"},{"ns":0,"exists":"","*":"Efavirenz"},{"ns":0,"exists":"","*":"Eicosatetraenoic acid"},{"ns":0,"exists":"","*":"Enantiomer"},{"ns":0,"exists":"","*":"Enantiomers"},{"ns":0,"exists":"","*":"Endothelial cells"},{"ns":0,"exists":"","*":"Endothelin"},{"ns":0,"exists":"","*":"Endothelium-Derived Hyperpolarizing Factor"},{"ns":0,"exists":"","*":"Endothelium-derived hyperpolarizing factor"},{"ns":0,"exists":"","*":"Epileptic seizure"},{"ns":0,"exists":"","*":"Epithelial sodium channel"},{"ns":0,"exists":"","*":"Epoxide"},{"ns":0,"exists":"","*":"Epoxide hydrolase"},{"ns":0,"exists":"","*":"Epoxydocosapentaenoic acid"},{"ns":0,"exists":"","*":"Epoxygenase"},{"ns":0,"exists":"","*":"Erythroleukemia"},{"ns":0,"exists":"","*":"Esophageal cancer"},{"ns":0,"exists":"","*":"Estradiol"},{"ns":0,"exists":"","*":"Estrogen-related receptor"},{"ns":0,"exists":"","*":"Estrogen-related receptor alpha"},{"ns":0,"exists":"","*":"Estrogen-related receptor beta"},{"ns":0,"exists":"","*":"Estrogen-related receptor gamma"},{"ns":0,"exists":"","*":"Estrogen receptor"},{"ns":0,"exists":"","*":"Eucalyptol"},{"ns":0,"exists":"","*":"Eucalyptus"},{"ns":0,"exists":"","*":"Eugenol"},{"ns":0,"exists":"","*":"Euodia ruticarpa"},{"ns":0,"exists":"","*":"Euphorbia poissonii"},{"ns":0,"exists":"","*":"Euphorbia resinifera"},{"ns":0,"exists":"","*":"Evodiamine"},{"ns":0,"exists":"","*":"Farnesoid X receptor"},{"ns":0,"exists":"","*":"Fatty acid synthesis"},{"ns":0,"exists":"","*":"Fatty liver"},{"ns":0,"exists":"","*":"Fexaramine"},{"ns":0,"exists":"","*":"Fibrinolysis"},{"ns":0,"exists":"","*":"Flufenamic acid"},{"ns":0,"exists":"","*":"Flutamide"},{"ns":0,"exists":"","*":"Formalin"},{"ns":0,"exists":"","*":"Fructose"},{"ns":0,"exists":"","*":"G protein\u2013coupled receptor"},{"ns":0,"exists":"","*":"Gap junctions"},{"ns":0,"exists":"","*":"Garlic"},{"ns":0,"exists":"","*":"Gene knockout"},{"ns":0,"exists":"","*":"Genistein"},{"ns":0,"exists":"","*":"Geraniol"},{"ns":0,"exists":"","*":"Ginger"},{"ns":0,"exists":"","*":"Gingerol"},{"ns":0,"exists":"","*":"Glioblastoma"},{"ns":0,"exists":"","*":"Glucagon"},{"ns":0,"exists":"","*":"Glucocorticoid receptor"},{"ns":0,"exists":"","*":"Glucose"},{"ns":0,"exists":"","*":"Gs protein"},{"ns":0,"exists":"","*":"Guggulsterone"},{"ns":0,"exists":"","*":"HL-60"},{"ns":0,"exists":"","*":"Halogen"},{"ns":0,"exists":"","*":"HeLa"},{"ns":0,"exists":"","*":"Heart attack"},{"ns":0,"exists":"","*":"Heat"},{"ns":0,"exists":"","*":"HepG2"},{"ns":0,"exists":"","*":"Hepatic portal system"},{"ns":0,"exists":"","*":"Hepatoma"},{"ns":0,"exists":"","*":"Hepoxilin A3"},{"ns":0,"exists":"","*":"Hepoxilin B3"},{"ns":0,"exists":"","*":"Homocapsaicin"},{"ns":0,"exists":"","*":"Homodihydrocapsaicin"},{"ns":0,"exists":"","*":"Hormone"},{"ns":0,"exists":"","*":"Horseradish"},{"ns":0,"exists":"","*":"Hydrogen peroxide"},{"ns":0,"exists":"","*":"Hydroxycitronellal"},{"ns":0,"exists":"","*":"Hyperforin"},{"ns":0,"exists":"","*":"Hypertension"},{"ns":0,"exists":"","*":"Hypertrophy"},{"ns":0,"exists":"","*":"ICAM-1"},{"ns":0,"exists":"","*":"Icilin"},{"ns":0,"exists":"","*":"Incense"},{"ns":0,"exists":"","*":"Incensole"},{"ns":0,"exists":"","*":"Indigo dye"},{"ns":0,"exists":"","*":"Indirubin"},{"ns":0,"exists":"","*":"Infarct"},{"ns":0,"exists":"","*":"Inflammation"},{"ns":0,"exists":"","*":"Insulin"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"Ischemic stroke"},{"ns":0,"exists":"","*":"Isoforms"},{"ns":0,"exists":"","*":"Isothiocyanate"},{"ns":0,"exists":"","*":"K562"},{"ns":0,"exists":"","*":"Ki67"},{"ns":0,"exists":"","*":"Lanthanum"},{"ns":0,"exists":"","*":"Large-conductance calcium-activated potassium channels"},{"ns":0,"exists":"","*":"Lepidium"},{"ns":0,"exists":"","*":"Leukocytes"},{"ns":0,"exists":"","*":"Leukotriene"},{"ns":0,"exists":"","*":"Linalool"},{"ns":0,"exists":"","*":"Lindera"},{"ns":0,"exists":"","*":"Lipoxin A4"},{"ns":0,"exists":"","*":"Liver X receptor"},{"ns":0,"exists":"","*":"Liver cancer"},{"ns":0,"exists":"","*":"Liver fibrosis"},{"ns":0,"exists":"","*":"Liver sinusoid"},{"ns":0,"exists":"","*":"Long pepper"},{"ns":0,"exists":"","*":"Low-density lipoprotein"},{"ns":0,"exists":"","*":"Lung cancer"},{"ns":0,"exists":"","*":"Lysophosphatidic acid"},{"ns":0,"exists":"","*":"MCF7"},{"ns":0,"exists":"","*":"MDA-MB-231"},{"ns":0,"exists":"","*":"MDA-MB-435"},{"ns":0,"exists":"","*":"Macrophages"},{"ns":0,"exists":"","*":"Meclofenamic acid"},{"ns":0,"exists":"","*":"Mefenamic acid"},{"ns":0,"exists":"","*":"Melegueta pepper"},{"ns":0,"exists":"","*":"Mentha"},{"ns":0,"exists":"","*":"Menthol"},{"ns":0,"exists":"","*":"Metabolite"},{"ns":0,"exists":"","*":"Metastasize"},{"ns":0,"exists":"","*":"Methacholine"},{"ns":0,"exists":"","*":"Methyl salicylate"},{"ns":0,"exists":"","*":"Methylglyoxal"},{"ns":0,"exists":"","*":"Microsomal epoxide hydrolase"},{"ns":0,"exists":"","*":"Miliary tuberculosis"},{"ns":0,"exists":"","*":"Millimeter of mercury"},{"ns":0,"exists":"","*":"Mineralocorticoid receptor"},{"ns":0,"exists":"","*":"Monocyte"},{"ns":0,"exists":"","*":"Monocytes"},{"ns":0,"exists":"","*":"Muscarinic acetylcholine receptor M1"},{"ns":0,"exists":"","*":"Muscarinic acetylcholine receptor M3"},{"ns":0,"exists":"","*":"Mustard plant"},{"ns":0,"exists":"","*":"Myelopoiesis"},{"ns":0,"exists":"","*":"Myocardial infarction"},{"ns":0,"exists":"","*":"N-(p-amylcinnamoyl)anthranilic acid"},{"ns":0,"exists":"","*":"N-Arachidonoyl dopamine"},{"ns":0,"exists":"","*":"N-Methylmaleimide"},{"ns":0,"exists":"","*":"N-Oleoylethanolamide"},{"ns":0,"exists":"","*":"National Institutes of Health"},{"ns":0,"exists":"","*":"Neuroactive steroid"},{"ns":0,"exists":"","*":"Neuropathic pain"},{"ns":0,"exists":"","*":"Nicotine"},{"ns":0,"exists":"","*":"Niflumic acid"},{"ns":0,"exists":"","*":"Nitric oxide"},{"ns":0,"exists":"","*":"Nociception"},{"ns":0,"exists":"","*":"Non-alcoholic fatty liver disease"},{"ns":0,"exists":"","*":"Nonclassic eicosanoid"},{"ns":0,"exists":"","*":"Nonivamide"},{"ns":0,"exists":"","*":"Nordihydrocapsaicin"},{"ns":0,"exists":"","*":"Nuclear receptor"},{"ns":0,"exists":"","*":"Obeticholic acid"},{"ns":0,"exists":"","*":"Ocimum kilimandscharicum"},{"ns":0,"exists":"","*":"Oleocanthal"},{"ns":0,"exists":"","*":"Olive oil"},{"ns":0,"exists":"","*":"Omega-6 fatty acid"},{"ns":0,"exists":"","*":"Omega oxidation"},{"ns":0,"exists":"","*":"Onion"},{"ns":0,"exists":"","*":"Oregano"},{"ns":0,"exists":"","*":"PAVA spray"},{"ns":0,"exists":"","*":"PF-4840154"},{"ns":0,"exists":"","*":"PH"},{"ns":0,"exists":"","*":"PPAR\u03b1"},{"ns":0,"exists":"","*":"Pacific yew"},{"ns":0,"exists":"","*":"Paclitaxel"},{"ns":0,"exists":"","*":"Paracetamol"},{"ns":0,"exists":"","*":"Paracrine signalling"},{"ns":0,"exists":"","*":"Peripheral neuropathy"},{"ns":0,"exists":"","*":"Peroxisome proliferator-activated receptor"},{"ns":0,"exists":"","*":"Phenacyl chloride"},{"ns":0,"exists":"","*":"Phorbol esters"},{"ns":0,"exists":"","*":"Phosphatidylinositol 3,5-bisphosphate"},{"ns":0,"exists":"","*":"Phospholipase A2"},{"ns":0,"exists":"","*":"Phospholipid"},{"ns":0,"exists":"","*":"Piperine"},{"ns":0,"exists":"","*":"Platelet"},{"ns":0,"exists":"","*":"Platelet aggregation"},{"ns":0,"exists":"","*":"Polychlorinated dibenzodioxin"},{"ns":0,"exists":"","*":"Polycyclic aromatic hydrocarbon"},{"ns":0,"exists":"","*":"Polycystic kidney disease"},{"ns":0,"exists":"","*":"Polygodial"},{"ns":0,"exists":"","*":"Portal hypertension"},{"ns":0,"exists":"","*":"Portal vein thrombosis"},{"ns":0,"exists":"","*":"Pre-clinical development"},{"ns":0,"exists":"","*":"Pregnancy-induced hypertension"},{"ns":0,"exists":"","*":"Pregnane X receptor"},{"ns":0,"exists":"","*":"Pregnenolone sulfate"},{"ns":0,"exists":"","*":"Probenecid"},{"ns":0,"exists":"","*":"Progesterone"},{"ns":0,"exists":"","*":"Progesterone receptor"},{"ns":0,"exists":"","*":"Promyelocyte"},{"ns":0,"exists":"","*":"Prostacyclin"},{"ns":0,"exists":"","*":"Prostaglandin E2"},{"ns":0,"exists":"","*":"Prostaglandin G2"},{"ns":0,"exists":"","*":"Proton"},{"ns":0,"exists":"","*":"Pseudogenes"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Radish"},{"ns":0,"exists":"","*":"Receptor modulator"},{"ns":0,"exists":"","*":"Renovascular hypertension"},{"ns":0,"exists":"","*":"Reperfusion injury"},{"ns":0,"exists":"","*":"Resiniferatoxin"},{"ns":0,"exists":"","*":"Retinoid receptor"},{"ns":0,"exists":"","*":"RhTx"},{"ns":0,"exists":"","*":"Rosemary"},{"ns":0,"exists":"","*":"Ruta graveolens"},{"ns":0,"exists":"","*":"Ruthenium red"},{"ns":0,"exists":"","*":"Sanshool"},{"ns":0,"exists":"","*":"Sarcoidosis"},{"ns":0,"exists":"","*":"Schistosomiasis"},{"ns":0,"exists":"","*":"Severe combined immunodeficiency (non-human)"},{"ns":0,"exists":"","*":"Shogaol"},{"ns":0,"exists":"","*":"Sichuan pepper"},{"ns":0,"exists":"","*":"Single nucleotide polymorphism"},{"ns":0,"exists":"","*":"Small cell lung carcinoma"},{"ns":0,"exists":"","*":"Small interfering RNA"},{"ns":0,"exists":"","*":"Sodium-hydrogen antiporter"},{"ns":0,"exists":"","*":"Sodium\u2013hydrogen antiporter"},{"ns":0,"exists":"","*":"Soluble epoxide hydrolase"},{"ns":0,"exists":"","*":"Somatostatin"},{"ns":0,"exists":"","*":"Spinasterol"},{"ns":0,"exists":"","*":"Squamous-cell carcinoma"},{"ns":0,"exists":"","*":"St John's wort"},{"ns":0,"exists":"","*":"Steroid hormone receptor"},{"ns":0,"exists":"","*":"Stevia rebaudiana"},{"ns":0,"exists":"","*":"Steviol glycoside"},{"ns":0,"exists":"","*":"Stevioside"},{"ns":0,"exists":"","*":"Stomach cancer"},{"ns":0,"exists":"","*":"Stroke"},{"ns":0,"exists":"","*":"Structural isomer"},{"ns":0,"exists":"","*":"Subarachnoid hemorrhage"},{"ns":0,"exists":"","*":"Substance P"},{"ns":0,"exists":"","*":"Sucrose"},{"ns":0,"exists":"","*":"Systemic circulation"},{"ns":0,"exists":"","*":"T47D"},{"ns":0,"exists":"","*":"Taste"},{"ns":0,"exists":"","*":"Tear gas"},{"ns":0,"exists":"","*":"Terfenadine"},{"ns":0,"exists":"","*":"Tetrahydrocannabinol"},{"ns":0,"exists":"","*":"Tetrahydrocannabivarin"},{"ns":0,"exists":"","*":"Tetrapyrole"},{"ns":0,"exists":"","*":"Thiopropanal S-oxide"},{"ns":0,"exists":"","*":"Thromboxane A2"},{"ns":0,"exists":"","*":"Thrombus"},{"ns":0,"exists":"","*":"Thyme"},{"ns":0,"exists":"","*":"Thymol"},{"ns":0,"exists":"","*":"Thyroid hormone receptor"},{"ns":0,"exists":"","*":"Tinyatoxin"},{"ns":0,"exists":"","*":"Tobacco"},{"ns":0,"exists":"","*":"Tolfenamic acid"},{"ns":0,"exists":"","*":"Tramadol"},{"ns":0,"exists":"","*":"Transient receptor potential ankyrin channel"},{"ns":0,"exists":"","*":"Transient receptor potential canonical channel"},{"ns":0,"exists":"","*":"Transient receptor potential channel"},{"ns":0,"exists":"","*":"Transient receptor potential channels"},{"ns":0,"exists":"","*":"Transient receptor potential melastatin channel"},{"ns":0,"exists":"","*":"Transient receptor potential mucolipin channel"},{"ns":0,"exists":"","*":"Transient receptor potential polycystin channel"},{"ns":0,"exists":"","*":"Transient receptor potential vanilloid channel"},{"ns":0,"exists":"","*":"Triphenylphosphine oxide"},{"ns":0,"exists":"","*":"Tripterygium wilfordii"},{"ns":0,"exists":"","*":"Triptolide"},{"ns":0,"exists":"","*":"Tryptophan"},{"ns":0,"exists":"","*":"Tumor adhesion"},{"ns":0,"exists":"","*":"Turmeric"},{"ns":0,"exists":"","*":"Type II diabetes"},{"ns":0,"exists":"","*":"Type I diabetes"},{"ns":0,"exists":"","*":"U251"},{"ns":0,"exists":"","*":"Umbellulone"},{"ns":0,"exists":"","*":"VCAM-1"},{"ns":0,"exists":"","*":"Vanilla"},{"ns":0,"exists":"","*":"Vanillin"},{"ns":0,"exists":"","*":"Vasoconstriction"},{"ns":0,"exists":"","*":"Vasodilation"},{"ns":0,"exists":"","*":"Vasodilator"},{"ns":0,"exists":"","*":"Vernonia"},{"ns":0,"exists":"","*":"Vicinal (chemistry)"},{"ns":0,"exists":"","*":"Vitamin D receptor"},{"ns":0,"exists":"","*":"WIN 55,212-2"},{"ns":0,"exists":"","*":"WS-3"},{"ns":0,"exists":"","*":"Wasabi"},{"ns":0,"exists":"","*":"Wild bergamot"},{"ns":0,"exists":"","*":"Wintergreen"},{"ns":0,"exists":"","*":"XCT790"},{"ns":0,"exists":"","*":"Xenobiotics"},{"ns":0,"exists":"","*":"Zebrafish"},{"ns":0,"exists":"","*":"Zucapsaicin"},{"ns":0,"*":"NCL-H446"},{"ns":0,"*":"LS-174"},{"ns":0,"*":"SiHa"},{"ns":0,"*":"ScaBER"},{"ns":0,"*":"Tapinarof"},{"ns":0,"*":"7-Ketocholesterol"},{"ns":0,"*":"6,3\u2032,4\u2032-Trihydroxyflavone"},{"ns":0,"*":"DY-131"},{"ns":0,"*":"GSK-4716"},{"ns":0,"*":"Cilofexor"},{"ns":0,"*":"GW-4064"},{"ns":0,"*":"Nidufexor"},{"ns":0,"*":"Tropifexor"},{"ns":0,"*":"24S-Hydroxycholesterol"},{"ns":0,"*":"Cholestenoic acid"},{"ns":0,"*":"N,N-Dimethyl-3\u03b2-hydroxycholenamide"},{"ns":0,"*":"GW-3965"},{"ns":0,"*":"Hypocholamide"},{"ns":0,"*":"T-0901317"},{"ns":0,"*":"Dehydroligustilide"},{"ns":0,"*":"Farnesyl thiosalicylic acid"},{"ns":0,"*":"Ligustilide"},{"ns":0,"*":"GSK1702934A"},{"ns":0,"*":"3\u2032-5-Dichlorodiphenylamine-2-carboxylic acid"},{"ns":0,"*":"GSK417651A"},{"ns":0,"*":"GSK2293017A"},{"ns":0,"*":"Pyr3"},{"ns":0,"*":"BCTC (drug)"},{"ns":0,"*":"Coolact P"},{"ns":0,"*":"Cooling Agent 10"},{"ns":0,"*":"CPS-369"},{"ns":0,"*":"Frescolat MGA"},{"ns":0,"*":"Frescolat ML"},{"ns":0,"*":"PMD 38"},{"ns":0,"*":"Rutamarin"},{"ns":0,"*":"Thio-BCTC"},{"ns":0,"*":"WS-12"},{"ns":0,"*":"WS-23"},{"ns":0,"*":"Elismetrep"},{"ns":0,"*":"MK6-83"},{"ns":0,"*":"SF-22"},{"ns":0,"*":"Bisandrographolide"},{"ns":0,"*":"GSK1016790A"},{"ns":0,"*":"N-Oleoyldopamine"},{"ns":0,"*":"4\u03b1-phorbol 12,13-didecanoate"},{"ns":0,"*":"AMG-517"},{"ns":0,"*":"Asivatrep"},{"ns":0,"*":"Cannabigerolic acid"},{"ns":0,"*":"Cannabigerovarin"},{"ns":0,"*":"GRC-6211"},{"ns":0,"*":"HC-067047"},{"ns":0,"*":"NGD-8243"},{"ns":0,"*":"RN-1734"},{"ns":0,"*":"RN-9893"},{"ns":0,"*":"SB-705498"},{"ns":0,"*":"Tivanisiran"},{"ns":10,"exists":"","*":"Template:Nuclear receptor modulators"},{"ns":10,"exists":"","*":"Template:Transient receptor potential channel modulators"},{"ns":10,"exists":"","*":"Template:Androgen receptor modulators"},{"ns":10,"exists":"","*":"Template:Estrogen receptor modulators"},{"ns":10,"exists":"","*":"Template:Glucocorticoid receptor modulators"},{"ns":10,"exists":"","*":"Template:Ion channel modulators"},{"ns":10,"exists":"","*":"Template:Leukotriene signaling modulators"},{"ns":10,"exists":"","*":"Template:Mineralocorticoid receptor modulators"},{"ns":10,"exists":"","*":"Template:PPAR modulators"},{"ns":10,"exists":"","*":"Template:Progesterone receptor modulators"},{"ns":10,"exists":"","*":"Template:Prostanoid signaling modulators"},{"ns":10,"exists":"","*":"Template:Receptor modulators"},{"ns":10,"exists":"","*":"Template:Retinoid receptor modulators"},{"ns":10,"exists":"","*":"Template:Thyroid hormone receptor modulators"},{"ns":10,"exists":"","*":"Template:Vitamin D receptor modulators"},{"ns":10,"exists":"","*":"Template:Xenobiotic-sensing receptor modulators"},{"ns":11,"exists":"","*":"Template talk:Nuclear receptor modulators"},{"ns":11,"exists":"","*":"Template talk:Transient receptor potential channel modulators"}],"templates":[{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:ClinicalTrialsGov"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Nuclear receptor modulators"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":10,"exists":"","*":"Template:Abbrlink"},{"ns":10,"exists":"","*":"Template:Abbr"},{"ns":10,"exists":"","*":"Template:Transient receptor potential channel modulators"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Navbox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:String"}],"images":["Lock-green.svg","Epoxyeicosatrienoic_acid.png"],"externallinks":["//doi.org/10.1016/S0163-7827(03)00049-3","//www.ncbi.nlm.nih.gov/pubmed/14636671","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4226225","//doi.org/10.3389/fphar.2014.00239","//www.ncbi.nlm.nih.gov/pubmed/25426071","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4314516","//doi.org/10.1016/j.bbalip.2014.07.020","//www.ncbi.nlm.nih.gov/pubmed/25093613","//doi.org/10.1016/j.pharmthera.2014.05.011","//www.ncbi.nlm.nih.gov/pubmed/24882266","//doi.org/10.1124/pr.113.007781","//www.ncbi.nlm.nih.gov/pubmed/25244930","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3804913","//doi.org/10.1007/s10555-011-9315-y","//www.ncbi.nlm.nih.gov/pubmed/22009066","//doi.org/10.1291/hypres.26.237","//www.ncbi.nlm.nih.gov/pubmed/12675279","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4500322","//doi.org/10.1111/bcp.12603","//www.ncbi.nlm.nih.gov/pubmed/25655310","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3733540","//doi.org/10.1016/j.gene.2013.05.008","//www.ncbi.nlm.nih.gov/pubmed/23701967","//doi.org/10.1089/ars.2014.6150","//www.ncbi.nlm.nih.gov/pubmed/25330284","//doi.org/10.1097/FJC.0b013e318273b007","//www.ncbi.nlm.nih.gov/pubmed/23011468","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4254344","//doi.org/10.1016/j.prostaglandins.2014.09.001","//www.ncbi.nlm.nih.gov/pubmed/25240260","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3578707","//doi.org/10.1146/annurev-pharmtox-011112-140244","//www.ncbi.nlm.nih.gov/pubmed/23020295","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3405717","//doi.org/10.1155/2012/605101","//www.ncbi.nlm.nih.gov/pubmed/22848834","http://ajpheart.physiology.org/cgi/pmidlookup?view=long&pmid=16473964","//doi.org/10.1152/ajpheart.00071.2006","//www.ncbi.nlm.nih.gov/pubmed/16473964","http://www.fasebj.org/cgi/pmidlookup?view=long&pmid=16415108","//doi.org/10.1096/fj.05-4341fje","//www.ncbi.nlm.nih.gov/pubmed/16415108","//doi.org/10.1124/dmd.106.013839","//www.ncbi.nlm.nih.gov/pubmed/17431031","//doi.org/10.1016/j.prostaglandins.2015.05.008","//www.ncbi.nlm.nih.gov/pubmed/26072731","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4260681","//doi.org/10.1097/MNH.0000000000000088","//www.ncbi.nlm.nih.gov/pubmed/25427230","https://www.pharmgkb.org/variant/rs1799853?previousQuery=rs1799853","https://www.pharmgkb.org/variant/rs1057910?previousQuery=rs1057910","//doi.org/10.1016/j.prostaglandins.2011.11.007","//www.ncbi.nlm.nih.gov/pubmed/22173545","//doi.org/10.1016/j.bbapap.2010.09.009","//www.ncbi.nlm.nih.gov/pubmed/20869469","//doi.org/10.1111/bcp.12855","//www.ncbi.nlm.nih.gov/pubmed/26620151","https://www.clinicaltrials.gov/show/NCT00847899","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4115045","//doi.org/10.1016/j.yjmcc.2014.05.016","//www.ncbi.nlm.nih.gov/pubmed/24893205","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4779674","//doi.org/10.1016/j.prostaglandins.2015.12.007","//www.ncbi.nlm.nih.gov/pubmed/26747234","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4480190","//doi.org/10.1161/STROKEAHA.114.008560","//www.ncbi.nlm.nih.gov/pubmed/25991416","//doi.org/10.1016/j.bbi.2014.07.016","//www.ncbi.nlm.nih.gov/pubmed/25135858","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4547526","//doi.org/10.1016/j.prostaglandins.2011.12.008","//www.ncbi.nlm.nih.gov/pubmed/22245571","//doi.org/10.1016/s1098-8823(03)00077-7","//www.ncbi.nlm.nih.gov/pubmed/14626496","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4540347","//doi.org/10.1016/j.prostaglandins.2011.08.002","//www.ncbi.nlm.nih.gov/pubmed/21856435","//doi.org/10.1158/0008-5472.CAN-04-4173","//www.ncbi.nlm.nih.gov/pubmed/15930289","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2683771","//doi.org/10.1124/jpet.109.152017","//www.ncbi.nlm.nih.gov/pubmed/19289568","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3033713","//doi.org/10.1124/jpet.110.174805","//www.ncbi.nlm.nih.gov/pubmed/21030485","//doi.org/10.1016/j.addr.2011.03.006","//www.ncbi.nlm.nih.gov/pubmed/21477627","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3093829","//doi.org/10.1074/jbc.M110.198515","//www.ncbi.nlm.nih.gov/pubmed/21402692","//doi.org/10.1016/bs.apha.2015.04.005","//www.ncbi.nlm.nih.gov/pubmed/26233908","//doi.org/10.1111/1753-0407.12358","//www.ncbi.nlm.nih.gov/pubmed/26621325","//doi.org/10.2174/187152812800392823","//www.ncbi.nlm.nih.gov/pubmed/22280237","https://www.pharmgkb.org/variant/rs11572082"],"sections":[{"toclevel":1,"level":"2","line":"Structure","number":"1","index":"1","fromtitle":"Epoxyeicosatrienoic_acid","byteoffset":3338,"anchor":"Structure"},{"toclevel":1,"level":"2","line":"Production","number":"2","index":"2","fromtitle":"Epoxyeicosatrienoic_acid","byteoffset":4929,"anchor":"Production"},{"toclevel":1,"level":"2","line":"Metabolism of EETs","number":"3","index":"3","fromtitle":"Epoxyeicosatrienoic_acid","byteoffset":9941,"anchor":"Metabolism_of_EETs"},{"toclevel":1,"level":"2","line":"Biological effects","number":"4","index":"4","fromtitle":"Epoxyeicosatrienoic_acid","byteoffset":14420,"anchor":"Biological_effects"},{"toclevel":1,"level":"2","line":"Clinical significance","number":"5","index":"5","fromtitle":"Epoxyeicosatrienoic_acid","byteoffset":19034,"anchor":"Clinical_significance"},{"toclevel":2,"level":"3","line":"Regulation of blood pressure","number":"5.1","index":"6","fromtitle":"Epoxyeicosatrienoic_acid","byteoffset":19061,"anchor":"Regulation_of_blood_pressure"},{"toclevel":2,"level":"3","line":"Heart disease","number":"5.2","index":"7","fromtitle":"Epoxyeicosatrienoic_acid","byteoffset":28748,"anchor":"Heart_disease"},{"toclevel":2,"level":"3","line":"Strokes and seizures","number":"5.3","index":"8","fromtitle":"Epoxyeicosatrienoic_acid","byteoffset":30759,"anchor":"Strokes_and_seizures"},{"toclevel":2,"level":"3","line":"Portal hypertension","number":"5.4","index":"9","fromtitle":"Epoxyeicosatrienoic_acid","byteoffset":33315,"anchor":"Portal_hypertension"},{"toclevel":2,"level":"3","line":"Cancer","number":"5.5","index":"10","fromtitle":"Epoxyeicosatrienoic_acid","byteoffset":36236,"anchor":"Cancer"},{"toclevel":2,"level":"3","line":"Inflammation","number":"5.6","index":"11","fromtitle":"Epoxyeicosatrienoic_acid","byteoffset":44598,"anchor":"Inflammation"},{"toclevel":2,"level":"3","line":"Diabetes, non-alcoholic fatty liver disease, and kidney disease","number":"5.7","index":"12","fromtitle":"Epoxyeicosatrienoic_acid","byteoffset":46085,"anchor":"Diabetes,_non-alcoholic_fatty_liver_disease,_and_kidney_disease"},{"toclevel":2,"level":"3","line":"Pain","number":"5.8","index":"13","fromtitle":"Epoxyeicosatrienoic_acid","byteoffset":47690,"anchor":"Pain"},{"toclevel":1,"level":"2","line":"References","number":"6","index":"14","fromtitle":"Epoxyeicosatrienoic_acid","byteoffset":48677,"anchor":"References"}],"parsewarnings":[],"displaytitle":"Epoxyeicosatrienoic acid","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q5383831"}]}}